A clinical replication series to investigate if EMDR has the potential to treat clients with long term depression, its acceptability to them and possible mechanisms of change. by Wood, Emily
1 
 
School of Health and Related Research 
University of Sheffield 
 
 
A clinical replication series to investigate if EMDR has the potential to treat clients with long 
term depression, its acceptability to them and possible mechanisms of change.  
 
A thesis submitted to the University of Sheffield 
For the degree of Doctor of Philosophy 
 
 
Emily Wood 
January 2016 
 
 
Supervisors: 
Prof Glenys Parry  
Dr Tom Ricketts 
Dr Kim Dent-Brown 
  
2 
 
  
3 
 
Acknowledgements 
 
I would like to thank my supervisors, Professor Glenys Parry, Dr Tom Ricketts and Dr Kim Dent-
Brown for all the help and support they have given me. 
 
I would also like to thank Professor Chris Brewin and Dr David Blore for the assistance they gave 
me in understanding some of the theoretical concepts involved in models of memory and 
psychological theories of psychotherapy, in particular EMDR. 
 
Thank you to the EMDR therapists and participants who made this research possible and to 
Stephen Clark from Vilistus who helped me to work the psychophysiological response equipment. 
 
Thanks to Dave Saxon and Mike Campbell for their invaluable support with statistics and Alicia 
O’Cathain for advice about integrating results in a mixed methods study. 
 
The financial support that I have received from The National Institute of Health Research – 
Collaboration for Leadership in Applied Health Research and Care for South Yorkshire (NIHR-
CLAHRC-SY), The University of Sheffield and The RCN Foundation has been invaluable and I thank 
all of these organisations. I also thank Sheffield Health and Social Care NHS FT who allowed me to 
conduct research within the Trust. 
 
Most of all my thanks go to my family, friends and especially to my partner, Phil Nicholls, who have 
supported me emotionally, financially and at times, physically, and who got me through my PhD. I 
could not have done it without you. 
  
4 
 
Abstract 
Depression is one of the world’s leading causes of disability. Current methods used to treat it, both 
medication and psychotherapy, are effective for some but not all; new approaches need to be 
developed to complement the ones already available. This need is particularly acute for chronic 
and recurrent depression. 
A single case experimental design with replications was implemented for a preparatory 
investigation into the potential of Eye Movement Desensitisation and Reprocessing (EMDR) to 
treat long term depression. Ten people with recurrent and/or chronic depression were recruited 
from primary care mental health services and received Standard Protocol EMDR for a maximum of 
20 sessions. Levels of depression and social functioning were measured before and after 
treatment and at follow up, clients also rated their mood each day. Before and after treatment the 
participants recorded their target memories whilst recording psychophysiological parameters and 
after treatment they were interviewed about their experience of EMDR. 
Eight people engaged with the treatment, seven of these had clinically significant and statistically 
reliable improvement on the Hamilton Rating Scale for Depression and this improvement was 
linked to the progress of treatment. Heart rate variability was significantly reduced indicating a 
less withdrawn parasympathetic nervous system. Interviews elicited a highly favourable opinion of 
EMDR from the participants including all participants saying they would recommend it to others. 
EMDR has shown potential to be an effective treatment for depression. This phase I study has 
provided a platform for a phase II pilot trial and phase III randomised controlled trials to gauge 
efficacy and effect size in a larger sample. This study’s results are consistent with the working 
memory taxation theory of mechanism of change in EMDR.  
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Introduction 
Levels of depression are reaching pandemic proportions. The World Health Organisation predicts 
depression will be the second leading cause of disability by 2020 (Üstün et al., 2004). At any one 
time approximately 10% of people have depression (Singleton et al., 2003) and 20% will be 
diagnosed in their lifetime (Kessler et al., 2005). As well as the personal and social costs, 
depression is estimated to have an economic cost of $36bn a year in the United States of America 
alone (Monroe and Harkness, 2011). 
For a diagnosis of Major Depressive Disorder (MDD) the Diagnostic and Statistical Manual (DSM 
version IV – text revision) produced by the American Psychiatric association (APA) requires that 
the client reports at least five of the following symptoms during the same two week period and 
that at least one symptom is (1) depressed mood or (2) loss of interest:  
(1) Depressed mood 
(2) Markedly diminished interest or pleasure  
(3) Significant weight loss (not dieting) or weight gain or marked change in appetite  
(4) Insomnia or hypersomnia nearly everyday 
(5) Psychomotor retardation or agitation nearly everyday 
(6) Fatigue nearly everyday 
(7) Feelings of worthlessness or excessive or inappropriate guilt 
(8) Diminished ability to think/ concentrate nearly everyday 
(9) Recurrent thoughts of death, suicidal thoughts (with or without plan), suicide attempt 
 Long term depression refers to either chronic depression (when the episode of depression has 
lasted at least two years without remission) or recurrent depression (when the client has had two 
or more episodes of depression in their lifetime) (APA, 2003). Although only around 10% of cases 
last longer than one year (Keller et al., 1997) approximately 60% of clients will go on to have a 
second episode (Solomon et al., 2000).  
The DSM fifth edition included the diagnosis of Persistent Depressive Disorder (PDD) (APA, 2013), 
where low mood is experienced on most days for at least two years along with at least two of the 
other symptoms listed above. Chapter one will give more detail on these different definitions. 
Current recommended treatments for depression include antidepressant medication, Cognitive 
Behavioural Therapy (CBT), Counselling, and Interpersonal Therapy (NCCMH, 2010) however, 
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despite the efficacy of these interventions (Olfson et al., 2006, Butler et al., 2006) they do have 
limitations.  
A review of pharmaceutical trials (including unpublished data) suggested an overall efficacy of 
antidepressants of only 32% (Turner et al., 2008). In chronic depression typical response rates to 
both medication and psychotherapy may be less than 50% (Torpey and Klein, 2008). This is 
compounded by the findings that in practice as few as 21% of clients seeking treatment for 
depression are actually receiving adequate treatment (i.e. minimal concordance with the 
published guideline) (Kessler et al., 2003). Cuijpers and colleagues also found that psychotherapy 
(CBT, interpersonal therapy, and cognitive behavioural analysis system of psychotherapy) may be 
less effective for chronic depression than for acute phase depression (Cuijpers et al., 2010).  
Although current treatments are very helpful for some people, they are not for everyone. There 
are several hundred documented psychotherapies (Roth and Fonagy, 2005) but one which has 
generated interest recently is Eye Movement Desensitisation and Reprocessing (EMDR) (Shapiro, 
1995). Despite much enthusiasm, reviews of early research on EMDR found that much of it did not 
meet rigorous research standards (Foa and Meadows, 1997, Lohr et al., 1998). More recently 
improvements in the research quality and a growing body of evidence led the Cochrane 
Collaboration review of treatments for post-traumatic stress disorder (PTSD) to recommend only 
EMDR and trauma focussed CBT (Bisson and Andrew, 2007). Most of the research into EMDR has 
been done on PTSD, it was after all developed to treat trauma, but recently interest has spread to 
using EMDR with other diagnoses. The theoretical model behind EMDR, the Adaptive Information 
Processing model (AIP), is clear that problematic memories are the cause of pathology and this is 
not limited to PTSD. Equally, several randomised controlled trials into EMDR for PTSD also noticed 
significant improvements in comorbid depression (van der Kolk et al., 2007, Arabia et al., 2011, Lee 
et al., 2002, Ironson et al., 2002). Despite this the research into using EMDR with clients with a 
primary diagnosis of depression amounts to only a few case studies and clinical reports (Wood and 
Ricketts, 2013).  
Major Depressive Disorder and Post Traumatic Stress Disorder are independent but related 
conditions (Blanchard et al., 1998). These disorders have three diagnostic symptoms in common 
(sleep disturbance, lack of concentration and anhedonia) (APA, 2003) and share other 
characteristics such as guilt and overgeneral memories (Reynolds and Brewin, 1999) and they are 
associated with high levels of comorbidity (Nixon et al., 2004, Campbell et al., 2007). Crucially both 
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conditions are also characterised by intrusive memories of negative life events (Holmes and 
Mathews, 2010), and it has been suggested that distress in both conditions is due to the inability 
to correctly process the memories formed during these events (Brewin et al., 2010, Shapiro, 1995).  
 
Depression is often associated with negative life events (Lenze et al., 2008) and people with 
chronic depression tend to report greater levels of early life adversity (Riso and Newman, 2003). 
Childhood trauma is a direct and strong risk factor for developing depression later in life (Heim et 
al., 2008). Given the accumulating evidence of common characteristics between depression and 
PTSD in terms of aetiology, symptoms, memory processing, and intrusive negative memories, 
there is a case for exploring the possibility of improving therapeutic outcomes in depression, by 
adapting methods known to be effective in PTSD. EMDR was designed to treat problematic 
memories stemming from traumatic incidents. Therefore this research intended to investigate if 
EMDR has the potential to be a treatment for long term depression. By using 20 sessions, and by 
working with people who have already not responded to a NICE recommended course of therapy, 
I aimed to investigate if EMDR has the potential to be another ‘step’ in the stepped care model 
utilised by UK primary care mental health services.  The rationale for using EMDR as a therapeutic 
method in depression is developed in depth in Chapters 1 and 2. 
The intent of this two-phase sequential mixed methods study was to investigate the claims that 
EMDR can improve peoples’ mental health symptoms and does so by altering their 
autobiographical memories. In the first quantitative phase, a single case experimental design 
investigated the efficacy of EMDR to treat long term depression. Thirteen participants were 
recruited from the primary care Improving Access to Psychological Therapies service and treated 
at Sheffield Health and Social Care NHS Foundation Trust’s Focussed Depression Team in 
Psychological Services. Information from this first phase was explored further in the qualitative 
second phase. Here all of the participants from phase one were interviewed to explore aspects of 
therapy experience. The reason for following up with qualitative research in the second phase is to 
improve the understanding of the use of EMDR to treat depression far better than either method 
could do alone. This is because by mixing methods this study offers a more comprehensive 
account of what has occurred by including process questions and client views to whether or not it 
was effective, the different approaches will also offset the weaknesses and draw on the strengths 
of both methods. It can answer more questions and unexpected findings in one area may be 
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illuminated by findings in another and the diversity of views may improve the practical usefulness 
of the findings by helping to understand which parts of the EMDR method are helpful in 
depression treatment. 
 
Chapter 1 will provide an overview of the current knowledge on depression and define long term 
depression. 
 
Chapter 2 introduces EMDR, including the controversy surrounding it, a review of the current 
literature on EMDR and depression and an overview of the competing theories around the 
mechanism of action behind EMDR. 
 
Chapter 3 discusses research design and is split into two parts. Chapter 3.1 discusses some of the 
methodological issues surrounding research paradigms, single case experimental design, mixed 
methods and using skin conductance response and heart rate variability. Chapter 3.2 describes the 
methods used in the Sheffield EMDR and Depression Investigation. 
 
The results are described in chapters 4, 5 and 6. Chapter 4 details the impact of EMDR on the 
depression of the participants and includes details on the quality of the data in the study. Chapter 
5 is concerned with the mechanism of change in EMDR and details the outcome from the memory 
investigations. Chapter 6 focuses on the acceptability of EMDR, what the participants thought of it. 
 
Chapter 7 then reviews the results in a mixed methods analysis. It combines the purely 
quantitative chapter 4 and 5 with the purely qualitative interview data from chapter 6. 
 
Chapter 8 discusses all the results both separately and then combined. It also considers the 
limitations of the study and what recommendations for research and implications for clinical 
practice come from it. 
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Chapter 1 – Depression  
1.1 Classification and prevalence  
Depression is a common mental health disorder, at any one time approximately 10% of people in 
the United Kingdom (UK) meet the criteria for a depressive episode (Singleton et al., 2003) and 
approximately 20% of Americans will have at least one episode in their lifetime (Kessler et al, 
2005). Human despondency was described as early as the fifth century BC by Hippocrates who 
called it melancholia as he believed it to be caused by an imbalance of black bile (Leventhal and 
Rehm, 2005). It is now thought by the World Health Organisation to be the fourth leading cause of 
disease burden in the world (Üstün et al., 2004). These are two main systems for classifying mental 
health problems, the International Classification of Disease (ICD-10) from the World Health 
Organisation (WHO) and the Diagnostic and Statistical Manual revised fourth edition (DSM-IV-TR)1 
from the American Psychiatric Association (APA) (APA, 2003). The two systems are slightly 
different.  For a diagnosis of Major Depressive Disorder (MDD) the APA requires that the client 
reports at least five of the following symptoms during the same two week period and that at least 
one symptom is (1) depressed mood or (2) loss of interest:  
1. Depressed mood 
2. Markedly diminished interest or pleasure  
3. Significant weight loss (not dieting) or weight gain or marked change in appetite 
4. Insomnia or hypersomnia nearly everyday 
5. Psychomotor retardation or agitation nearly everyday 
6. Fatigue nearly everyday 
7. Feelings of worthlessness or excessive or inappropriate guilt 
8. Diminished ability to think/ concentrate nearly everyday 
9. Recurrent thoughts of death, suicidal thoughts (with or without plan), suicide attempt 
Whereas the ICD-10 specifies that the client must have two of three key symptoms, depressed 
mood, lack of interest and lack of energy (symptom 6) (WHO, 1993). Both systems use an 
increasing number of symptoms along with increasing disability to define the severity of the 
episode. 
                                                          
1
 Although the DSM-5 was published in 2013 it came out after ethics and research and development 
applications had been made so the decision was made to continue with the DSM-IV-TR definitions. 
Comparisons between the two systems are made later in Chapter 1. 
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Both systems also assume that ‘depression’ is one homogenous illness. Although they do allow for 
different specifiers to be attached to the diagnosis, these are more to describe the length or 
severity of the illness rather than the existence of different disorders. The validity of this is 
contested, not only by those who look at mental health from a social perspective (Moncrieff and 
Timimi, 2013) but also those from biological psychiatry (Bosch et al., 2012). There is some 
evidence to suggest ‘depression’ may actually be made of several subtypes, including but not 
limited to, melancholic and non-melancholic depression (Parker et al., 2013) and mixed depression 
(Azorin et al., 2012). There also appears to be significant differences between acute and long term 
depression (Klein et al., 2006), recurrent and chronic depression (Klein and Santiago, 2003) and 
dysthymia (long term subclinical depression) remains a contentious diagnosis (Rhebergen et al., 
2012). This lack of clarity has led some to call for more research into the subtypes of depression 
especially concerning the way the different types respond to different therapies available (Maj, 
2012, Torpey and Klein, 2008).  
1.2 Determinates of depression 
Major Depressive Disorder, as defined by the APA and WHO, is a common disorder, but it is twice 
as common in women as in men (Levinson, 2009) and those from lower socio-economic 
backgrounds are also more susceptible (Monroe et al., 2009). There is a strong relationship 
between experiencing a major life stress and developing depression (Monroe et al., 2009); there is 
evidence that there are significantly more ‘life events’ immediately before the onset of depression 
than in a control population (Tyrer and Steinberg, 2006). Life events describe any stressful 
occurrence in a person’s life, these can be positive such as moving house or getting married, or 
negative such as getting ill or being assaulted. Depression is often associated with negative life 
events (Lenze et al., 2008) and people with chronic depression tend to report greater levels of 
early life adversity (Riso and Newman, 2003). Childhood trauma is a direct and strong risk factor 
for developing depression later in life (Heim et al., 2008). There is a strong dose-response 
relationship between adverse childhood experiences and lifetime depressive illness (Chapman et 
al., 2004) and it can be considered a determinate for chronicity (Wiersma et al., 2009), earlier 
onset (Bernet and Stein, 1999), more lifetime episodes (Bernet and Stein, 1999)and treatment 
resistance (Kaplan and Klinetob, 2000). 
Not all depression is linked to childhood trauma (Heim et al., 2008), it would appear to have 
biological as well as social risk factors. Researchers have found smaller hippocampal volumes in 
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depressed clients, that this has been found even in people in a first episode suggests the 
depression itself is not the cause (Frodl et al., 2002). Others have found neuropsychological 
impairment, suggesting dysfunction in the prefrontal cortex/ anterior cingulate, in elderly 
depressed clients, although it was unclear whether this was a cause or effect of the depressed 
state (Lockwood et al., 2002). Another potential biological risk factor, which may be linked to the 
previous two, is excessive cortisol activity (Schatzberg, 2002). These abnormalities in the different 
brain regions are more associated with chronic and long term depression than with a single short 
episode (APA, 2013). 
It would seem likely that a number of different factors increase the risk of depression in certain 
individuals and they have been classified as stressful life events, biological/genetic vulnerability, 
and psychological factors (personality, cognitive and interpersonal vulnerabilities) (Hankin, 2006). 
The DSM-5 lists risk factors as neuroticism, adverse childhood experiences, stressful life events, 
first degree family members with MDD, chronic or disabling medical conditions and a diagnosis of 
all major non-mood mental disorders (APA, 2013).  
1.3 Models of depression 
Biological – The biological or disease model of mental health problems suggests that an 
abnormality of the mind must have its origins in a malfunction of the nervous system (Tyrer and 
Steinberg, 2006). The biomedical model is concerned with the relationship between 
psychopathology and physiological processes (Davies and Bhugra, 2004). This raises questions 
about the mind and the brain and the relationship between the two, but the term mental ‘illness’ 
implies ‘disease’ (Tyrer and Steinberg, 2006). As the illness is caused by physiological problems, 
the treatment should be to address this. The client is a passive recipient of this treatment and 
failure to improve is a failure of the treatment not the client (Tyrer and Steinberg, 2006). In 
depression the malfunction is thought to be associated with the monoamine neurotransmitters 
(especially serotonin and noradrenaline) and cortisol, a glucocorticoid hormone (Thase, 2009). It 
has been suggested that sustained stress can dysregulate noradrenaline neurotransmission and 
serotonin receptors, susceptibility of the serotonin receptors to stress also appears to be genetic 
(Thase, 2009). So genetics can also be thought to play some role in depression, up to 50% of the 
susceptibility to it may be caused by our genetic makeup but it is a complex interaction and 
depression does not appear to be directly inheritable (Levinson, 2009). 
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Cognitive – The cognitive theories of mental illness argue that it is a person’s thoughts, 
interpretations, attitudes and inferences about events and the way in which they attend to and 
remember them that determines their emotional response (Joormann et al., 2009). Most involve a 
stress-vulnerability model where some kind of stressor (e.g. a life event) occurs and interacts with 
our psychological vulnerability to the stress (e.g. the way we process information) (Joormann et al., 
2009). Beck’s cognitive theory comprises three such vulnerabilities or components of emotional 
disorders, ‘negative automatic thoughts, systemic logical errors and depressogenic schemas’ 
(Williams, 1995). The cognitive model differs from the other models of mental illness because it 
sees the symptoms (e.g. negative thoughts) as the heart of the illness, i.e. ‘the negative thought is 
the ‘neurosis’ it is not caused by it’ (Tyrer and Steinberg, 2006).  
Social – Our social environment can affect us in many different ways, on large scale level our 
culture or socioeconomic status may affect our ability to access help in a crisis or on a more 
personal level it may reflect individual differences in the negative life events (e.g. bullying, 
accident or illness) that we experience (Monroe et al., 2009).  The social model states that mental 
illness is caused by life events which appear to be independent of one’s health, social forces such 
as class, occupation and social role can not only lead to but also maintain mental disorder. This has 
led some to argue that much of what is labelled as illness should actually be regarded as a 
temporary maladjustment (Tyrer and Steinberg, 2006).  
In practice many clinicians will refer the ‘biopsychosocial’ model. This multifactorial approach 
reflects the idea that depression, and mental ill-health in general, is caused and maintained by a 
complex interaction of biological, psychological and social factors (Gilbert, 2000). 
1.4 Onset 
Surveys of depressive symptoms (rather than diagnoses) in relation to age show a U shaped curve; 
the highest reports of symptoms occur among the young and the old (Kessler et al., 1992). 
Primarily however, depression is an illness which begins in young adults, between 20-50% of 
adolescents report significant, but subdromal, symptoms (Hankin, 2006), many will recover and 
not go back to being depressed but it may persist throughout adulthood and ten percent of all first 
onsets of depression occur after the age of 55 years (Kessler et al., 2005).  
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1.5 Long term depression 
Long term depression has, until recently, been poorly studied but it is a common, often a lifelong, 
condition and can be broken down into several classifications. In the DSM-IV-R it is not one 
diagnosis but comprises four types: dysthymia (subclinical depressive symptoms lasting over 2 
years), chronic major depressive disorder (MDD) (fitting the criteria for MDD for more than 2 
years), double depression (dysthymia as a baseline with episodes of MDD) and recurrent MDD 
with incomplete recovery between episodes (APA, 2003). However, there is little evidence that 
these types are differ significantly from each (McCullough Jr et al., 2003). Also under the 
nomenclature of long term depression is recurrent MDD, this is defined as two or more episodes 
of MDD (APA, 2003), and it is considered to be different to chronic depression (Klein and Santiago, 
2003).  
To clarify this position the DSM-5 attempted to reorganise these classifications into two broad 
categories, major depressive disorder and persistent depressive disorder (PDD). The clear aim 
being to separate recurrent depression from chronic depression. MDD then, includes different 
specifiers so it may be single episode or recurrent,  in full or partial remission and of any severity 
(APA, 2013). PDD is any long lasting none-remitting depressive illness rather than the four 
previous ones i.e. any depressive illness that has lasted for over two years; even if it doesn’t 
always meet the criteria for a full major depressive episode (APA, 2013). However these diagnoses 
do still overlap. It is difficult to judge from the DSM-5 whether a client who is currently not 
meeting the criteria for a full major depressive episode, but has in the past and is displaying some 
depressive symptoms would be classified as having major depressive disorder in partial remission 
or persistent depressive disorder with intermittent major depressive episodes, without current 
episode (APA, 2013). However, as the treatment guidelines in the United Kingdom (see section 1.8) 
are based on the ICD classifications, these overlaps are only really of importance to research. 
Some of those who relapse may take a long time to achieve a subsequent remission (Boland and 
Keller, 2009). Once someone has suffered a recurrence then the chances of further episodes 
increase, the risk of a new episode increases by 16% with each recurrence (Solomon et al., 2000) 
and reoccurrences are more common in women than in men (Williams, 1995). 
Thus when referring to long term depression this study encompasses those with depression that 
has lasted at least two years or those who have had two or more episodes of MDD.  
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1.6 Prognosis 
Although depression is often considered an acute illness, that will last four months or longer 
untreated (APA, 2003), around 60% of people suffering a first episode of depression will go on to 
have a second (Solomon et al., 2000). The vast majority (90%) of all depression cases are expected 
to recover within one year (Keller et al., 1997) but this is not a predictor of recurrence. Despite 
differing studies having differing definitions for key terms such as ‘depression’ and ‘early onset’ it 
does appear that child/adolescent onset depression is associated with poorer outcomes including 
longer time to remission and lower likelihood of remission (Greden, 2001). Studies tend to 
disagree on whether or not early onset depression increases the risk of multiple episodes (Boland 
and Keller, 2009). Certain clusters of symptoms may also be predictive of chronic courses of 
depression, including severe fatigue, insomnia, suicidal ideation, loss of interest and social 
withdrawal (Moos and Cronkite, 1999, Gilchrist and Gunn, 2007). Comorbid illnesses can also have 
an effect on the course of depression. Panic disorder, anxiety, personality disorder, substance 
abuse and medical illnesses occurring with the depression can lead to longer recovery times for 
depressive illness (Boland and Keller, 2009). Depression has been reported to be of comparable 
strength to smoking as a risk factor for mortality (Mykletun et al., 2009). 
1.7 Economics 
The economic and personal costs of chronic depression are high (Robinson et al., 1990). Clients 
with chronic depression use up to twice as many medical services as non-depressed clients, and 
have higher rates of suicide and hospital admission than acutely depressed clients (Arnow and 
Constantino, 2003). Up to 20% of all depressed clients have a chronic course (Klein and Santiago, 
2003), which translates to around 3% of the adult population of Western countries (Cuijpers et al., 
2010b), and it accounts for 12% of the total years lived with disability (Üstün et al., 2004). By 2020 
depression is expected to have become the world’s second leading cause of disability and is 
estimated to cost $36bn a year in the United States of America (USA) alone (Monroe and Harkness, 
2011). It also points to poorer educational outcomes for adolescents; early onset depression 
predicts high school and college dropout and increased rates of teen pregnancy (Kessler et al., 
1995). Major Depressive Disorder is associated with high mortality (APA, 2013), depressive 
symptoms may be a factor in predicting early mortality in otherwise healthy individuals (Takeshita 
et al., 2002) and it appears to adversely affect the course of other diseases such as breast cancer 
and cardiovascular disease (Greden, 2001). 
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1.8 Treatment 
In the UK, the National Institute for Health and Clinical Excellence (NICE) recommends those with 
moderate or severe depression should be treated with a combination of antidepressant 
medication and Cognitive Behavioural Therapy (CBT) (NCCMH, 2010). Despite the efficacy of these 
approaches (Olfson et al., 2006, Butler et al., 2006) both do have limitations. A review of 
medication for treatment resistant depression found that after initial treatment failure on a 
selective serotonin reuptake inhibitor (SSRI) switching to another SSRI gave remission rates of 27-
70% and combining a SSRI with a tricyclic antidepressant saw remission in 54-71% (Shelton et al., 
2010). However this leaves 29-73% of clients still not responding to medication and it may be 
optimistic, a review of unpublished medicine trials suggested an overall efficacy of antidepressants 
of only 32% (Turner et al., 2008).  In chronic depression typical response rates to both medication 
and psychotherapy may be less than 50% (Torpey and Klein, 2008). This is compounded by the 
findings that in practice as few as 21% of clients seeking treatment for depression are actually 
receiving adequate treatment (i.e. minimal concordance with the published guideline) (Kessler et 
al., 2003). Cuijpers et al, (2010) also found that psychotherapy (CBT, interpersonal therapy, and 
cognitive behavioural analysis system of psychotherapy (CBASP)) may be less effective for chronic 
depression than for acute phase depression. 
Even in the studies where the CBT approaches had an effect on the depressive symptoms reported 
by clients they did not improve in social functioning and did not appear to be doing well at follow 
up (Schramm et al, 2011, Kocsis et al, 2009). As long term depression is a relapsing – remitting 
illness then the need for long term follow up is paramount in assessing the effectiveness of a 
treatment. Due to the significant impairment in social functioning that is seen in long term and 
chronic depression (Klein and Santiago, 2003) then a treatment that does not affect any 
improvement in this aspect cannot be said to be a truly effective one. The UK NICE guidance on 
depression recommends differing treatments for depression based on severity but not on 
chronicity (NCCMH, 2010). Considering the evidence that acute and chronic depression are 
different illnesses (Klein and Santiago, 2003) that respond differently to treatments including 
psychological treatments (Cuijpers et al., 2010b) this could be a mistake. Although Interpersonal 
Psychotherapy was developed specifically to treat depression it may not be as helpful in chronic 
depression as it is in acute depression (Cuijpers et al., 2010b, Schramm et al., 2011) but NICE 
recommend that it is offered to those who have not responded to initial treatment (CBT, 
computerised CBT and medication). CBASP, which was specifically developed to treat chronic 
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depression, does not yet feature in the recommendations despite initial positive results due to a 
lack of good quality, randomised controlled trial based evidence (Schramm et al., 2011, Kocsis et 
al., 2009). NICE does consider long term depression differently when it comes to relapse 
prevention, here CBT or mindfulness should be offered to people with a history of recurrent 
depression.  This advice could be questioned because, in common with other NICE guidance, it 
does not take account of the lack of evidence on other approaches: although mindfulness does 
appear to be better than medication (Kuyken et al., 2008) and  General Practitioner standard care 
(Bondolfi et al., 2010) at reducing relapse, it has not been compared to any other active 
psychological therapy. 
1.9 Summary and the need for new treatments   
Depression is a common and devastating illness. It has high costs for both the individual and 
society. Despite this the best treatments we have available can only hope to achieve a 50-60% 
success rate. It is of paramount importance that we continue to research treatments for 
depression. Although it is unlikely that any one treatment will be found that is suitable for all 
suffers the more approaches we have the more likely it is that we will be able to treat more people 
and help get them to a state of remission.  
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Chapter 2 – Eye Movement Desensitisation and Reprocessing (EMDR)  
 
2.1 Background 
Eye Movement Desensitization and Reprocessing (EMDR) is said by its developers to be a 
comprehensive psychotherapy approach (Shapiro and Laliotis, 2011). It was developed by Francine 
Shapiro (1995) to treat the victims of trauma. It uses bilateral stimulation, e.g. taps, tones or eye 
movements, aiming to stimulate information processing systems of the brain in addition to 
employing other psychotherapeutic methods of known effectiveness. It consists of a structured 
eight-phase protocol and is usually delivered in weekly 90-minute sessions (Shapiro, 1995). A 
typical session begins with the therapist evaluating the imagery, cognition, emotion and body 
sensations related to a traumatic memory. The client and therapist also decide upon a positive 
cognition that may be substituted for the negative one and then check the scores of the Subjective 
Units of Disturbance Scale and the Validity of Cognition scale. After this, clients are instructed to 
attend to their memories of the traumatic event and simultaneously follow the bilateral 
stimulation (usually eye movements). This process of attending to both internal and external 
stimuli is called dual attention. If new material comes up after 28-30 eye movements, clients are 
asked again to attend to the event and move their eyes. This dual attention and association are 
repeated until the memory of the traumatic event is no longer stressful (Shapiro, 1995).  
The theoretical model behind EMDR is the Adaptive Information Processing (AIP) model; this was 
developed alongside the EMDR treatment model for Post-Traumatic Stress Disorder (PTSD).  The 
AIP model claims that mental pathology is caused by incorrectly processed memories getting 
‘stuck’ in an emotional and vivid state. It is suggested that EMDR alleviates pathology by helping 
the client to reprocess these memories so they are no longer traumatic (Shapiro, 1995). 
Research evidence for the effectiveness of EMDR treatment is mixed.  Many of the early studies 
were not rigorously carried out. When Foa and Meadows reviewed all treatments for Post-
Traumatic Stress Disorder (PTSD) in 1997 EMDR got a footnote only.  They said “the picture 
emerging from the studies reviewed here is mixed, some found improvement but methodological 
flaws rendered most, though not all, of these findings uninterpretable” (Foa and Meadows, 1997). 
A year later another review identified 16 studies and although they concluded that the treatment 
effects of EMDR were not measurement artefacts only two of the studies they found met full 
methodological rigour (Lohr et al., 1998). More recently the quality has improved and a series of 
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systematic reviews and meta-analyses including one by the Cochrane Collaboration have found 
that EMDR is significantly better at treating PTSD than no treatment and not significantly different 
from trauma focussed CBT (Van Etten and Taylor, 1998, Shepherd et al., 2000, Davidson and 
Parker, 2001, Bisson and Andrew, 2007, Ho and Lee, 2012). As a result of the improved quality and 
quantity of research evidence, EMDR is now a recommended treatment for Post-Traumatic Stress 
Disorder (PTSD) in clinical guidelines (NICE, 2005). One review of treating PTSD in children found 
that EMDR was significantly better than CBT (Rodenburg et al., 2009) although it only had a very 
small number of studies to analyse. 
The quality of the research is not the only criticism levelled against EMDR. Several authors have 
been concerned about the pseudoscientific nature of the AIP, chiefly its lack of falsifiable 
predictions (Herbert et al., 2000) and that it makes no reference to other cognitive science 
theories or experimental data (Lohr et al., 1998). There has also been plenty of controversy over 
the use of eye movements or other types of bilateral stimulation most potently whether they are 
of any use what so ever (Lohr et al., 1998) or actually whether they are doing more harm than 
good by causing a distraction during imaginal exposure (Devilly et al., 2013). The AIP model and 
theories around mechanism of change will be examined more closely in part 2.3. Finally questions 
have been raised about aggressive marketing tactics by EMDR providers and trainers in the USA 
and about the way that the EMDR International Association (EMDRIA) runs training programmes 
(Herbert et al., 2000). These issues have led to one comparison being made between EMDR and 
Mesmerism (McNally, 1999). In reply to this article Ricky Greenwald wrote “Mesmer’s theory [was 
exposed] as invalid however the eminent scientists apparently failed to consider that the method 
itself might have been valid regardless” (Greenwald, 1999). Whilst Greenwald was talking about 
the development of hypnosis from Mesmerism his argument could equally relate to EMDR. There 
are concerns about the AIP model, leading members of the UK & Ireland and European EMDR 
Associations have publically stated that the way training is run needs to be changed urgently 
(Farrell, 2013) and the mechanism of change is not established. However this does not preclude 
EMDR being helpful for many people with trauma issues. Many of the authors who express 
concerns about EMDR state that EMDR is no more effective than CBT so argue that it is not worth 
using in preference to CBT (Davidson and Parker, 2001). It could equally be argued that although 
meta-analysis may indicate EMDR is no more effective than CBT, they do not demonstrate the 
superiority of CBT either. As chapter one discussed CBT, although it is the first choice treatment, 
does not work for everyone and it is unlikely that EMDR or any other psychotherapy will work for 
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every person in all circumstances. This is why it is important to have a range of treatments 
available and to undertake research to find out what works for whom and when.    
Major Depressive Disorder and Post Traumatic Stress Disorder are independent but correlated 
conditions (Blanchard et al., 1998). These disorders have three diagnostic symptoms in common 
(sleep disturbance, lack of concentration and anhedonia) (APA, 2003) but also share other 
characteristics such as guilt and overgeneral memories (Reynolds and Brewin, 1999) and they are 
both associated with high levels of mutual comorbidity. Up to 50% of PTSD clients have depression 
(Nixon et al., 2004) and around 36% of clients with MDD also have PTSD (Campbell et al., 2007). 
Crucially both conditions are also characterised by intrusive memories of negative life events 
(Holmes and Mathews, 2010), and it has been suggested that distress in both conditions is due to 
the inability to optimally process the memories formed during these events (Brewin et al., 2010, 
Shapiro, 1995).  
EMDR was developed to help people process traumatic memories usually associated with one or 
two major events but also with numerous small incidents that have been traumatising if not life 
threatening. It may therefore be an effective treatment for depression which is often closely 
associated with negative life events (Lenze et al., 2008). It can be hypothesized that using EMDR to 
process the stressful memories preceding the onset of depression may reduce symptoms (Bae et 
al., 2008). There is some support for this from studies using EMDR with PTSD and phantom limb 
pain suffers, which have noticed improvements in comorbid depression scores during treatment 
(Maxfield and Hyer, 2002, van der Kolk et al., 2007, Korn and Leeds, 2002, Schneider et al., 2008). 
However this does not tell us if EMDR is directly responsible for the reduction in depression or if it 
is merely a by-product of the reduction in PTSD. Very little research on EMDR with clients with a 
primary diagnosis of depression is available. The studies that have been undertaken suggest that 
EMDR is a promising but as yet unproven treatment for depression (Hofmann, 2012). Section 2.2 
systematically reviews the evidence on EMDR and depression.  
There is also a lack of explanation to link the AIP model to the treatment of depression.  The AIP 
considers negative behaviours and characteristics to be the result of dysfunctionally held 
information (Solomon and Shapiro, 2008). This is consistent with cognitive theories of depression 
but much of the language of the AIP is centred around the pathology of PTSD, as AIP was 
developed alongside EMDR by EMDR practitioners and this meant it initially developed as theory 
on the cause of and treatment to traumatic stress.  
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The two main competing theoretical models used to explain the change mechanisms in EMDR, are 
AIP and Emotional Processing, the conditioning theory that suggests EMDR is little more than 
exposure.  Although both models are cognitive theories they have different explanations for the 
causes of pathology. Emotional Processing and the CBT model assert that it is the cognitions that it 
is the way you think about a situation, that causes pathology. AIP posits that it is dysfunctionally 
stored memories that led to problem symptoms that include the negative thoughts (Solomon and 
Shapiro, 2008). This also leads to a differing approach in the practical application of the therapies; 
in CBT the goal is to change the way the client thinks about a situation (Brewin, 2006) and in EMDR 
the goal is to change the memory. Once the memory is properly processed and linked with 
adaptive information about how to cope in stressful situations then it is posited that the pathology 
will subside (Solomon and Shapiro, 2008). Recent developments in imagery rescripting have found 
clinically important improvements in some depressive clients by working through the visual 
imagination alone with no challenging of negative beliefs (Brewin et al., 2009); this may work by 
allowing a new more elaborate contextualised representation which blends the negative 
experience with novel positive elements to be created and then compete with the original 
memory in stressful situations (Brewin et al., 2010). Section 2.3 aims to summarise and explain 
some of the main theories on the workings of EMDR.  
Finally, although a detailed review of the neuropsychology of memory is beyond the scope of this 
thesis, section 2.4 reviews and summarises relevant memory research studies and theories, aiming 
to understand if it is possible for EMDR to change problematic memories and how that might 
happen. 
2.2 A systematic review of EMDR as a treatment for depression  
  
Introduction 
A scoping review (Wood and Ricketts, 2013) revealed little research on the subject of using EMDR 
to treat depression. Much of what does exist is case studies or clinical anecdotes and cannot 
demonstrate the efficacy of the approach. For this reason a systematic review of the research 
literature with systematic search strategy, data extraction and quality appraisal was undertaken to 
look for randomised trials to investigate if the question of efficacy has been addressed. 
Background 
 Description of the population 
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The review is focussed on adults (over 18 years old) with Major Depressive Disorder. Depression is 
a common mental health problem, at any one time approximately 10% of people in the UK meet 
the criteria for a depressive episode (Singleton et al., 2003). It is now thought by the World Health 
Organisation (WHO) to be the fourth leading cause of disease burden in the world (Üstün et al., 
2004). For a diagnosis of Major Depressive Disorder (MDD) the Diagnostic and Statistical Manual 
(DSM-IV-TR) (APA, 2003) states that the client must report at least five of the following symptoms 
during the same two week period of which at least one symptom is (1) depressed mood or (2) loss 
of interest:  
1. Depressed mood 
2. Markedly diminished interest or pleasure  
3. Significant weight loss (not dieting) or weight gain or marked change in appetite 
4. Insomnia or hypersomnia nearly everyday 
5. Psychomotor retardation or agitation nearly everyday 
6. Fatigue nearly everyday 
7. Feelings of worthlessness or excessive or inappropriate guilt 
8. Diminished ability to think/ concentrate nearly everyday 
9. Recurrent thoughts of death, suicidal thoughts (with or without plan), suicide attempt 
 
Current treatment guidelines in the UK recommend that MDD is treated at step three with 
cognitive behavioural therapy, interpersonal therapy, behavioural activation, or behavioural 
couple therapy. If that is declined counselling and psychodynamic therapy should be considered, 
as well as the use of antidepressants or a combination of medication and talking therapy (NICE, 
2009). However, a review of pharmaceutical trials (including unpublished data) suggested an 
overall efficacy of antidepressants of only 32% (Turner et al., 2008). In chronic depression typical 
response rates to both medication and psychotherapy may be less than 50% (Torpey and Klein, 
2008). In addition, Cuijpers and colleagues found that psychotherapy (CBT, interpersonal therapy, 
and cognitive behavioural analysis system of psychotherapy) may be less effective for chronic 
depression than for acute phase depression (Cuijpers et al., 2010).  
 
 Description of the intervention 
Eye Movement Desensitization and Reprocessing (EMDR) was developed by Francine Shapiro 
(1989) to treat the victims of trauma. It uses bilateral stimulation, e.g. taps, tones or eye 
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movements, aiming to stimulate information processing systems of the brain in addition to 
employing other psychotherapeutic methods of known effectiveness. It consists of a structured 
eight-phase protocol and is usually delivered in weekly 90-minute sessions (Shapiro, 1989). A 
typical session begins with the therapist evaluating the imagery, cognition, emotion and body 
sensations related to a traumatic memory. The client and therapist also decide upon a positive 
cognition that may be substituted for the negative one and then check the scores of the Subjective 
Units of Disturbance Scale (SUDS) and the Validity of Cognition scale (VoC) (Shapiro, 1995). After 
this, clients are instructed to attend to their memories of the traumatic event and simultaneously 
follow the bilateral stimulation (usually eye movements). This process of attending to both 
internal and external stimuli is called dual attention. If new material comes up after 28-30 eye 
movements, clients are asked again to attend to the event and move their eyes. This dual 
attention and association are repeated until the memory of the traumatic event is no longer 
distressing (Shapiro, 1995).  
EMDR is now a recommended treatment for Post-Traumatic Stress Disorder (PTSD) based on 
meta-analytic evidence for its efficacy in treating this condition (Bisson and Andrew, 2007).  
 
 Description of the comparisons 
Cognitive Behavioural Therapy (CBT) for depression 
Cognitive behaviour therapy (CBT) refers to the pragmatic combination of concepts and 
techniques from cognitive and behaviour therapies, common in clinical practice.  Cognitive therapy 
is a structured treatment approach derived from cognitive theories.  Cognitive techniques (such as 
challenging negative automatic thoughts) and behavioural techniques (such as activity scheduling 
and behavioural experiments) are used with the main aim of relieving symptoms by changing 
maladaptive thoughts and beliefs.  Behaviour therapy is a structured therapy originally derived 
from learning theory, which seeks to solve problems and relieve symptoms by changing behaviour 
and the environmental factors which control behaviour.  Graded exposure to feared situations is 
one of the commonest behavioural treatment methods and is used in a range of anxiety disorders 
(DH, 2001). 
 
Meta-analysis of CBT suggests that it is a successful treatment for depression and at least as 
successful in treating depression as other psychotherapies or medication (Butler et al., 2006). 
However, there is some suggestion that publication bias and researcher allegiance could have led 
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to an overestimate of the effectiveness of CBT and psychotherapy in general (Cuijpers et al., 
2010a).  
 
Other therapies 
There are numerous types of antidepressants available to treat depression. Many have been the 
subject of Cochrane collaboration reviews, for example Fluoxetine (Magni et al., 2013), Citalopram 
(Cipriani et al., 2012) and Sertraline (Cipriani et al., 2010). There appears to be little to separate 
the different medications in terms of clinical effectiveness (Cipriani et al., 2012) and may be more 
a degree of tolerability of side effects for the patient. Guidelines recommend the first choice of 
antidepressants should be from the Selective Serotonin Reuptake Inhibitors as they have a greater 
risk-benefit ratio (NCCMH, 2010). For this reason any comparison of EMDR to medication will be to 
the class of antidepressants rather than individual medications. 
 
 Why is it important to do this review? 
There are several references to depression in the EMDR literature including those that claim EMDR 
is an effective treatment for depression (Shapiro, 2009a). However, much of this is based on 
randomised controlled trials of EMDR as a treatment for PTSD which include depression as a 
secondary outcome (van der Kolk et al., 2007) or clinical case studies that report EMDR as a 
treatment for depression (Grey, 2011, Bae et al., 2008). Many RCTs of EMDR for PTSD include 
depression scales as a secondary outcome measure and the majority report significant 
improvements in depression (Wood and Ricketts, 2013); however, this improvement in depression 
occurs at the same time as the PTSD is treated. This does not show that EMDR is treating the 
depression directly. It is possible that as the PTSD symptoms improve so do the co-morbid 
depression symptoms for no other reason than the PTSD has improved. This is therefore not 
evidence that EMDR treats depression but that it treats depression when it occurs co-morbidly 
with PTSD. 
There are several case studies and clinical anecdotes reporting EMDR treating people with a 
primary diagnosis of depression. The clinical anecdotes rarely include any reported outcome 
measures and therefore one cannot be sure that any change in depression genuinely occurred 
(Shapiro, 2009a). The case studies are often only on one or two participants, without 
randomisation or control for the effect of time (Grey, 2011, Bae et al., 2008) and as such are not 
able to answer questions of efficacy.  
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 Research Question  
Is there any evidence in the peer reviewed literature that examines the effectiveness or efficacy of 
EMDR as a treatment for depression compared to other treatments or no treatment? 
 
 Objectives 
To review systematically the evidence for the effectiveness of EMDR compared with other 
psychotherapy or antidepressant medication interventions or no intervention in the treatment of 
depression. 
 
Methods 
 Types of studies 
To be included papers must describe a randomised controlled trial investigating the use of EMDR. 
Randomisation was determined to have occurred if the authors have used terms such as random 
or randomised to describe the way participants have been allocated to each group. The quality of 
the randomisation was part of the quality assessment. 
The full text of studies had to be available in English. No date limit was applied nor country of 
origin excluded, if it is in English. 
 Types of participants 
Participants were men or women, over the age of 18 (no upper age limit) with a diagnosis of 
depression using DSM diagnoses, ICD diagnoses or clinically assessed not otherwise specified. All 
types and subtypes of depression will be included. Other diagnoses may have been present but 
the primary diagnosis and the condition being targeted by the intervention must have been 
depression.  
 Types of intervention (experimental and comparator) 
The intervention was EMDR; this may be as a stand-alone treatment or as an adjunct to another 
treatment.  
The comparators included were another form of psychotherapy, anti-depressant medication, 
waiting list, no treatment group or a non-active control condition. Electroconvulsive therapy, 
magnetic resonance or other physical treatments were excluded. 
 Types of outcomes (primary and secondary) 
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The primary outcome was any continuously distributed measure of depression measured before 
and after the intervention. Common measures are the Beck Depression Inventory and the 
Hamilton Rating Scale for Depression. When more than one scale is used the main outcome 
measure will be determined as the one identified by the trial authors as the primary outcome 
measure or the first one reported in the results.  
 Search methods for identification of studies (electronic and other) 
Medline, Embase, CINAHL, the Cochrane Library and PsycINFO were searched using the following 
terms: 
Eye movement desensitisation and reprocessing OR EMDR 
AND depression (MESH) 
Multiple spellings were used to include the UK English (desensitisation) and the American English 
(desensitization) spellings as well as ‘re-processing’ and ‘reprocessing’. The full search strategy 
used in OVID (Embase, Medline and PsycINFO) can be found in the appendix (p213). 
 
Following the electronic database searches the grey literature was searched via the Francine 
Shapiro library for the term ‘depression’ to ensure a comprehensive search as a scoping review 
revealed very few publications in this area. The Francine Shapiro library is a repository of EMDR 
literature held at the EMDR International Association and available to the public via the internet. 
The Library aims to keep an up to date repository of all EMDR literature. Whilst citations of all 
forms of publications appear in the Library, only the journal articles were searched (total 1687).  
The reference lists of included trials were searched to look for any further studies missed by the 
other searches. 
 Exclusion criteria 
Studies investigating intervention for PTSD as the primary diagnosis were excluded. Meta-analysis 
has demonstrated the efficacy of EMDR in treating PTSD (Bisson and Andrew, 2007).  
 
Data collection and analysis 
 Selection of studies 
One author (EW) screened the citations to decide which full texts should be retrieved. The 
inclusion criteria were then applied to the studies.  
 Data extraction  
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Data extracted were the intervention and comparator (including dosage), primary and secondary 
outcomes at the end of the intervention and where available at follow up, length of follow up, 
drop out, number of people screened, randomised, allocated to each group and completing 
treatment, adverse events and main conclusions 
 Main comparisons 
EMDR v control (no treatment, waiting list or other control) 
EMDR v other psychotherapies 
EMDR v anti-depressant medication 
 Assessment of risk of bias 
The Cochrane risk of bias tool was used to assess the risk of bias of each of the included studies 
(Higgins et al., 2011). There are six domains within the tool, each are assessed separately: 
1. Sequence generation: Was the allocation sequence adequately generated? 
2. Allocation concealment: Was allocation adequately concealed? 
3. Blinding: Was knowledge of the allocated intervention adequately prevented during the 
study? 
4. Incomplete outcome data: Were incomplete outcome data adequately addressed? 
5. Selective outcome reporting: Are reports free of suggestion of selective reporting? 
6. Other sources of bias: Was the study free of problems that could put it at high risk of bias? 
In psychotherapy research this can include the allegiance of the researchers to the therapy 
under investigation. 
Each of these domains was graded as low risk of bias, unclear risk of bias or high risk of bias by the 
researcher. A list of quality criteria designed specifically for psychological interventions was used 
to inform section 6 of the Cochrane tool (Lackner et al., 2004).   
 
Results 
Description of studies 
 Results of the search  
The search of the research data bases uncovered 400 hits, of which 127 were duplicates leaving 
273 for screening. The Francine Shapiro library yielded 147 hits. Some of these overlapped with 
the other databases but it was not possible to export the findings from this library so they were 
screened separately. The screening process is outlined in figure 2.1. No additional papers were 
found from the reference lists. 
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Figure 2.1: The systematic review flow diagram 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OVID: Embase, Medline, PsycINFO 
Hits - 370 
EBSECO: CINAHL 
Hits - 11 
Cochrane Library 
Hits - 19 
Combined – 400 
Duplicates removed - 127 
For screening by title and abstract  
- 273 
Francine Shapiro Library 
Hits - 147 
Not included: 
primary focus not 
depression 
121 
Not included: Not 
RCT 
16 
Not included: Not 
in English 
4 
Not included: Not 
about EMDR 
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Papers included in quality check - 2 
Not included: 
primary focus not 
depression 
212 
Not included: Not 
RCT 
49 
Not included: Not 
in English 
5 
Not included: Not 
available in full 
text 
2 
Not included: Not 
about EMDR 
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Papers included in quality check - 0 
Total papers included -2 
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 Included studies 
Two studies by the same research group (Behnammoghadam et al., 2015a, Behnammoghadam et 
al., 2015b) were found in the Francine Shapiro library. These two papers did not appear in the 
other searches, this is likely to be due to the Journals that they were in, the Global Journal of 
Health Science and the Iranian Journal of Critical Care Nursing.  The second paper describes the 
same trial as the first but also includes 12 month follow up data on the intervention group. 
 Study designs, participants, interventions and outcomes 
Both Behnammoghadam papers describe the same randomised controlled trial. The 60 
participants were all cardiovascular patients with a diagnosis of depression and were split equally 
between the intervention group (EMDR) and the control group (not described). The primary 
outcome was the Beck Depression Inventory. The paper describing the follow up also reports a 
‘mental distress scale’ which is unnamed but from the description could be the Subjective Units of 
Distress Scale (SUDS) which is used routinely in EMDR. 
 Excluded studies  
Studies were excluded because the primary focus was not on depression or EMDR was not used as 
a treatment. Other studies were excluded as the full text was not available in English or it was not 
a randomised controlled trial (see figure 2.1).  
 
 Risk of bias in included studies 
Risk of bias in the papers was judged using the Cochrane tool. The primary findings are displayed 
in Table 2.1 and then considered in more detail below. 
Table 2.1: Outcomes from the assessment of risk of bias 
Study Sequence 
generation 
Allocation 
concealment 
Blinding Incomplete 
outcome 
data 
Selective 
outcome 
reporting 
Other 
sources 
of bias 
Behnammoghadam 
et al 2015a 
unclear unclear low high high high 
Behnammoghadam 
et al 2015b 
unclear unclear low high high high 
 
Sequence generation 
In Behnammoghadam et al 2015a, the groups are described as randomly assigned but the method 
by which the randomisation occurred is not described further. Behnammoghadam et al 2015b 
does not add anything to make this clearer. 
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Allocation concealment 
As no method for randomisation and allocation to groups is described it is not possible to judge if 
allocation could have been foreseen in advance of or during enrolment.  
Blinding 
It is not possible to blind the participants or therapists in psychological therapy trials leading to a 
high risk of bias (Churchill et al., 2013). This can be mitigated to a certain extent by having blind 
researchers collecting the outcome data. In the study the primary outcome measure (BDI) is self-
rated so bias of the researcher is less of a factor.  
Incomplete outcome data  
Exclusion criteria are listed but numbers excluded and whether exclusion happened before or 
after randomisation are not reported. There is no reporting of attrition at any stage.  
Selective outcome reporting 
The trial registration number is reported but no protocol is available. The trial register entry is for 
a study on anxiety and reports the primary outcome as the Beck Anxiety Inventory but the paper is 
on depression and reports the Beck Depression Inventory as the primary outcome. It is unclear 
whether this is a language confusion (the study is Iranian), a different study or if the focus of the 
study was changed or why that may have occurred. The second paper does reference an 
unpublished Master’s thesis by the first author looking at EMDR to treat anxiety in patients who 
have had a Myocardial Infraction (MI). However, it is unclear what the researchers initially 
intended to measure with the patient group. 
The researchers have reported the difference between the two groups and between before and 
after measures using t tests which is appropriate but it falls short of what they could have done. 
They do not include intention to treat analysis or calculate an effect size for EMDR. As there is no 
sample size calculation and fairly small numbers in each group this study should be considered a 
pilot study and as such a key aim should have been to calculate effect size. The groups are also 
significantly different on smoker status before the study began. Although this should not be 
directly related to the efficacy of EMDR it may be indirectly related. The participants in this study 
have all had MI and as such smoker status is important for their physical health outcomes. It 
would have been helpful to undertake additional analysis to control for smoker status.  
Other sources of bias 
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As with all psychotherapy research the allegiance of the researchers is a potential source of bias in 
EMDR research (Luborsky et al., 1999).  Levels of training in EMDR or numbers of therapists 
involved are not reported. No assessment of treatment fidelity is reported, although they do 
report the use of the standardised protocol. The treatment received by the control group is not 
reported nor are any medications for either group, either for MI or depression. 
Experimental group was significantly more depressed at start than the control group. No sample 
size calculation is reported. Details of side effects or adverse events are not reported. The primary 
outcome measure was the BDI which is a well-recognised scale, well validated in many situations; 
however, it is old and has been replaced by the more rigorous BDI-ii. There is no stated funding 
source for the study and no declaration of interests. 
 
 Effect of the intervention 
Over the course of the study the participants in the EMDR group went from an average BDI score 
indicating moderately severe depression (range is not reported), to a score indicating mild 
depression. This reduced further to subclinical levels at the 12 month follow up period. For the pre 
and post measurements standard deviations were reported and the change score was significant. 
Standard deviations and significance are not reported for the follow up data. 
The control group went from an average BDI score indicating moderate depression to one 
indicating severe depression from the pre to post measurements. This was also statistically 
significant. No follow up for the control group is reported. 
 
Discussion 
 Summary of main results 
Only one comparison is possible due to a lack of evidence, that is EMDR v control or no treatment 
group to treat depression. Only one study is reported (twice) investigating the use of EMDR to 
treat depression in a randomised controlled trial. The study is of low quality and can be considered 
to be at high risk of bias. However, in this one study EMDR did lead to a significant reduction in 
depression and the control group saw a significant increase over the same period. 
 Uncertainties 
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Many uncertainties remain about the efficacy of EMDR in treating depression. No studies were 
found comparing EMDR to recognised treatments and no studies were found in patients without 
physical health co-morbidities. No high quality studies were found. 
 Overall applicability of the evidence 
The only study found investigates depression in MI patients so it is unclear whether this can be 
related to depression patients in general. Having a MI is a life threatening experience which can 
lead to PTSD in as many as 30% of patients (Chung et al., 2006). It could be that these patients had 
PTSD or were traumatised by their experience, as EMDR can be expected to treat trauma with a 
degree of efficacy these patients may not be comparable to the wider depressed population. 
 Quality of the evidence 
The quality of the evidence is low, so no firm conclusions can be based on this limited data. 
 Potential biases in the review process 
This review only included papers published in English due to lack of funds to pay for translations 
from other languages. It may be that there are studies in other languages that could add to the 
evidence. 
 Agreements/disagreements with other studies/reviews 
This review concurs with a previous scoping review which concluded that there is insufficient 
evidence to claim EMDR was an evidenced based treatment for depression and that further 
research is required (Wood and Ricketts, 2013).  
 
Author’s conclusions 
Due to the current lack of good quality evidence EMDR cannot be considered an evidenced based 
treatment for depression. However, there are indications from a low quality RCT and from other 
research methods that EMDR has the potential to treat depression. 
 Implications for practice 
EMDR should not be used as a first line treatment for depression as other evidenced based 
treatments are available.  
 Implications for research 
High quality feasibility and pilot studies are required to investigate the possibility of using EMDR to 
treat depression. Factors such as the acceptability of the treatment have not been established. 
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High quality randomised controlled trials are needed to investigated the efficacy of EMDR to treat 
depression.  
If patients have received the recommended first line treatments but not responded there is 
justification for offering EMDR in a research setting as long as the patient is aware that it remains 
an experimental option at this point (WMA, 2001). 
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2.3 Theories regarding EMDR’s mechanism of action  
 
Although much Health Service Research is pragmatically focussed on the outcomes of treatment, 
to test which treatments yield greatest benefit, one of the criticisms levelled at EMDR is the lack of 
a coherent theoretical underpinning and no agreed mechanism of action. Therefore although it is 
not the goal of this research to undertake pure cognitive science research, to evaluate an effective 
treatment for depression it is important to understand some of the cognitive theory. There is no 
comprehensive and definitive explanation of the mechanism of action in EMDR but there are 
many theories. The Adaptive Information Processing Model was developed to try to explain in 
psychological terms how EMDR works. There are also many theories regarding specific biological 
and psychological memory processes that have been seen in clinical practice and in research 
laboratories. This is a summary and critique of these theories in relation to the processing of 
trauma memory.  
Adaptive Information Processing   
The Adaptive Information Processing (AIP) model was developed by Francine Shapiro alongside 
the development of EMDR. AIP is a cognitive learning theory and consistent with that, it posits an 
‘information processing system that assimilates new experiences into already existing memory 
networks. These memory networks are the basis of perception, attitudes and behaviour’ (Solomon 
and Shapiro, 2008). Current experiences are linked with their associated memory networks, useful 
information is integrated into the networks and is then available as part of our learned experience 
in the future (Shapiro, 1995). Pathology occurs when a distressing incident is unable to connect 
with the memory networks that hold the adaptive information required to deal with the situation, 
the memory is ‘frozen in time’ and stored in a state- specific form (Solomon and Shapiro, 2008). 
Therefore AIP views negative behaviours, thoughts and personality characteristics to be a result of 
incorrectly stored information, and negative cognitions are symptoms of a dysfunctionally stored 
memory. Successful treatment with EMDR leads to a memory which is no longer isolated and has 
been integrated within the larger memory network (Solomon and Shapiro, 2008). This is consistent 
with the process of assimilation and accommodation, rather than habituation (Rogers and Silver, 
2002). This isolated memory theory is consistent with other theories of PTSD but it is when AIP is 
translated to other illnesses it becomes more complicated. AIP suggests that all mental health 
issues are caused by these isolated, unprocessed memories but it has been argued that in 
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depression the problem with the traumatic memory is that it is too well processed and fixed 
within the client’s schema not that it does not connect at all (Brewin, 2012). AIP has come under 
further criticism for not generating falsifiable hypotheses and therefore not being a true scientific 
theory (Devilly, 2002). 
Conditioning/ exposure 
The Emotional Processing Model, proposed by Foa and Kozak (1986), offers a mechanism of action 
to explain the success of behavioural therapy, specifically exposure therapy, to treat pathological 
fear such as Post Traumatic Stress Disorder (PTSD) and phobias. Fear is represented in memory 
networks that incorporate information about the fear stimulus, behavioural responses to it and 
the meaning of the stimulus. We all experience fear throughout our lives and these networks are 
adapted (positively and negatively) through new experiences (Foa and Kozak, 1986). Pathological 
fears involve excessive response elements and resistance to modification; this persistence is, in 
part, down to ‘impairments in mechanisms for processing the fear-relevant information’. 
Treatment of these pathological fears requires the activation of the fear memory (exposure to fear 
stimuli), noticeable reduction in anxiety by remaining with the stimulus rather than 
fleeing/avoiding (habituation) and longer term ‘unlearning’ of the fear reaction to the initial 
stimuli (extinction) (Foa and Kozak, 1986). The emotional processing model has its roots in operant 
conditioning and is backed up by countless experimental and theoretical papers, the model itself is 
not under question. However, there is a question as to whether or not it is applicable to EMDR. 
It has been argued that EMDR is a form of exposure therapy; this is due to the fact that in part four 
of the standard eight-stage protocol for EMDR the client is asked to bring up an image of the 
distressing memory and hold it in mind. Then, as processing occurs the relaxation or orientating 
response (see below) that follows is a form of habituation and hence emotional processing. 
However, others would argue that there are some problems with this explanation of EMDR. 
Habituation is a slow and gradual process taking between 20-100 minutes per exposure (Rogers 
and Silver, 2002). This is because when a fear response is generated the body releases adrenaline, 
as this wears off the body relaxes again and fear decreases. In EMDR, the ‘exposures’ are very 
short, often only 20-30 seconds which should not be enough time for the physiological responses 
to occur and because the client is splitting his or her attention between the memory and the 
bilateral stimulation (BLS) this should slow down any habituation response not speed it up (Rogers 
and Silver, 2002). In fact, Foa and Kozak (1986) are clear that distraction during exposure will 
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reduce its effectiveness and can lead to the failure of between-session habituation, which in turn 
will inhibit long term habituation. In other words, the emotional processing model suggests that 
due to short exposure periods and bilateral stimulation during the act of bringing the memory to 
mind EMDR will not be very successful at reducing distress. Likewise, exposure therapy involves 
‘reliving’ the event whereas in EMDR psychological distancing is encouraged (see below) (Lee, 
2008). EMDR also contains an element of free association, during processing clients are 
encouraged to just ‘see what comes up’, which is actively discouraged in exposure where the 
object is to concentrate on the distressing situation and not avoid it by thinking of other things 
(Rogers and Silver, 2002).  
The Neural Systems model 
Brewin and colleagues’ 2010 revision of the Dual Representation Theory suggests a different 
explanation for the mechanisms underlying EMDR. They suggest that memory and imagery rely on 
common networks and that both utilise flexible, contextualised representations (C-reps) and 
inflexible sensory bound representations (S-reps). In healthy individuals who experience an 
extreme event the S-rep is associated with a corresponding C-rep allowing it to be contextualised 
semantically and autobiographically. Pathology occurs when the sensory representation is not 
linked to context. This means the feelings of fear can occur even the context does not warrant it 
and this can manifest as intrusive thoughts, images and feelings. This model suggests that EMDR 
works via extinction, forming a new C- rep memory containing not only the traumatic image but 
also identifying with the safe present (rather than the dangerous past) and containing the 
distracted or disambiguating information from the bilateral stimulation phase. This would then 
compete effectively with the original traumatic S-rep when the individual encounters reminders of 
trauma (Brewin et al., 2010). Thus EMDR is one way of creating new, contextual C-reps to compete 
with out-of-context sensory representations of distress. Other methods include exposure therapy 
and imagery rescripting (the client focuses on their intrusive image/ memory and concentrates on 
creating a new more positive outcome which they then rehearse with the therapist). However the 
neural systems model is a model of PTSD not psychotherapy and so although it may explain EMDR 
in PTSD clients it does not transfer to depression clients (Brewin, 2012).  
As well as the cognitive model explanations of change processes there are also other psychological 
and physiological explanations for some of the effects seen in EMDR. 
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Orientating response 
The orientating response (OR) is a physiological process, it involves paying attention to significant 
and new stimuli. It is geared towards information processing as it compares novel incoming 
information with that which is already familiar (Bergmann, 2010). It is different from the startle 
response and defensive response as they direct us to action. As such they are associated with a 
sympathetic response in the nervous system whereas the OR is generally regarded as 
parasympathetic in nature (Bergmann, 2010) and therefore a relaxation response (Gunter and 
Bodner, 2009). Some have expressed the belief that the BLS in EMDR triggers an OR; however this 
is not without controversy (Gunter and Bodner, 2009). OR is characterised by a decreased pulse 
and breathing rate and skin temperature and an increase in skin conductance (Sondergaard and 
Elofsson, 2008) but there have been inconsistencies in the psychophysiological research on EMDR, 
including increases in finger temperature (Sondergaard and Elofsson, 2008). Bergman (2010) does 
argue however that in the literature, OR has often failed to be adequately differentiated from 
startle and defensive responses and therefore conflicting results are a distinct possibility.  
Working memory disruption 
Gunter and Bodner (2008) cast some doubt on the OR and theories of relaxation as a mechanism 
of action for EMDR and emphasise the importance of dual attention to the trauma memory and to 
the BLS. Their findings suggest that the benefits of eye movements are only significant when they 
correspond to the traumatic memory being held in mind. They also found that during eye 
movements their participants showed a decrease in arousal (Gunter and Bodner, 2008). They 
argue these findings would be consistent with the working memory account. The working memory 
account of EMDR asserts that when the image of the traumatic memory is called to mind it is held 
in the visuospatial sketchpad part of the working memory, BLS is then a divided attention task and 
leads to a reduction in vividness and emotionality of the image by taxing the capacity of the 
working memory (Gunter and Bodner, 2008). In this model the eye movements are a useful 
distracter task but otherwise not special in themselves (Gunter and Bodner, 2009). This model has 
not been tested in a clinical population.  Although it has been shown that dual attention leads to a 
reduction in emotionality during BLS (Andrade et al., 1997, Kavanagh et al., 2001, van den Hout et 
al., 2001, Barrowcliff et al., 2004, Kemps and Tiggemann, 2007, Lee and Drummond, 2008, 
Maxfield et al., 2008), it is not known if this change lasts outside the therapy session (Lilley et al., 
2009). In 2001, Kavanagh and colleagues found that this reduction in emotionality was not 
maintained. However, it could be argued that as their participants only received a total of 64 
48 
 
seconds of eye movements this was long enough to produce an initial reduction but not to 
maintain it. It is possible that a longer ‘dose’ may have maintained the effect. The role of eye 
movements remains one of the controversial aspects of EMDR with some saying they are 
unnecessary at best and at worst interfere with exposure (Devilly, 2002). However, the weight of 
current research is tipping in favour of the need for bilateral stimulation (Jeffries and Davis, 2013). 
Jeffries and Davis performed a systematic review of the literature concerning eye movements and 
other tasks from the clinical and non-clinical research. Although there is contradictory evidence 
from some clinical studies they found no evidence to suggest that eye movements should be 
removed from the protocol. The authors conclude that it remains unclear whether eye 
movements are superior to other distraction tasks and call for more thorough research into the 
subject. A theoretical rationale for why bilateral eye movements may be a specific requirement is 
reviewed below. 
Psychological distancing 
Distancing refers to the detached observation of the traumatic memory and is one of the major 
arguments against EMDR being considered to be an exposure therapy (Gunter and Bodner, 2009). 
In prolonged exposure treatment for PTSD the client is expected to attend to the memory in as 
much detail as possible, reliving the experience, EMDR however, instructs the client to be an 
‘observer’ (Shapiro, 1995) and remember that their experiences are transient (Lee, 2008). Lee and 
colleagues have focused on this and in clinical and analogue studies on university students they 
investigated the levels of distancing and changes in emotion and vividness associated with 
distressing memories. The degree of distancing has been found to be significantly associated with 
improvement and the distancing process was more likely to have been due to eye movements 
than therapist instructions (Lee, 2008). These studies did not have control groups, instead of 
measuring the same outcomes in an exposure treatment group and comparing them to the eye 
movement group they measured what occurred during the eye movements and compared that to 
the theoretical principles of exposure.    
Increased inter-hemispheric communication 
It has been postulated that saccadic horizontal eye movements have a specific influence on inter-
hemispheric interaction and episodic memory (Propper and Christman, 2008). Propper and 
Christman (2008) reviewed the evidence that saccadic horizontal eye movements improve 
episodic memory in non-pathological populations and found that the benefits are seen at the 
retrieval stage. They do not state whether this relationship is inhibitory or excitatory in nature 
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simply that leftward-rightward eye movements may equalise the activation of both hemispheres 
and as one side is usually more active than the other by equalising them then communication 
between the two may be enhanced (Propper and Christman, 2008). Gunter and Bodner (2009) 
have asserted that inter-hemispheric communication cannot be the whole story in the mechanism 
of EMDR as vertical eye movements have been shown to decrease emotionality as much as 
horizontal ones despite this approach not having an effect on the two hemispheres.  
REM like states 
As the horizontal eye movements induced during EMDR resemble the eye movements seen during 
Rapid Eye Movement (REM) sleep, Stickgold has proposed that EMDR produces a brain state 
similar to that of REM sleep which allows for improved facilitation of memories as seen in both 
processes (Stickgold, 2008). Some aspects of the physiological changes seen during EMDR fit well 
with this hypothesis, for example increased skin temperature is seen in EMDR and REM 
(Sondergaard and Elofsson, 2008). The model suggests that EMDR induces an REM like state that is 
able to support ‘cortical integration of the traumatic memories into general semantic networks’ 
this will lead to a reduction in the strength of the episodic memory and negative affect associated 
with it (Stickgold, 2002). It has not been directly tested. 
Integrated approach 
As no single mechanism has been shown to explain EMDR, Gunter and Bodner (2009) have 
suggested an integrated model. They suggest that the dual attention task of keeping the memory 
in mind and focussing on the BLS leads to a disruption in working memory, this aids psychological 
distancing. This may lead to beneficial memory reprocessing leading to the reported 
psychophysiological effects similar to the orientating response and relaxation phenomenon. 
Memory reprocessing and psychophysiological changes then work together to reduce the 
symptoms of  PTSD (and potentially other pathologies) (Gunter and Bodner, 2009).  
There are many possibilities to explain the effectiveness of EMDR but all are poorly researched, 
they have only been studied on subjects with PTSD or non-clinical populations if they have been 
studied directly at all. This reduces their explanatory power in understanding the potential for 
EMDR to be useful in depression.  Most of these explanations are not mutually exclusive but some 
are; EMDR cannot be AIP and emotional processing. AIP posits that the underlying cause of 
pathology is unprocessed memories and that by resolving this, the pathology can come to an 
adaptive resolution. Emotional processing on the other hand states that it is the cognition around 
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the memory that causes the pathology and by learning a new response to fearful stimuli, fear can 
be reduced. The AIP does allow for the model to be transferred to pathologies other than PTSD for 
which it was developed. In the case of depression, unprocessed memories may be linked with low 
mood, sadness and loss which remain at the forefront of consciousness until the memories are 
correctly processed with the aid of EMDR. Gunter and Bodner’s (2009) integrated model has not 
been directly tested although its individual components have some merit. It has been suggested 
that EMDR is analogous to the processes occurring in REM sleep has some logical and theoretical 
support but again has not been directly empirically validated (Stickgold, 2002). Brain imaging with 
a few nonclinical and PTSD case studies has found interesting activations in the ventral medial 
Prefrontal Cortex and hippocampus but this has not been seen in enough people to be 
categorically the result of the EMDR process. The increase in hippocampal volume is of interest to 
the treatment of long term depression as clients with 3 or more episodes of depression have a 
decreased recruitment of the right hippocampal and left parahippocampal gyrus leading to 
impairments in memory performance (Milne et al., 2012) and a reduction in hippocampal volume 
both of which appears to be caused by repeated depressive episodes  (McKinnon et al., 2009). 
Although much of this theory and neuroscience does not appear directly relevant to clinical 
practice it can be. By understanding how a treatment works it can be made more effective, more 
cost-efficient and more acceptable to the client by removing parts of the treatment that are 
unnecessary or even counter-productive. For example, we can consider the EMDR technique 
known as the ‘butterfly hug’ (Artigas and Jarero, 2009). This is a method of bilateral stimulation 
which the participant does on themselves. It was developed by a disaster relief worker who had a 
classroom full of traumatised children and did not have time to give them all one to one therapy. 
He taught the children to tap themselves on the shoulders by ‘hugging’ themselves then tapping 
with alternate hands as fast as they could. Whilst it is still primarily used in disaster zones it has 
growing popularity for people offering therapy over the phone or internet and for group therapy. 
The butterfly hug appears to cause a relaxation response like some of the other methods but it 
should not really be called bilateral stimulation. Yes, the participant taps alternate shoulders but 
they tap it with their opposite hand, therefore getting simultaneous left and right stimulation. 
Whilst this is no problem for the working memory models of EMDR, as it is just another method of 
distraction, it is a problem for the models which state that alternate bilateral stimulation is 
essential to the process. This demonstrates that the theory is important: is the butterfly hug EMDR 
if it is not bilateral stimulation? Does it work at all, should it be stopped, should it be encouraged 
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and theories surrounding left brain / right brain stimulation thrown out? At present these 
questions cannot be answered but they remain important. 
2.4 Memory, Depression and the AIP 
In summary then, although there is plenty of evidence that EMDR can help at least some people 
with PTSD, there is little to assume it can be used equally as well with depression.  However, this is 
due to a lack of any studies rather than disconfirming research. There is poor understanding as to 
the mechanism of action behind EMDR which makes it difficult to state definitively that EMDR 
should be considered a treatment for long term depression. However, few of the posited 
mechanisms rule out the possibility of benefit in reducing the influence of negative depressive 
memories on mood.  As mentioned previously (section 2.1) PTSD and depression have many 
symptoms in common but more than that they often have a trauma history in common too 
(chapter 1.2). All three cognitive science theories mentioned in part 2.3 (AIP, emotional processing 
and neural systems model) refer to problems with the memory of the traumatic event. So 
however EMDR works in people with PTSD it is working on that traumatic memory and if a large 
proportion of people with long term depression also have problematic traumatic memories it is 
possible that EMDR would benefit such clients too. 
 
Exactly how the brain stores memories is not known but Baddeley’s multi-component model 
allows all the components of the short term memory to interact and connect with both perception 
and the long term memory (Baddeley, 2009). Several theories have been developed to try to 
explain how the different components of our memories are stored and retrieved including the 
Interacting Cognitive Subsystems (Barnard and Teasdale, 1991) and the Neural Systems Model 
(Brewin et al., 2010). These models suggest different elements such as emotions and contexts of 
situations are stored separately and then are retrieved either as a whole memory or as fragments 
of feelings or perceptions which can be the basis for pathological memories such as sadness, 
anxiety or fear. The key then would be to realign these disconnected fragments and change the 
memory. 
The process of memory consolidation allows a temporary memory trace to become stabilised and 
established in the long term memory, once consolidated the learnt memory is resistant to change 
(Walker et al., 2003).  However it can be destabilised again. There are two ways to change learnt 
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information: reconsolidation and extinction. ‘Reactivation of an apparently stable, long term 
memory can render it fragile and dependant on a restabilisation process referred to as 
reconsolidation’ (Hupbach et al., 2009). During this process memories can be either reinforced or 
altered (Suzuki et al., 2004). Animal studies have shown that fear memories can change during this 
process (Kindt et al., 2009). During reconsolidation the memory is activated, this makes it labile 
and vulnerable to disruption, when it is restabilised it may contain new information (Taylor et al., 
2009), this may have impaired or enhanced the memory trace (Dudai, 2006). Few studies have 
looked at reconsolidation of memories in humans as the main methods used in rats (protein 
synthesis inhibitors) are highly toxic (Schiller and Phelps, 2011), even fewer have looked at clinical 
populations. Only two appear to have looked at the pathological thoughts of mental health clients, 
however they do suggest that it is possible (Rubin, 1976, Brunet et al., 2008).  
 In extinction, a new memory is formed to compete with the old one (Taylor et al., 2009). The 
Emotional Processing model of CBT and exposure therapy and neural systems theory would come 
under extinction (Brewin, 2006). During exposure therapy the client is placed in a stressful 
situation but encouraged to remain rather than avoiding it. As nothing bad happens and the stress 
subsides through habituation to the stimulus and a new memory is formed of this stress free 
situation. Research suggests that CBT works via the retrieval competition account - new learning 
deactivates problematic memories, rather than changing them, by strengthening the competing 
positive representations (Brewin, 2006).  Brewin and colleagues have also hypothesised that this 
may be the mechanism behind EMDR, as the bilateral stimulation reduces emotion this becomes 
associated with a new safe, contextualised representation of the memory (Brewin et al., 2010). 
The AIP model of EMDR states that when the memory is brought to mind it can then be altered 
and restored in a more stable and adaptive manner (Shapiro, 1995). This would be coherent with 
the idea of reconsolidation (Solomon and Shapiro, 2008). Logically then, if EMDR works by 
reconsolidating the memory, after therapy it should be less distressing and contain adaptive and 
non-traumatic information that was not present before. Schiller and Phelps (2011) have shown 
how it is possible to update memories in humans during reconsolidation in a nonclinical 
population. During EMDR the memory is reactivated when the client is asked to bring to mind the 
disturbing memory. They consider the thoughts, emotions and somatic experiences that are 
associated with it, they are then asked to identify a key image and negative thought and these 
then cue the memory repeatedly during the bilateral stimulation phase. This does fit the criteria 
53 
 
needed for reconsolidation to be possible (Schiller and Phelps, 2011). These targeted memories 
could then be retested after therapy to see if their content and impact has changed.  
The theories of change for EMDR rely heavily on the idea of pathological memories. EMDR was 
developed to tackle the vivid emotional trauma memories in PTSD but negative intrusive imagery 
related to autobiographical memories are also a feature of depression (Holmes and Mathews, 
2010). Images can evoke powerful emotional states, both positive and negative and this impact on 
emotion can cause distress and contribute to the maintenance of various disorders but can also be 
harnessed in treatment (Holmes and Mathews, 2010). This is seen in imaginal exposure but can 
also be done by other methods such as imagery rescripting, imagery reduction via competition and 
EMDR. Several studies have shown that it is difficult to hold a negative image in mind and perform 
a task which uses related cognitive resources (Holmes and Mathews, 2010), doing this appears to 
reduce the impact of the negative intrusive image (Holmes and Mathews, 2010) this working 
memory disruption has been proposed by Gunter and Bodner (2008) to be at least part of the 
mechanism behind the success of EMDR to treat negative images. 
The biggest problem for the AIP model when it comes to depression is that it claims that 
problematic memories are isolated and ‘frozen in time’ and that EMDR will process them and help 
them integrate with the rest of the memory network (Solomon and Shapiro, 2008). However, 
negative memories, which are very salient in depression, could be described as overprocessed and 
incorporated into the self-schemata. They are certainly not isolated. A childhood memory that 
teaches a girl she is worthless is not separate, in depression it has become how she defines herself. 
However, there is a contradiction here as well. When you ask the adult to remember that event 
from childhood the memory is raw, vivid and emotional and she will avoid it if possible. This is 
exactly what the AIP predicts. The mix of both overprocessed elements and underprocessed 
elements of the same memory suggest a more complicated memory processing system than the 
AIP describes. Models like Interacting Cognitive Subsystems (Barnard and Teasdale, 1991), allow 
different elements of a memory to be overprocessed in one subsystem and underprocessed in 
another.  
The memory research does then indicate that it is possible for memories to be stored in a way that 
means the emotion and context are split. There are many similarities between onset and 
symptoms of long term depression and PTSD, including childhood trauma, negative and 
overgeneral autobiographical recall as well as sleep disturbance, anhedonia, disproportionate guilt 
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and poor concentration. Although the theories are divided as to how EMDR may be able to affect 
change in these problematic memories from childhood they are not divided on the key concept, 
that it is possible. 
2.6 Formulating the research questions 
As chapters one and two have shown, research looking at EMDR as a treatment for people with a 
primary diagnosis of long term depression is no more rigorous than a single case study; even in 
acute depression, studies are lacking. There have been conference reports of some unpublished 
work in Germany (Hofmann, 2012). However the EMDR community often cites studies that look at 
PTSD with comorbid depression as proof of success in treating depression (Shapiro, 2009a). 
Despite this, the collected case studies do suggest that EMDR as a treatment for depression is 
worth investigation. Theoretically this should be the case. Shapiro’s AIP model does state that the 
cause of mental distress is the inadequate processing of traumatic events (Solomon and Shapiro, 
2008) and a large number of cases of depression appear to be linked to early traumatic events and 
common to both depression and PTSD are the intrusive memories of these events (Holmes and 
Mathews, 2010). 
This led to the development of the first research questions and the main objective of this project; 
is there an improvement in depressive symptoms following a course of EMDR? As social 
functioning is an important factor in the quality of life for people with long term depression 
(Schramm et al., 2011) this was also included, as was a follow up period to see if any 
improvements were maintained. No form of psychotherapy is suitable or helpful to all people in all 
circumstances. Investigating who may benefit from an individual therapy is an important part of 
being able to target the correct type of therapy to the correct client. It is useful, when developing 
a treatment, to look into those who did not respond in as much detail as those who did. By looking 
for patterns in these two groups, health services can begin to treat people more effectively by 
treating them with the therapy that is more suited to them (Hunt, 2012). This can also reveal 
information about the processes involved, who may be likely to benefit from the new treatment 
and potentially improve the treatment (Craig et al., 2008). This forms the rationale and research 
questions for study 1.2 which will look for differences between the responders and non-
responders to EMDR to see if this can reveal any information about process, types of people who 
may benefit more than others and potential opportunities to improve the treatment protocol.  
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The research questions for study two are based on the theoretical basis for EMDR, the AIP model. 
It is important to know how treatments work and there is some argument in the literature as to 
whether AIP (rather than EMDR) has actually been tested (Greenwald, 2010, Shapiro, 2010). To 
develop questions that inquire into the processes of EMDR, how it may work and what is 
happening to the client, the advice of colleagues with expertise in the field was sought. Meetings 
took place with Professor Chris Brewin, University College London, who has developed some key 
theories in the field of imagery in PTSD and depression including the Neural Systems Model 
(Chapter 2.3) and Imagery Rescripting for depression, and Dr David Blore, head of EMDR Yorkshire 
and researcher on the subject of EMDR and positive psychology. Discussions were focussed on 
ensuring a good understanding of the theories and psychology behind the AIP, neural systems 
model and emotional processing. The initial aim was to test direct predictions from these models 
to see which best fit the clients experience however, it became clear that it would not be possible 
as identifying consistent predictions across the models is not straightforward. One of the few 
areas where all three models are explicit is how they affect the client’s memories, with emotional 
processing and the neural systems model asserting habituation whereas the AIP claims EMDR uses 
reconsolidation.  
The integrated model of EMDR proposed by Gunter and Bodner, (2009) and discussed in chapter 
two (2.3) combines some of the observed clinical changes that occur during EMDR however their 
model seems incomplete. They assert that the chain of events, working memory disruption, 
psychological distancing and physiological responses then allow PTSD symptoms to decrease. They 
do not describe how this occurs however. Reconsolidation of memory has been linked with EMDR 
theory too but not in a form that allows for testable predictions (Solomon and Shapiro, 2008). An 
extended version of Gunter and Bodner’s model is proposed here that incorporates theories of 
memory retrieval and reconsolidation as the processes by which EMDR effects long term change in 
pathological symptoms (Figure 2.2).  This model offers an explanation for the processes that occur 
during EMDR and how that improves pathology in mental health clients. Investigators of working 
memory have shown that the first three stages (activation and destabilisation of the memory trace 
and imagery reduction via competition in the working memory) of the model occur under 
laboratory conditions (Baddeley, 2009, Hupbach et al., 2009, Holmes and Mathews, 2010, Lilley et 
al., 2009). Numerous studies have shown that physiological stress responses are affected by the 
EMDR process during the therapy session (Bergmann, 2010). This model proposes that the 
pathological memory is reactivated when the memory is targeted in EMDR, destabilised and then 
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the dual attention (bilateral stimulation) taxes the working memory. This allows the emotionality 
of the memory to reduce, likewise the physiological responses also reduce, and the installation of 
the positive cognition and future template during the EMDR process allow the memory trace to 
access adaptive material. The original memory is then reconsolidated as less distressing, less 
emotional, with a reduced physiological response and adaptive material incorporated. This 
reconsolidated memory should then remain stable and adaptive unless a new situation occurs that 
reconsolidates it again.  This model links current work on working memory with the results of 
observational studies on the effect of bilateral stimulation to promote a more comprehensive 
theory on the working of EMDR. 
Figure 2.2: An extended integrated model of memory retrieval and reconsolidation as a 
mechanism of change in EMDR – The reconsolidation model of EMDR. 
  
Previous research has looked at memory retrieval mechanisms but later stages of the model 
(boxes 4, 5, 7 and 8) which are specific to EMDR have not been fully tested (Gunter and Bodner, 
2009). Lilley et al (2009) have shown that bilateral stimulation leads to a reduction in emotionality 
and vividness during dual attention (box 4) but the lasting effect of this can be measured by 
continuing the ratings after therapy and at follow up, the same is true of the physiological effects 
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(box 8). If the original memory is reconsolidated then analysing the content of the memory before 
and after therapy should allow researchers to evaluate if this has changed, the model predicts that 
the memory will have changed and it will contain positive and adaptive information that was not 
present before therapy (box 7). As a reconsolidated memory is a stable one then this content 
should remain consistent at follow up (box 8), unless the memory has been reactivated by a new 
event. If it has this may have led to another reconsolidation event which may be positive or 
negative. Directly testing reconsolidation of existing memories in humans is very difficult, most 
studies look at cue/response test/retest methods (Schiller and Phelps, 2011). So other stages of 
the model in Figure 2.2 must be the focus of this study. The model in figure 2.2 predicts that 
bilateral stimulation during EMDR will lead to the reduction of the emotional response triggered 
by the memory and the vividness of the memory experienced by the client (box 4). This study will 
test this by using Likert rating scales before and after treatment. It also predicts that there will be 
a corresponding reduction in physiological arousal triggered by the target memory (box 5), this 
study will also measure heart rate variability and skin conductance response before and after 
treatment. The model predicts that when the memory is recalled by the participant after 
treatment it will be less distressing and contain adaptive material that was not present before (box 
7). This study will test this using content analysis of the participant’s descriptions of their 
memories. Finally this should all be stable at a follow up period if reconsolidation has occurred 
(box 8). This study will therefore repeat the post therapy tests at a follow up period some months 
after treatment has finished. As these tests could be run in conjunction with a standard course of 
therapy they could also be compared to psychometric tests of pathological symptoms and social 
functioning. This series of tests would not only investigate the effects and processes involved in 
EMDR but also whether any changes in memories  are linked to changes in pathology which is, 
after all, the goal of psychotherapy.   
During EMDR, the AIP model tells us, the traumatic memory that has caused the mental distress is 
accessed and ‘reprocessed’ so that it becomes integrated with the wider memory network and 
able to link to adaptive knowledge (Solomon and Shapiro, 2008). Transcripts of EMDR sessions 
where clients are describing how these memories change are common in books written by EMDR 
professionals (Shapiro, 1995, Shapiro, 2009a) however, this does not show what happens to these 
memories in the long term, outside of the therapy session. By asking participants to describe their 
memories and rate their distress in a standardised way before reprocessing, after it and after a 
follow up period it may be possible to assess what EMDR is doing to the client’s memory content 
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on a longer term basis. An important issue here is whether it can be considered stable enough to 
research over a six month period. Earlier work has shown that the central features of 
autobiographical memory are accurate and stable over time and despite the memory difficulties 
which characterise depression recall of significant past events does not appear to be affected by 
mood state (Brewin et al., 1993).  
Several studies have investigated the psychophysiological responses within the EMDR session that 
appear to accompany the decreasing subjective distress of the participant (Gunter and Bodner, 
2009, Bergmann, 2010). Again these measurements have been done during the session and do not 
show what happens outside the therapist’s office and over a longer time period. Nor have these 
studies performed correlation analyses to see if these observed changes in psychophysiological 
response, distress ratings and memory content are related to changes in symptomatology. 
Without these correlations there are too many questions we cannot answer. If EMDR changes 
memories but not symptoms then it is interesting but not a treatment and if it changes symptoms 
but not memories then it is a treatment but it does not work in the way the theory says it does. If 
these correlations do exist then is should be possible to attribute this change to EMDR and would 
be consistent with, at least in part some of the AIP’s assertions about the mechanism of change 
during therapy.  
Finally, but importantly, many studies comparing EMDR with other treatments have commented 
on the fact that clients find EMDR more acceptable than the comparisons. Several papers claim 
clients find that EMDR more acceptable than CBT for treating PTSD but these seem to comment 
without much information about how they came to this conclusion (Hogan, 2001), or infer this 
from lower dropout rates in the EMDR group (Ironson et al., 2002). However, there is a paucity of 
literature utilising qualitative methods to ask clients about their experiences of EMDR. Study three 
has a primarily evaluative aim. To identify the factors that contribute to the intervention (EMDR) 
being successful (or unsuccessful). For the purposes of study three the intervention is judged 
successful if the participant says it is regardless of the scores from the quantitative studies. Any 
treatment must be acceptable to clients; if someone receives a treatment that is so unpleasant 
they immediately drop out of therapy they have not been helped. Nor is it helpful if their 
symptoms ease but their quality of life remains poor as they still cannot function in society.  The 
qualitative and quantitative data will then be reanalysed as a mixed methods analysis to attempt 
to provide further evaluation. The aim here is to provide a summative evaluation of the 
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intervention – did it work? And a formative evaluation – how can it be made more effective/more 
acceptable?  
 
2.6 Summary 
EMDR’s efficacy to treat PTSD has been shown in several trials but so far research on other 
pathologies is lacking. The collection of practice based evidence suggests that EMDR has the 
potential to be a new treatment for depression but further research is necessary. Despite many 
theories and investigations into the workings of EMDR, the mechanism of action is still unknown. 
This may be partly because the way we store and retrieve memories is also not well understood. 
As well as investigating if EMDR can treat depression it will also be helpful to contribute to 
knowledge about how it does this.  
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Chapter 3 Part 1 - Discussion of the methodology 
3.1.1 Study rationale 
Despite the growing suggestion from case studies and comorbidity literature that EMDR may be a 
suitable treatment for long term depression there are no English language papers published of 
trials investigating this. Conversations with other European researchers have revealed two 
unpublished pilots but both involved adding a small number of sessions of EMDR into other 
therapeutic approaches (Hofmann, 2012).  As far as the published literature is concerned, no 
investigation has looked at EMDR as a therapy in its own right in a national healthcare setting for 
treating a primary diagnosis of depression. This is a gap in knowledge that needs addressing. 
EMDR claims to be a comprehensive psychotherapy (Solomon and Shapiro, 2008) but has not been 
investigated as a treatment for one of the world’s most common and costly mental health 
problems. The most effective approaches reviewed by the literature so far have included elements 
of cognitive, behavioural and interpersonal work but the AIP model claims that these problem 
areas are all symptoms of dysfunctional memories (Solomon and Shapiro, 2008). Preliminary work 
is needed to address whether or not EMDR has potential to be used in an NHS setting to treat long 
term depression and this requires a full course of treatment comparable to that which is provided 
by the NHS already.  
3.1.2 An introduction to mixed method research 
Before undertaking research that attempts to understand someone else’s view of the world and 
their experiences of it, it is important to have an understanding of how you view the world. This 
worldview (or paradigm) is usually defined in terms of a researcher’s beliefs about ontology (what 
is the nature of reality?) and epistemology (theory of knowledge: what is the relationship between 
researcher and knowledge? – can we know the ‘truth’?) (Denzin and Lincoln, 2011). This author 
believes in a substantial, objective reality, a world that exists ‘out there’ regardless of human 
knowledge of it or interaction with it and that with carefully designed and well conducted 
measurement and experiment it should be possible to describe this world. The author does 
acknowledge that there are significant limits on that, due to human intelligence, comprehension, 
unavoidable a priori assumptions and biases and the ability to build the precision instruments for 
measurement, that inevitably mean that the absolute ‘truth’ is frequently and maybe always 
outside of our ability to capture it, but it is nonetheless something that should be continually 
striven for. It is also important to remember that the object being measured in health service 
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research is not always the same as in the natural sciences. In the natural sciences the aim is to 
measure an event or a thing, a tangible item with an objective reality. Although health service 
research is interested in events it is also interested in human responses to these events and the 
way that a person perceives an event, both contemporaneously and later when recalling the 
memory, maybe be very different to the objective occurrence.  
As with all things, placing an individual’s beliefs into predefined boxes is never straight forward but 
these stated attitudes place the researcher in broad agreement with post-positivism and critical 
realism. Although it has been suggested that critical realism is a form of post-positivism (Lincoln et 
al., 2011) it is unclear from his writing that Roy Bhaskar agrees with this summation of his theory 
(Bhaskar, 1975) as he sees critical realism as distinct from positivism but neither he nor more 
modern writings on the subject compare it to post-positivism. Both theories maintain that an 
external reality exists and that it is not dependant on human perceptions however that scientific 
observations of this reality are flawed (McEvoy and Richards, 2003, Collier, 1994). Critical realism 
is distinguished by its position that the world is composed of events, physical and psychological, 
and underlying structures, powers and tendencies. It is the latter that than provide the conditions 
for the possibility of actual events and understanding them should be the ultimate aim of research 
(Patomaki and Wight, 2000). Both post-positivism and critical realism move away from the ‘naïve’ 
realism of positivism, where there is a true reality and a suitably objective researcher will be able 
to find this truth (Lincoln et al., 2011). Positivism is usually associated with quantitative research 
and theory testing typically using numerical data and statistical analysis (Creswell, 2009). 
Qualitative research, typically used to explore and understand meaning for individuals and groups, 
is associated with a constructivist/interpretivist approach (Creswell, 2009). Constructivists, at their 
most extreme, consider that reality is entirely subjective and socially constructed (McEvoy and 
Richards, 2006). For critical realism, it is not reality which is socially constructed but our theories of 
reality therefore ‘we can, and should, make attempts at investigating reality in itself, but do so 
cautiously and critically’ (Pilgrim and Bentall, 1999). 
Mixed methods research is research in which a researcher combines elements of quantitative and 
qualitative approaches to improve the breadth and depth of understanding and corroboration 
(Johnson et al., 2007). The increasing use of mixed methods approaches (O'Cathain et al., 2007) 
has seen the debate surrounding paradigms extend to include issues surrounding the mixing of 
approaches (Morgan, 2007). Some have argued that the two approaches are mutually exclusive 
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and contradictory and are therefore incommensurable (Lincoln et al., 2011), a mixing of methods 
is not only undesirable, it is not possible. However this author is in agreement with Bryman (2012) 
that this position confuses the difference between philosophical worldviews and research 
methods. Whilst it is true that constructivist and realist positions are contradictory and so it is not 
possible to hold both beliefs, it is not necessary to believe that all reality is a social construct in 
order to analyse the data produced in an interview. The differing research methods are tools to 
enable a researcher to answer the research question and a tool can be put to a variety of uses 
(Bryman, 2012).  
There are many reasons to want to mix methods to create a more robust research strategy, these 
include but are not limited to, offsetting the weaknesses and utilising the strengths of both 
approaches and developing a more comprehensive account of the phenomenon by getting 
different points of view. The researcher may wish to answer different research questions within 
the project that are suited to different approaches. Findings from one part of the investigation 
may be helpful in illuminating unexpected findings from the other. A mixed methods approach 
may help to improve the utility of the findings, by not just looking at whether an intervention 
works but also how people have reacted to it and experienced it, the findings may be more useful 
to the practical application of the intervention in the real world (Bryman, 2006, O'Cathain et al., 
2007). In light of the controversy regarding paradigms, there are different theoretical arguments 
to justify mixed methods research.  
Pragmatism is a fairly new philosophy of research and has developed with mixed methods 
research; it is not concerned with the arguments of epistemology and ontology and advocates 
purely that a researcher uses the method which best suits the research question he or she is trying 
to answer (Creswell, 2009). Pragmatism can be considered as a set of conceptual tools to solve 
problems rather than a philosophical position (Teddlie and Tashakkori, 2011). Critical realism is 
logically in favour of mixed methods; it claims there are three overlapping domains in the world, 
the ‘empirical’, which is those aspects of reality that we can experience directly or indirectly, the 
‘actual’, aspects of reality that occur but may not be experienced and the ‘real’ which is the 
underlying structures and mechanisms that generate phenomena (Bhaskar, 1975, McEvoy and 
Richards, 2006). Quantitative methods investigate the ‘empirical’, qualitative, the ‘actual’ and by 
combining the two the researcher can begin to develop an understanding of the ‘real’ (McEvoy 
and Richards, 2006). Post-positivist thinking also welcomes mixed methods as a way of capturing 
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as much of reality as possible (Denzin and Lincoln, 2011), especially when the mixed method 
design has the quantitative section occurring first and given priority (Creswell et al., 2003), but 
also because post-positivists are open to the idea of aspects of society being social constructions 
(Onwuegbuzie, 2000). The extent and importance of these arguments varies in different disciplines, 
within the social sciences there is still a ‘quant-qual divide’ but in health service research mixed 
methods approaches are increasingly used and accepted with a view that they complement each 
other and the discipline’s aims (Pope and Mays, 2006). 
3.1.3 Single Case Experimental Design 
There remains some controversy over the best way to investigate a psychotherapeutic approach. 
The NICE guidelines are based heavily on the results from randomised controlled trials (RCTs). This 
has been heavily criticised by the UK Council for Psychotherapy, who consider that this approach 
has led to the favouritism of CBT. RCTs are very expensive to run and as such there are not many 
to be found which investigate the psychotherapies which last for years rather than weeks. As there 
are no RCTs to show their effectiveness then they are not recommended. This does not mean, 
however, that they are not effective at reducing symptoms (Guy et al., 2010). Other criticisms of 
RCT come from practiced based evidence and that RCTs are not actually as representative as they 
claim to be because of the strict exclusion criteria usually associated with them. In the real world 
most clients have multiple problems (comorbidities) so what we actually need to know is whether 
the treatment is effective in these circumstances (Parry, 2000). RCTs have very good ‘internal 
validity’ but we cannot be sure of their ‘external validity’ (Hunt, 2012). This is the rationale for 
conducting RCTs in clinical practice. This still has the problem however, that a client who agrees to 
be randomised may not be a typical client.  
The hourglass model (Salkovskis, 1995)and also the current Medical Research Council’s (MRC) 
guidelines (Craig et al., 2008) on developing and evaluating complex interventions, consider the 
RCT to be one step in the process. There is much to be done before we can conduct an RCT 
effectively and there is much to be done after it to confirm and refine our knowledge. The MRC 
guidelines state that there are five key stages to the process; develop an intervention, piloting and 
feasibility, evaluating the intervention, reporting and implementation. The guidance states that at 
this stage there are two questions that need answering, does the intervention work in everyday 
practice and how does it work (Craig et al., 2008)? Many would argue that in the case of EMDR 
there is sufficient evidence to be confident it works in everyday practice for many people with 
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PTSD. How it works has been less convincingly argued, and there is scant evidence at all that it is 
an acceptable treatment for depression (Chapter 2). The design of this study has then started at 
the beginning of this process. The intervention has already been developed but little more than 
that is known about it.  
For this reason alone it would then be difficult to justify an RCT at this stage. The MRC warn 
against forgetting about the piloting and feasibility part of the process (Craig et al., 2008). This is 
essential to lay the groundwork if future RCTs will be worth the expenditure, resource and burden 
to the clients. The other question raised from the idea of doing an RCT is what will the comparison 
arms of the trial be. In mental health this is commonly medication or the usual psychotherapy 
treatment. Without access to pharmacological support a medication comparison was unlikely in 
this study and to compare with a different type of psychotherapy would require a very large 
number of therapists to be dedicated to the research. To get funding for these types of 
comparisons it is vital to show that the new intervention is able to compete with these established 
treatments. As chapter two has demonstrated there is little evidence to suggest EMDR may be as 
successful at treating depression as CBT. One option is to compare EMDR to no treatment. A pilot 
RCT like this was considered as this design could be a test to find out if there is any reason to do a 
large RCT however this means denying therapy to depressed clients and the potential unnecessary 
distress it may cause in the control group was considered unacceptable. There were also concerns 
about moving to a trial prematurely without first conducting a feasibility study to develop a safe, 
acceptable and potentially effective intervention. After consulting with the local NHS ethics 
committee it was clear that this would not be supported. Using a single case design was 
considered so that a control group was not necessary. 
 
Single Case Experimental Designs (SCED) are common at this stage of developing a psychological 
intervention. They are more robust than an anecdotal case study and attempt to show 
effectiveness in the individual (Barker et al., 1994). Although this can cause a problem for the 
generalisability of the results, undertaking a clinical replication series, preferable on a 
heterogeneous client group, can help (Kazdin, 1998). SCED or ‘N of 1’ studies are not new they 
have been around since the 1950’s and when done properly can be considered among the highest 
levels of evidence, higher for some purposes than an RCT (Glasziou, 2011). The Oxford Centre for 
Evidence Based Medicine recently suggested that the SCED trial (along with the systematic review 
of randomised trials) was the best way to answer the questions, ‘does this intervention help?’, 
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‘what are the common harms?’ and ‘what are the rare harms?’ (OCEBM, 2011). They are 
particularly suited to research questions that investigate causal relations by examining the effects 
that introducing or manipulating an independent variable (for example psychotherapy) has on a 
dependant variable (such as depression and social functioning) (Horner et al., 2005).  
How the method will provide rigorous data 
Single case experimental designs address individual uniqueness and complexity (Barker et al., 
1994); they have been used extensively in the history of psychotherapy research especially in 
Behaviour Therapy and clinical psychology. In SCED, data are collected throughout the research 
period not just at the start and end of treatment. This continuous or repeated measure is begun 
before treatment starts. This baseline phase is designed to show the stability (or lack thereof) of 
the participant’s symptoms prior to the onset of treatment and is often called a predictive baseline 
as it is predictive of a person’s symptoms if the treatment had not been administered. In this way 
the participant acts as their own control by providing data showing how their symptoms change 
with and without treatment, these can then be compared (Barlow and Hersen, 1984). By studying 
one person in detail the design seeks to exclude other explanations for any effect seen during the 
treatment period.  The standard design for demonstrating change during a SCED study is to use an 
ABAB design where a baseline period (A) precedes treatment (B); the treatment is stopped (A) and 
then reinstated (B). However this raises two serious issues, firstly that if a treatment is helping to 
address a serious or life threatening condition then removing it is unethical (Turpin, 2001) and 
secondly, not all treatments are reversible, indeed many are intended to have sustained effects 
after the treatment is completed, so removing it may not actually lead to a relapse of symptoms 
even if the therapy is highly effective (Barker et al., 1994). In this case EMDR is not considered to 
be reversible. The current presiding theory supporting EMDR, the AIP, predicts that once change 
has occurred in the problem memory then it will not revert back to causing distress without a new 
distressing incident occurring. Although using an ABAB design could test this theory this is not the 
aim of this research. Before we can test the theory that memory change caused by EMDR is 
irreversible we must first be sure there is memory change. One of the aims of this research is to 
investigate this. As it is not clear what the mechanism of change is in EMDR, at this point we must 
assume that whatever it is, it is irreversible. It is also not appropriate to test the predication that 
the effects of EMDR are non-reversible in a novel population. 
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Due to this an ABAB design is not appropriate in this research. An AB design will therefore be used. 
This will see a baseline period, of at least one week, followed by a treatment period, up to 20 
twice weekly sessions. The problem with the AB design is that it is weaker at demonstrating the 
causal influence of treatment than the ABAB design (Barker et al., 1994). However, this 
disadvantage can be offset with additions to the research process. Firstly it is necessary to 
demonstrate that change actually occurred. A repeated (daily) measure, based on the DSM-IV-R 
criteria for depression (APA, 2003), will show how the participant’s depressive symptoms have 
changed over time and will reveal trends over the research period, such as a difference between 
the baseline phase and the treatment phase (Kazdin, 1998). Additional standardised measures 
before and after therapy and at follow up will allow differing aspects of the participant’s 
symptoms to be analysed. The additional assessment point at follow up should show if any 
improvement during the therapy period has been maintained. By repeating the SCED design on 
multiple participants it is possible to improve the generalisability of the findings, especially if the 
participants are heterogeneous in areas such as gender, social class, severity of symptoms and 
other demographics (Kazdin, 1998).  
It is also necessary to link any change to the therapy provided (Barker et al., 1994). It is unlikely 
that any one measure can definitively answer this point but by taking several measures and linking 
this evidence it improves validity of the conclusions. However, if a participant has change in a 
chronic or stable condition it is likely that change is due to the intervention. Another method is to 
ask the participant for their view of what has caused change to occur. It is also possible to look for 
correlation between symptom change and therapy events. It is also important to rule out 
alternative explanations for change, these can be that change did not actually occur (participant 
shows no improvement or deterioration, reported improvement is due to statistical or relational 
artefacts) or that change did occur but it was not due to the specific therapy (participant engages 
in self-correction due to improved self-awareness, extra therapy factors such as positive life 
events occurred, psychobiological factors or the reactive effects of research caused change) 
(Barker et al., 1994). 
SCED designs also allow for an examination of the therapy process. By using a self-report session 
measure, such as the Helpful Aspects of Therapy (HAT) form, it is possible to get the participant’s 
view on which parts of the therapy process they are finding helpful and which are not and why. 
This is often very different from the therapist’s view which is more usually reported. Here the HAT 
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will inform the interview schedule which will allow the participant to explore their experiences and 
give their views on the therapy process.  
Analysis of the SCED data  
The data from SCED studies are typically analysed by visual inspection of a graphical 
representation of the changes recorded by the ideographic measure. In the visual analysis a graph 
of the ideographic data are plotted in a time series analysis and the reader judges the immediacy 
of the effect, the proportion of overlap between baseline and intervention and the magnitude and 
consistency of change (Horner et al., 2005). An example of this type of graph is displayed in Figure 
3.1.1.   
 
There are several advantages to this method; it is quick to make graphs and draw conclusions from 
them, graphed messages are immediate and accessible to the reader, minimal transformation of 
the data is required and the theoretical premises underlying graphs are minimal, well known and 
well understood (Parsonson and Baer, 1992). In the example in figure 3.1.1, a higher outcome 
score indicates worse symptoms so we have a client with a stable but severe baseline who initially 
responds well to treatment, there is a reversal in her symptoms which then responds again and 
remains stable over the follow up period. However there are serious problems with relying on 
visual inspection alone; outliers can skew results, results may be autocorrelated (client A’s mood 
today is linked to his mood yesterday) and cyclicity in biological rhythms may appear as treatment 
Figure 3.1.1: A time series graph of ideographic data 
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effects and even experienced researchers can have difficulty recognising and interpreting such 
data (Franklin et al., 1996). Integrating the visual analysis with a statistical approach is advisable 
when a stable baseline cannot be established, a new treatment is being evaluated or findings are 
to be shared with other professionals (Franklin et al., 1996). This is because the visual display is 
descriptive and the statistical analysis is inferential and predictive and so by combining the two it 
may increase the validity of the findings (Franklin et al., 1996).  
Autocorrelation (or serial dependency) is a problem for SCED studies because it means there are 
non-random processes in the time series and this can affect both visual and statistical analyses 
leading to an increased risk of a type one error (Busk and Marascuilo, 1992). Autocorrelation is the 
extent to which values at time t(Yt) are correlated with values at time t-i(Yt-i) (Matyas and 
Greenwood, 1996). There are different types of non-random patterns that can be present in the 
data, trends (also referred to in the literature as maturation - systematic increases or decreases in 
observed values over time), periodicity (regular, rhythmic or cyclic fluctuations of values over time) 
and variability (deviations around a mean level) (Gorman and Allison, 1996). AB designs are 
particularly susceptible to maturation and ABA or ABAB designs are more vulnerable to cyclicity 
(Beasley et al., 1996). The presence of autocorrelation does not mean the data from a SCED is not 
useful, but it does mean that it will require a more complex statistical analysis. Although there is 
some disagreement about the extent of autocorrelation and its effect, it is wise to assume that 
observations are not independent; however this invalidates the assumptions of many parametric 
tests (Busk and Marascuilo, 1992). By using time series methods or randomisation tests the data 
can be transformed to remove the effect of the autocorrelation and then standard statistical tests 
can be performed (Busk and Marascuilo, 1992, Beasley et al., 1996).   
One of the criticisms of SCEDs is that an intensive study of one case cannot be generalised to the 
larger population. This can be mitigated through replication. If it does matter it is possible to 
perform a meta-analysis on a collection of case studies (Manolov and Solanas, 2008). By 
combining the results from many case studies the meta-analysis can be used to provide a point 
estimate of effect size, confidence intervals around the effect size and search for variables that 
mediate the effect size (Faith et al., 1996). Meta-analysis of SCED studies allows comparison across 
individuals, systematically investigates effect size and allows objective and systematic review of 
large numbers of replications (Busk and Serlin, 1992). As this study will include several SCED 
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studies that will all have been carried out under near identical conditions they will be suited to 
meta-analysis as they will be very homogenous and equally weighted. 
Skin conductance response  
The link between treatment outcomes and theoretical explanation is remarkably weak in 
psychotherapy in general (Salkovskis, 2002) and in EMDR in particular. When Ricky Greenwald 
challenged the AIP as untested, Francine Shapiro’s response was that because EMDR had been 
shown to be successful in over 20 RCTs this also showed the accuracy of the AIP model (Greenwald, 
2010, Shapiro, 2010). This is an unjustified assertion. It is possible for treatment trials to inform 
theory but only if the correct mechanisms are built into the experimental design.  
As was highlighted in chapter 2.3 there are many theories as to the mechanism of action in EMDR 
but one with slightly more empirical evidence behind it is the working memory model. To recap, 
several working memory researchers have shown that a memory stored in the long term memory 
but brought to mind in the working memory is changeable and a distressing memory can lose its 
emotionality and vividness in the presence of eye movements (Andrade et al., 1997, Kavanagh et 
al., 2001, Gunter and Bodner, 2009).There are two main ways to measure this change in response, 
by asking the participant to mark scores on a Likert scale or to measure physiological indicator of 
arousal. This is why this research will also consider the client’s psychophysiological response to 
their target memory. Heart rate variability (HRV) is recognised to be generally lower in depression 
clients than non-depressed controls (Rechlin et al., 1994, Carney et al., 1995, Agelink et al., 2002, 
Licht et al., 2008) and has been used in several studies to look at the change in arousal levels after 
EMDR (Sack et al., 2008, Sondergaard and Elofsson, 2008, Gunter and Bodner, 2008). Skin 
conductance response (SCR) is frequently used in anxiety and distress research. Numerous studies 
have used SCR to look at the effect of EMDR on a participant’s stress levels. However, in anxious or 
stressful situations SCR is high. Several studies have shown that skin conductance in depressed 
clients is often lower than controls (Argyle, 1991, Ward et al., 1983). The common usage of these 
two measures in the depression and EMDR literature and the ease of data collection without the 
need for large scanners or high investment mean this study will also use SCR and HRV. 
Conductance is the degree to which an object conducts electricity (Oxford dictionary). Electrical 
conductance is measured in Siemans and is equivalent to electrical current (Amperes) divided by 
electric potential difference (Volts) and it is the inverse of electric resistance (Ohms) (Thompson 
and Taylor, 2008). Skin conductance response is therefore a change in the electrical properties of 
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the skin in response to a given stimulus (Tarvainen et al., 2000). In the literature skin conductance 
response (SCR) is often used interchangeably with galvanic skin response (GSR), sympathetic skin 
response (SSR), skin conductance orientating response (SCOR) and skin conductance level (SCL). 
However, there appears to be some confusion over what is actually being measured in these five 
different responses. For example, galvanic skin response has been described as a measure of skin 
resistance and sympathetic skin response is a measure of potential difference (Arunodaya and Taly, 
1995). As resistance should be measured in ohms and conductance in µSiemens it is then odd that 
Tarvainen et al (2000) then report their GSR in microSiemans (µSiemens).  
There is also an issue with exactly what is being measured as the response, SSR, which is described 
by Kanzato et al (1997) as a transient change in the electrical potential of skin, is demonstrated in 
their paper to be a biphasic response with negative wave followed by a positive wave before the 
voltage returns to normal. This gives three possible ways of measuring sympathetic skin response 
the amplitude of the negative peak, the amplitude of the positive peak or the peak to peak 
amplitude. Tarvainen et al (2000) also describe GSR as a biphasic response. Those who describe 
which one they have used describe the peak to peak amplitude (Kanzato et al., 1997, Kucera et al., 
2004) but there is a huge range of ‘normal’ values for SSR in the literature and this may indicate 
that not everybody is using the same measure. In Raines et al’s (1991) investigation of skin 
conductance orientating response four different measures are quoted, all measured in µSiemens 
but all with markedly different values with no explanation as to why they are different. These are 
SCOR, SCR at rest, SCL and amplitude of SCR. This is important because to compare (Kucera et al., 
2004) results with the literature it is imperative to know what is being compared. For example 
Guinjoan et al (1995) found that depressed clients had a significantly larger SSR than controls 
however Ward et al (1983), who was looking at skin conductance level, found the exact opposite. 
In fact this paper found the skin conductance level for clients with major depressive disorder was 
significantly lower than controls consistently enough to recommend this as a biological test for 
depression with a sensitivity of 87% and specificity of 89%.  
From the different language used in the names of these measures and the way they are used 
across the literature it could be assumed that skin conductance level should refer to the resting 
level of conductance of the skin measured in µSiemens. The skin conductance response should be 
to change in that level of conductance following a given stimulus and would be the peak to peak 
amplitude measured in µSiemens. Sympathetic skin response would be the same thing but 
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measured as a change of potential rather than conductance. No definition was found for the skin 
conductance orientating response and galvanic skin response is either exactly the same as skin 
conductance response or may be a measure of resistance as opposed to conductance. Due to this 
confusion this study will focus on skin conductance response (using the definition above) and does 
not consider that these five terms are necessarily interchangeable; although they are all clearly 
related. 
However whatever name, these skin conductance responses are measures of electro-dermal 
activity and as such reflect activity in the sympathetic nervous system (Vetrugno et al., 2003). The 
sympathetic nervous system (SNS) is the part of the autonomic nervous system which mobilises 
our fight and fight response as opposed to our parasympathetic nervous system which maintains 
rest and digestion states. The SNS also has a large role in maintaining homoeostasis and as such, it 
is nerve impulses from the SNS which trigger sweating. There are two types of sweating, 
thermoregulatory and emotional (Vetrugno et al., 2003). Whilst thermoregulatory sweating is a 
response to being too warm and occurs all of the body emotional sweating is a component of the 
orientating response and occurs when our attention is directed to a novel significant stimulus. As 
sweat contains salts, as we sweat we increase the conductive properties of the skin and this is 
what skin conductance response measures. As the SNS causes us to sweat when we are 
emotionally aroused we can therefore use electro-dermal response is a measure of sympathetic 
arousal. Brain mechanisms underlying the generation of the SCR are also those implicated in 
emotional processing (Critchley et al., 2000). By measuring skin conductance response whilst 
recording target memories identified during the EMDR process, this research is testing the 
hypothesis that before therapy these target memories are causing the client distress and therefore 
increasing sympathetic arousal. The AIP model then claims that after therapy the EMDR process 
will have reduced the distress associated with these memories and as a consequence reduce the 
level of arousal that occurs when these memories are brought to mind. 
There have been five studies which look into electro-dermal activity and EMDR or eye movements 
specifically. Barrowcliffe et al (2004) investigated eye movements in nonclinical settings and with a 
nonclinical population, skin conductance response was reported as the square root of µSiemens; 
this was to reduce skewedness. Their results showed that eye movements did reduce the level of 
arousal. Sondergaard and Elofsson (2008) measured skin conductance response in PTSD clients 
and found that there had been a significant decrease by the end of the session this was again 
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measured in µSiemens. Wilson et al (1996) investigated GSR in clients with anxiety phobia and 
PTSD they found a significant reduction in GSR during the session of EMDR. GSR here was 
measured and reported in polygraph chart units (Wilson et al., 1996). Dunn et al (1996) 
investigated EMDR on nonclinical university students and found a decrease in skin conductance 
response measured in microvolts (further indication of the confusion surrounding SCR), however 
this was not significant (Dunn et al., 1996). Aubert-Khalfa et al (2008) measured skin conductance 
response of PTSD clients before and after an EMDR session they measured this in two states, one a 
relaxed state and then one when they were visualising their own traumatic event. There was a 
significant decrease in the difference between these two readings after therapy and this reduction 
in physiological state was correlated with a reduction in symptoms (Aubert-Khalfa et al., 2008). 
These results would appear to support the AIP claim that the EMDR process reduces the 
emotionality of past disturbing memories and as such reduces the negative effect that these 
memories than have on mood, stress levels and general emotional state. However when we are 
looking at anxiety disorders, we would expect a decrease in electro-dermal activity to correlate 
with a decrease in severity of symptoms. This is because anxiety is an over activation of the SNS 
leading the heightened levels of arousal in unnecessary circumstances. Depression however 
generally sees a dulling of affect and depressed clients regularly record lower than normal levels of 
electro-dermal activity. This then makes it difficult to predict how skin conductance response will 
alter following EMDR treatment for depression. 
Heart rate variability 
Heart rate variability (HRV) is another marker of autonomic activity. HRV however is more 
associated with the influence of the parasympathetic nervous system. The parasympathetic 
nervous system’s influence is mediated by the vagus nerve releasing acetylcholine. HRV, especially 
high-frequency HRV, is associated with this parasympathetic input. HRV is in fact not the variability 
of the heart rate but the variability of the interval between consecutive beats; it measures 
fluctuations in autonomic inputs to the heart rather than the mean level of autonomic inputs. 
Therefore both autonomic withdrawal and saturation lead to diminished HRV (Camm et al., 1996). 
Like skin conductance response there are numerous different ways with which to refer to heart 
rate variability. However unlike skin conductance response these are well defined and can be split 
in the time domain methods and frequency domain methods. The heart rate variability guideline 
(1996) covers the main measurements in each of these areas and has recommendations for 
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researchers to use in different circumstances. Of the time domain methods, the recommendation 
is to use the RMSSD, which is the root mean square difference of successive NN intervals. This is 
considered to have better statistical properties than other methods of measuring the NN ratio. 
Frequency domain methods, for example the ratio between high and low frequencies generated, 
are recommended by the guide as preferable however they also say that the results from 
‘frequency domain analysis were equivalent to those of time domain analysis and that the latter 
are easier to perform’ (Camm et al., 1996). HRV is frequently found to be significantly lower in 
depressed clients than in healthy controls, this is also found in clients with stress and anxiety 
disorders. The general consensus of the literature appears to be that the heart rate variability of 
anxious clients increases following session of EMDR. 
The literature reveals three studies that have looked into the use of heart rate variability as an 
indicator of arousal when using EMDR. Sack et al looked at the HRV readings taken during reading 
of a trauma memory script and a neutral script before and after an EMDR session on the trauma 
memory. They found whilst the change in heart rate data significantly decrease after therapy there 
was no significant increase in HRV. Sondergaard and Elofsson (2008), in the study mentioned 
before with PTSD clients also considered heart rate and heart rate variability. This team did find an 
increase in HRV as measured using the frequency domain method. Gunter and Bodner (2008) also 
used the natural log of the high-frequency power spectrum in their investigations. They also found 
an increase in HRV during processing. Their conclusion was that this meant there was an increase 
in arousal and that this is then a problem for the theory which claims eye movements cause ‘de-
arousal’; but as HRV is reduced in depressed and anxious clients and increased HRV is a the goal of 
treatment and signifies a reduction in arousal, so it is unclear what Gunter and Bodner mean by 
this.   
We can utilise these physiological markers of arousal within this study. As part of the normal 
process of EMDR clients identify at least one traumatic memory to desensitise. Once this memory 
was identified by the participants, the memory narrative was recorded. Whilst this memory was 
vocalised the participant had the SCR and HRV measures taken.  This happened before processing, 
at the end of therapy and at the follow up period. If the predictions of the AIP are correct then the 
HRV will increase, it is not clear what the SCR will do but it should be consistent across all 
participants. Any psychophysiological response should be correlated with any change in subjective 
rates of distress and with changes in the memory narrative. 
74 
 
Comparing responders and non-responders 
Non-responders to treatment can tell us about the different groups that may or may not benefit 
from different types of therapy. By comparing the responders and non-responders we may be able 
to discover who will be most effectively treated by EMDR for depression. It may be that non 
responders have not fully processed their memories, or that it was not the memories that were 
the problem in the first place. This forms the rationale and research questions for study 1.2 of this 
study which will look for differences between the responders and non-responders to EMDR to see 
if this can reveal any information about process, types of people who may benefit more than 
others and potential places to improve the treatment protocol. 
It is important to define non-response before the study begins. This definition will differ between 
studies depending on the conditions being studied and the treatment offered. Here remission was 
defined as a score of eight or lower on the 24 item Hamilton Rating Scale for Depression (HRSD), 
response was defined as at least a 50% reduction from baseline and a final score of 15 or less on 
the HRSD this definition was used by Schramm et al (2011) and the ReVAMP trial (Kocsis et al., 
2009). By defining both response and remission the study can look into groups of clients who, by 
the end of the treatment no longer meet the criteria for depression, but also those who are 
improving but are still depressed. This second group is important; their existence can mean several 
things. EMDR may be efficacious but need more than 20 sessions for most people or it may be that 
EMDR is only part of what is needed so although it can reduce symptoms it cannot remove them 
completely. Unless we look at response as well as remission we cannot begin to answer these 
questions. 
Some studies have tried to identify non-responders to treatment, to classify them and to treat 
those whose conditions are ‘treatment resistant’. The idea of treatment resistance is common but 
not well defined. Thase and Rush have attempted to classify non-response in depression, and 
described a five stage model of treatment resistance. However, this is primarily based on the use 
and failure of medication (and electroconvulsive therapy) and makes nothing but a passing 
mention of psychotherapy, which the authors consider offers little more than a supportive role 
(Thase and Rush, 1997). Likewise, the World Federation of Societies of Biological Psychiatry regard 
treatment resistance to be the failure of two or more antidepressants from different drug classes 
(Bauer et al., 2007). In much of the literature treatment failure and treatment resistance is 
assumed for chronic and long term depression although it is rarely defined. It is assumed that if 
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someone has been depressed for several years, they will have received at least one, probably 
more treatment and this has failed (Schramm et al., 2011, Cuijpers et al., 2010b).  
Other authors have tried to identify the characteristics of non-response to treatment and non-
response appears more likely in some presenting symptoms (Taylor and Abrams, 1975). Saxon et 
al (2008) found that one of the factors that was most associated with non-response was a 
diagnosis of long term depression. However they were looking at brief counselling and suggested 
that long term depression requires more than six sessions to treat (Saxon et al., 2008). Other 
factors that have been identified include economic inactivity (i.e. unemployment) and being male 
(Saxon et al., 2008, Shepherd et al., 2005), age at onset and number of problem episodes (Roth 
and Fonagy, 2005) and chronicity (Thase and Howland, 1994). Although there were significant 
differences between those who responded to treatment and those who did not these differences 
were not large enough to be predictive (Saxon et al., 2008). Due to the small number of 
participants in this study and that randomisation of these characteristics was not possible this 
study will not be able to claim it can predict response but it will be able to systematically explore 
the data generated (Shepherd et al., 2005) to see if these factors are also important here.  
3.1.4 Semi Structured Interviews  
The qualitative data were collected from semi structured interviews. Interviews were chosen to 
provide total focus on the individual and investigate their perspective (Ritchie, 2003). They were 
semi structured because although the aim was to uncover the attitudes and experiences of the 
clients, the study required some specific information from them (Bowling, 2009); it also allowed 
the interviewer leeway to respond to the answers given and topics do not need to be covered in a 
predefined structure. The semi structured format allowed the interview to be flexible and in depth 
(Bryman, 2012). Some of the questions were be derived from the Helpful Aspects of Therapy 
forms and therapy events, this was because one aim of the interview was to offer the opportunity 
to clarify unexpected findings during therapy (Ritchie, 2003).  
A badly designed topic guide or interview schedule would be confusing and could restrict the 
usefulness of the collected data (Arthur and Nazroo, 2003). When undertaking to write an 
interview schedule (or to evaluate one) there are several key questions to consider to ensure a 
high quality interview. Why did you ask this specific question, why did you formulate it in this way 
and why did you position it at this point of the schedule (Flick, 2006)? Questions should always 
avoid use of leading language, bias, double negatives and having two questions in one (Bowling, 
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2009). They should use language which is comprehensible and relevant to the participant (Bryman, 
2012). A suggested structure for the guide includes beginning with objectives and instructions, 
introducing the topics, section one – demographic questions, section two – the first main topic 
area, several subtopics and important bits to remember, section three - the second main topic 
area, several subtopics and important bits to remember, and then how to end the interview 
(Arthur and Nazroo, 2003). Suggested questions should include ‘content mapping’ questions, ones 
designed to encourage the participant to open up, ‘content mining’ questions, ones designed to 
explore, explain and clarify answers and ideas for probes achieve more depth (Arthur and Nazroo, 
2003). To improve the quality of the interview and the data collected from it a safe and sensitive 
atmosphere must be maintained (Bowling, 2009). To aid with this the interviewer should be 
prepared to be asked questions by the participant and to answer carefully, maintain control of the 
interview and critically appraise his/her own interviewing skills (Britten, 2006). 
To analyse the data collected from the interviews a technique called framework analysis was used. 
This is a series of interconnected stages which explicitly guide the systematic analysis of data from 
initial management to the development of explanatory accounts (Smith and Firth, 2011). 
Framework consists of three main stages, data management, descriptive accounts and explanatory 
accounts. Data management involves identifying initial themes from the data, sorting, labelling 
and tagging and beginning to assign meaning to portions of data. In the descriptive accounts, the 
data are summarised and synthesised, typologies are established and themes are refined to more 
abstract concepts. Finally explanatory accounts detect patterns and develop explanations from the 
data, concepts portray meaning and applications to wider theory are sought (Spencer et al., 2003). 
This analytic process is not a linear one. It may be necessary to keep going back a few steps or 
even to the raw data to check that your themes and concepts fit (Spencer et al., 2003). Framework 
is a versatile and useful technique as it allows for both a priori themes and also emergent ones to 
be handled side by side (Srivastava and Thomson, 2009). This allowed study three to investigate 
predictions from the theory behind EMDR but also deal with the unexpected results and 
previously unresearched concepts surrounding client experience.  
3.1.5 Combining Data – How to mix methods 
Although mixed methods maybe considered to yield more than the sum of their parts (O'Cathain 
and Thomas, 2006) consideration must be given to when and how to combine them. Creswell et al 
(2003) have suggested that the researcher should state the implementation order of a mixed 
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methods study, the priority given to each method and when the intended integration will occur. 
Figure 3.1.3 shows a representation of a classical sequential explanatory design for mixing 
methods (Creswell et al., 2003) and Figure 3.1.4 shows the modification of that design that better 
describes the research and analysis process. 
Figure 3.1.2: Sequential evaluation design for mixed methods (Creswell et al., 2003) 
 
Figure 3.1.3: Adapted sequential evaluation design for mixed methods (after Creswell et al., 2003)  
 
This research considers both the quantitative and qualitative parts of this study to be of 
importance. Both are covering new ground and will provide a contribution to knowledge. When 
evaluating a new treatment it is imperative that the primary outcome be whether or not the 
clients have improved because of the intervention. The accepted and most straight forward 
methods for this are quantitative. However, the views of clients are of fundamental importance 
when it comes to implementing an intervention. Further, by combining the two sets of results 
(Figure 3.1.4 box 5) the aim is to achieve greater illumination as to why some people responded to 
the treatment when others did not. This was achieved using the Framework analysis method 
because the chart structure means that Framework analysis leads itself very easily to both 
qualitative and quantitative data can be analysed together in a mixed methods matrix (O'Cathain, 
2013). Although the question of the impact of an intervention is traditionally a purely quantitative 
investigation, the views of the participants are also important here. If the measures suggest 
people have improved but the participants disagree, or vice versa, then this is important, both for 
the implementation of the intervention and it raises questions about the suitability of the 
measures in this subgroup of clients. This is of core significance in mental health where one of our 
most used diagnostic tools is the report of the client. 
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This is a necessarily sequential design. The quantitative data collection was done as before and 
after therapy assessments of the clients’ symptoms, the qualitative data came from interviews 
which attempted to understand the client experience of therapy. As such they had to be done 
after the therapy, and therefore after the quantitative data collection, took place. This study has 
an evaluation type of design as it attempted to explain how and why the results of the impact 
questions (does the EMDR intervention have an effect on depression symptoms?) occurred. It is 
hoped this will enable the treatment to be improved and targeted to clients who will respond to it.  
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Chapter 3 Part 2 Method 
 
3.2.1 Aim 
To investigate if EMDR has an impact on long term depression and if the mechanism of change is 
by changing distressing autobiographical memories 
 
3.2.2 Research questions 
Following a course of therapy comparable to ones delivered in the NHS: 
1. Is there an improvement in depressive symptoms and social functioning, and if so is it 
stable at follow-up? 
2. Are there any significant differences between the responder group and non-responder 
group of clients which might be able to predict response in others? 
3. Has the content of the target memory become less distressing and more adaptive, and if 
so is it stable at follow-up? 
4. Has the impact of the target memory and the psychophysiological response to it 
decreased? 
5. Is there a relationship between changes in symptoms and changes in memories? 
6. Do clients find EMDR to be an acceptable treatment for long term depression? 
 
3.2.3 Objectives 
To study the impact of standard protocol EMDR on depression and functioning symptoms, 
memory content, heart rate variability (HRV), skin conductance response (SCR) and psychological 
responses to distressing autobiographical memories of clients with long term depression over a 20 
session period. There were two primary outcomes for the study, Hamilton Rating Scale for 
Depression (HRSD-24) scores to measure symptom change and content analysis of memories to 
investigate the processes behind EMDR’s effect. The HRSD-24 was chosen as it is a comprehensive 
scale which is sensitive to change and as it is rated by the researcher it is less likely to be biased by 
the client or therapists involved. Other quantitative outcomes were used to measure interactions 
and correlations to answer the subsidiary research questions. Qualitative interviews were used to 
understand the therapy from a client’s perspective. 
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3.2.4 Null Hypotheses 
There will be no significant change in symptom or functioning scores after the therapeutic 
intervention. 
There will be no differences between the groups of responders and non-responders to treatment 
that may be predictive of who will be most likely to benefit from EMDR for long term depression. 
There will be no change in the way that distressing autobiographical memories are remembered 
after the therapeutic intervention.  
There will be no psychological change to the target memories, with respect to emotionality, 
vividness, completeness and psychological distance, following the therapeutic intervention. 
There will be no change in the physiological responses, HRV and SCR, to the stress of the target 
memory following the therapeutic intervention. 
There will be no correlation between the psychometric symptom/social functioning scores and 
psychological/physiological scores.  
 
3.2.5 Study design 
The investigations took the form of three studies. The first investigated the impact of EMDR on 
depressive symptoms. It utilised quantitative methods and relied on standardised measurements 
and compared the responders to non-responders to attempt to draw predictions regarding who 
may benefit most from EMDR therapy for depression. The single case experimental design allowed 
the comparison of before treatment and during treatment symptoms for each participant using 
the repeated measure.  It also used information from the interviews to assess what the participant 
view of impact was, as it can be argued that no matter what the outcome of the questionnaires, 
unless the clients’ report feeling better, then it is not truly successful. The two methods were 
brought together in a mixed methods matrix. Study two investigated possible mechanisms of 
change in EMDR. This involved testing the predictions of the adaptive information processing 
model and what, if anything happened to the targeted memory at different points. In the third 
study, semi structured interviews of the participants gathered information about their experience 
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of the therapeutic process and whether the participants found EMDR an acceptable treatment for 
long term depression.  
A feasibility study is justified at this point, as the literature does not contain any pilot studies or 
memory tests of clients with long term depression who have been treated with EMDR. A mixed 
methods approach will allow the study to investigate complementary research questions, as 
suggested by the Medical Research Council (MRC) guidelines for developing complex interventions. 
By providing a process evaluation we can investigate discrepancies between expected and 
observed outcomes in an attempt to provide insights that may aid implementation (Craig et al., 
2008). By providing data on a small number of clients treated by numerous clinicians the results 
should show, with reasonable reliability but low power, what may be expected in a larger trial 
(Craig et al., 2008). To achieve this aim a series of single case experimental design (SCED) studies 
(Barlow and Hersen, 1984) was conducted, a range of measures was taken before and after the 
course of therapy to answer the research questions. The participants identified key 
autobiographical memories and then completed a range of measures to test the content, impact 
of and physiological responses to these memories.  They also had a range of depression symptom 
scales and social functioning scales to measure changes in their mental health. All tests were 
completed before and after therapy and three months post therapy. As with all SCED studies a 
repeated measure was completed daily by the participants to look for trends in the data, sudden 
therapy gains and to be used with the interviews to help understand therapy events.    
3.2.6 Ethical considerations  
Four key concepts inform health care research and clinical practice; beneficence, non-maleficence, 
autonomy and justice. Beneficence is the ethical obligation to maximise benefit and non-
maleficence is its obverse - the obligation to do no harm. The World Health Organisation (WHO) 
follows the Belmont report (Ryan et al., 1978)and assumes these are two sides of the same coin 
and refers to both as beneficence (WHO, 2005). Autonomy means that potential research 
participants should be regarded as autonomous agents; they are capable of and should be given 
the opportunity to choose what shall or shall not happen to them. The WHO good clinical practice 
guidelines incorporate this into the category of ‘respect for persons’ and include the concept that 
the vulnerable should be protected (WHO, 2005). Justice refers to the moral principle of fairness.  
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To ensure fairness or justice entry to the study was conducted on a sequentially. No one was given 
preferential entry to the study and everyone who fulfilled the inclusion and exclusion criteria and 
consented to join the study was included. As recruitment was via the primary care mental health 
service - Improving Access to Psychological Therapies (IAPT) - then only people living in the area 
served by Sheffield South East and Sheffield South West IAPTs could join the scheme. However, as 
this was a feasibility study, restricting the number of recruitment sites was necessary. Had we 
recruited more widely it would possibly have meant that people were offered the research clinic 
but then later had to be refused due to the limited capacity of the clinicians. The NHS England 
Research and Development Strategy 2013-18 ‘Research is everyone’s business’ has the vision of, 
where possible, every patient has the option to participate in research (p7) (Minogue, 2013).  
 
Following the guidance of the Helsinki Declaration in order to maximise benefit and minimise 
harm, a thorough analysis of possible risks and benefits was undertaken (WMA, 2001). The 
suggested plan was discussed with a service user researcher and taken to the Sheffield NHS 
Research Ethics Committee and local NHS Research and Development service (paperwork in the 
appendix) for scrutiny and permission to proceed. Their suggestions lead to modifications of the 
protocol. Although adverse events in psychotherapy are rare and rarely reported they do occur 
(Duggan et al., 2014). For this reason adverse events were monitored, although none occurred 
that was attributable to the treatment or research. Theoretically, there is reason to believe EMDR 
may be a useful treatment for people with long term depression, however, the research evidence 
is lacking (see chapter 2). Each of the participants in this study had received at least one course of 
psychotherapy and failed to respond, they were given the opportunity to try something different 
(WMA, 2001).     
 
Autonomy and respect for the individual were of paramount importance. In accordance with the 
aforementioned guidance, the potential participants were all given the opportunity to make 
informed decisions about their own care (a choice between treatment as usual (CBT or counselling 
within the IAPT service) or EMDR within the research clinic). Choice, opportunity and informed 
decision making is the essence of patient centred care and a key strategic aim of the NHS (DoH, 
2010). Informed consent has been defined as ‘a process by which a subject voluntarily confirms his 
or her willingness to participate in a particular trial, after having been informed of all aspects of 
the trial that are relevant to the subject’s decision to participate’ (NIHR, 2011).  
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Each part of the study had different ethical issues associated with it. To implement EMDR in a 
manner that allowed it to be researched it had to be the only psychotherapy that the participants 
were receiving. This meant withholding a NICE recommended treatment from the participants. 
When the research clinic was first offered by the Psychological Well-being Practitioner (PWP), the 
potential participant was given a patient information sheet; if they remained interested they met 
with the researcher to discuss the study at a venue and time that was convenient to them. 
Potential participants were given the option to make an informed choice to decide their own 
treatment. They were given the option of remaining in IAPT or joining the research clinic. The 
differences between the treatments were explained along with the differences between being a 
research participant and being a patient. They were clearly told they could withdraw from the 
research or from EMDR at any time and return to IAPT with no penalty in their care. The decision 
was then left to them. Those who chose to join the research were asked to sign two identical 
copies of the consent form, one for the researcher and one for their own records. The recording of 
memories and responses to them was highly unusual for an NHS therapy. The purpose and 
procedure was explained and the participants were able to ask any questions they had. The 
service user researcher commented that measuring skin conductance may imply a small electrical 
shock would be given. This was not the case and this was explained and the researcher 
demonstrated the safety of the equipment on herself where required with anxious participants. As 
stated above, informed consent is a process not a single act (NIHR, 2011), each time the 
participants met with the researcher they were reminded that they did not have to complete any 
measures if they did not wish to and could withdraw consent at any time. 
 
All those who engaged with EMDR were invited for interview after therapy had finished. They 
were told at the start that this interview would be offered and that they could choose whether or 
not to participate. Two of those who were offered an interview did not respond to the letter. A 
second letter was sent to ensure they had received one but no further contact was made as failure 
to respond was considered to be a refusal to take part. The interviews were about the experience 
of receiving EMDR therefore those who did not receive EMDR were not invited for interview. 
Interviews about therapy have the potential to be distressing, these interviews focused on the 
experience of receiving EMDR rather than the subjects targeted during treatment. The interviewer 
was an experienced mental health nurse who did not ask questions about the targets of treatment 
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however, if they came up the participant was given time and support as required. All participants 
requested a summary of the results and this was sent after all the data had been collected.  
 
The study in its entirety was put before the Research Ethics Committee in December 2012. The 
Committee was keen for a non-inferiority randomised controlled trial to be conducted but as 
stated in Chapter 3.1 this was not considered appropriate at this point in developing a complex 
intervention. After some changes to the protocol, ethical approval for all parts of the study was 
given in January 2013, the local NHS Trust Research and Development department did not request 
any changes and gave permission for the study to be conducted within their organisation shortly 
after. 
3.2.7 Symptom scales 
To assess the impact that EMDR has on depression, standardised scales allow the study to assess 
symptom change in a recognised and reliable way that can be compared to other research. In long 
term depression social functioning is considered to be a serious problem so ratings of this were 
also done. The combination of clinician and self-report symptom scales should improve the validity 
of the results (Roth and Fonagy, 1996). EMDR has been shown to reduce depressive symptoms in 
PTSD clients (van der Kolk et al., 2007). It is possible that improvement in depression could be 
related to improvement in a comorbid but undiagnosed PTSD, so a PTSD scale was also completed 
with the clients (the impact of event scale). Symptom scales have been chosen as they have been 
used by other similar studies into long term depression and its response to psychotherapy 
(Schramm et al., 2011). These measures were done at the start and end of therapy and at follow 
up. Following screening, eligible participants signed a consent form and completed the symptom 
questionnaires. 
Hamilton Rating Scale for Depression (HRSD) 
The HRSD is a 24 item clinician rated scale for depression symptoms. It has been shown to have 
good reliability between raters (Hamilton, 1960) and is sensitive to change over time and 
treatment (Miller et al., 1985). This is the primary outcome for the indicators of symptoms change. 
Scores range from 0-75 and 8 or less = no symptoms, 9-18 = mild, 19-26 = moderate, 27-34 = 
severe, 35+ (max score 75) = very severe 
HRSD was chosen as the primary outcome measure as this is a validated and recognised scale 
worldwide. It has been the gold standard in depression rating scales for 40 years (Bagby et al., 
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2014). It enables the research to be compared to other research. However, EMDR research is a 
controversial area and some research shows significant bias. As the researcher was not blind to 
the treatment there is a possibility that only using a clinician rated scale leaves the study open to 
allegations of bias. As any change on HRSD was down to the researcher to record it would be 
possible to allege that any improvement has been exaggerated. Participant rated scales for 
depression were also included as an independent measure to triangulate with the HRSD.  Even 
without the controversy around EMDR, a single outcome measure can be argued to be insufficient. 
The HRSD is heavily biological in its design whereas the Beck Depression Inventory (BDI) is more 
responsive to the cognitive aspects of depression. It is advisable to have more than one scale 
covering differing perspectives and symptom domains (Roth and Fonagy, 2005). The HRSD and the 
BDI-ii are considered two of the best tested and reliable rating scales available for depression 
(Cusin et al., 2010) but are not commonly used in clinical practice in the UK. The BDI-ii is regularly 
used in American studies but less so in the UK. The PHQ-9 is a standard measure used in IAPT in 
the UK so allows the results to be comparable to the IAPT data set should that be appropriate. 
 
The Patient Health Questionnaire - 9 items (PHQ-9) 
The PHQ-9 (Kroenke and Spitzer, 2002) is a self-rated depression measure routinely used in IAPT 
services that takes about two minutes to complete and it is validated in a UK population (Gilbody 
et al., 2007). The IAPT handbook recommends the following interpretation of PHQ-9 scores, 1-4 
Minimal depression, 5-9 Mild depression, 10-14 Moderate depression, 15-19 Moderately severe 
depression, 20-27 Severe depression (DoH, 2011). 
Beck Depression Inventory (v.2) (BDI-II) 
The BDI is a 21 item self-report rating scale for depression (Beck et al., 1961), it was replaced by 
the BDI-II (Beck et al., 1996) which has been found to be a stronger instrument than the BDI, as it 
covers all nine of the DSM diagnostic criteria rather than the six of the BDI and it includes 
increases as well as decreases in somatic symptoms (Dozois et al., 1998). It is used in many 
research studies into depression and is the primary depression tool in the USA (Sharp and Lipsky, 
2002), it has good validity when compared with other self-rate scales and clinician rated measures 
for depression (Steer et al., 1997), the interpretation of the score should follow the table 3.2.1 
(Beck et al., 1988). 
Table 3.2.1 Classification for BDI-ii scores  
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Classification  Total Score  Level of Depression  
Low  1-10  Normal ups and downs  
                                                     11-16                            Mild mood disturbance  
Moderate  17-20  Borderline clinical 
depression  
                                                     21-30                             Moderate depression  
Significant  31-40  Severe depression  
                                                    Over 40                             Extreme depression  
 
 
The repeated measure 
As is usual in an SCED study a repeated measure is required. By using this repeated measure it is 
possible to track fluctuations in mood in between the sessions, this can add insight to the before 
and after measures and enable the research to be placed in context of the natural changes in 
depressive symptoms over time (Turpin, 2001). As has been used in other time series evaluations 
the repeated measure was based on the DSM-IV-R criteria for the disorder of interest (Kellett, 
2007), in this case major depressive disorder. However in order to keep the measure short and 
simple not all of the nine criteria were included. Included were questions about low mood and lack 
of interest in activities, which are required for a diagnosis. In the DSM-IV-R criteria a client must 
have at least one of the first two. These two criteria also form the basis for the screening 
questionnaire the PHQ-2; which GPs use when screening for depression which says that if neither 
‘low mood’ or ‘lack of interest or pleasure’ is present then the screening must be stopped and a 
different diagnosis sought (NCCMH, 2010). The third question regarding a lack of energy or 
feelings of tiredness is one of the essential criteria from the ICD-10 criteria for depression. 
Although this is not validated, as is common for repeated measures, it has been piloted and the 
wording has been borrowed from the PHQ-9 which has been validated for British adults with 
depression (Gilbody et al., 2007). The participants were given a paper copy of the scale to 
complete every day, figure 3.2.1 shows what each day’s questions looked like. The questions were 
set out in the standard visual analogue form and the participant made a mark on the line 
representing their mood at that time. Completed forms were brought to the therapy session 
where they collected the next week’s diary. It was possible to set up a text message alert to act as 
a reminder to the participants to complete the diary, if necessary. Afterwards, the mark was 
measured from the right-hand side to give a decreasing number as the symptoms improved. 
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Figure 3.2.1: An example of one day of the repeated questions 
 
Social Adaptation Self-evaluation Scale (SASS) 
The SASS is a 21 item self-report scale developed specifically for the evaluation of social 
motivation and behaviour in depression (Bosc et al., 1997). It has been shown to be valid, reliable 
and sensitive to change (Bosc et al., 1997) and has been used in other studies looking at 
treatments for chronic depression (Schramm et al, 2011). Scores range from 0-60 and higher 
scores indicate greater adaptation to the social environment. Using this scale, “normal” social 
functioning was determined to be a score of 35–52; therefore, impaired functioning is any score 
below 35. (McNamara et al) 
Global Assessment of Functioning (GAF) 
The GAF is a clinician rated scale of psychological, social and occupational functioning assuming a 
continuum of mental health – illness. It is provided by the DSM-VI for assessing psychological 
disturbance (APA, 2003). The GAF has been shown to be a reliable measure of psychological 
disturbance within a severely mentally ill population (Jones et al., 1995). As the total GAF (GAFT) is 
based on symptom severity or functional disability (whichever is worst) (APA, 2003), two 
additional scores can be used splitting symptoms (GAFSYM) and disability (GAFDIS) (Jones et al., 
1995). 
Impact of Event Scale – revised (IES-r) 
The IES-r is a self-report scale measuring traumatic stress; it was developed to improve the IES 
scale which did not include persistent hyper-arousal (Creamer et al., 2003). It is a useful 
Date              
Low mood/ 
depression 
‘I am 
extremely 
low or 
depressed’ 
           ‘I don’t have 
low mood’  
Interest or 
pleasure in 
activities 
‘I have no 
interest in 
doing  things’ 
           ‘I get 
involved’  
Energy levels ‘I have no 
energy’ 
           ‘I have 
enough 
energy’ 
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instrument for measuring traumatic stress and a score of 33 or more gives optimal diagnostic 
accuracy for PTSD (Creamer et al., 2003).  
Sessional measures 
Two brief questionnaires were given to the clients every session as repeated measures are 
important to understand the trajectory of change and as an insurance against attrition in final 
stage measures. These are Patient Health Questionnaire (9 item) (PHQ-9) and the Helpful Aspects 
of Therapy (HAT) form. The HAT was developed to enable researchers to gain an insight into which 
parts of therapy were considered helpful and unhelpful by therapists and clients (Llewelyn, 1984). 
This was done at the end of each session and informed the semi structured interview schedule in 
study two.  
Mechanism of change measures 
Often in EMDR several target memories will be identified for attention during therapy. These may 
include several different incidents that may or may not be related. For the research the memory 
that was identified as the ‘earliest’ will be the one for which responses are tested as this is the one 
that EMDR always aims to target first as it should be the key to the pathology. Once the target 
memories have been identified all participants were asked to complete a range of tests and scales 
to assess different aspects of the identified ‘earliest’ memory.  All participants were asked to recall 
and describe in detail the memory that they have identified. This was described verbally and 
recorded for transcription later. During the recall the client’s heart rate variability (HRV) and skin 
conductance response (SCR) were measured. 
The memory narrative was a modification of the one used by Foa and colleagues. They 
concentrated only on memories of rape so their script had to be adjusted to be applicable to all 
traumatic memories – ‘I’m going to ask you to recall the memory we have identified as vividly as 
possible. I don’t want you to tell a story about the incident in the past tense. Rather I would like 
you to describe the incident in the present tense, as if it were happening now, right here. I’d like 
you to close your eyes and tell me what happened during the incident in as much detail as you can 
remember. This includes details about the surroundings, your activities, the activities of others, 
how you felt and what your thoughts were during the incident.’ modified from (Foa et al., 1995). 
Once they finished the memory narrative they were asked to complete four Likert scales to assess 
the emotionality, vividness, completeness and psychological distance of the memory (after Gunter 
and Bodner, 2008). 
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0 – 10 
No emotion – overwhelmingly emotional 
Not clear at all – extremely vivid 
Not at all complete – extremely complete  
Very distant – extremely close 
As the participants finished therapy, they were invited back for a repeat of all the tests completed 
prior to the therapy. All tests were done focussing on the same memory as before i.e. the target 
memory of EMDR treatment. By using the same memory the HRV/SCR, Likert tests and recall 
descriptions will assess if the reaction to this memory has changed over the test period. 
Psychometric scales showed whether or not clinical symptoms changed too and were tested to 
see if this correlated with changes in memories.  
 
3.2.8 Participants and recruitment  
Thirteen clients with a primary diagnosis of long term depression (defined as at least two years in 
duration or two or more episodes over the lifetime) and referred to the Improving Access to 
Psychological Therapy (IAPT) team for treatment for depression were recruited for the treatment 
phase. Although they did not need to be native English speakers they did need sufficient English to 
be able to understand the testing and fully describe their memories. 
Inclusion criteria – People 18 and over, with depression, confirmed through structured interview 
to ensure they met the DSM-IV-R criteria for long term depression. Participants must meet the 
criteria for a current major depressive episode AND had at least two episodes (i.e. it is recurrent 
depression) OR the current episode lasted two years or more (chronic major depressive disorder 
or dysthymia were accepted). Clients had to be able to give informed consent. They were screened 
using the Mini International Neuropsychiatric Interview (MINI) - The MINI is a short structured 
diagnostic interview designed to allow rapid but accurate neuropsychiatric interview for clinical 
trials, epidemiology studies and clinical settings (Sheehan et al., 1998). The MINI was developed 
for both the DSM-IV and ICD-10 psychiatric diagnoses and is validated against the much longer 
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Structured Clinical Interview for DSM criteria (Sheehan et al., 1997) and the Composite 
International Diagnostic Interview for ICD-10 criteria (Lecrubier et al., 1997).  
Exclusions – those under 18, those unable to give informed consent, those with current suicidal 
intent or behaviour, psychosis, bipolar disorder, PTSD, dementia, brain injury, current drug/alcohol 
dependence, epilepsy, pregnancy, current opiate analgesic use, electro-convulsive therapy in the 
last six months or anyone whose primary mental health diagnosis is not long term depression. 
Data collection – age, gender, age at onset of depression, number of episodes, length of current 
episode, medication history, psychotherapy history, risk history, medical conditions. 
The project requested volunteers from the IAPT caseload.  IAPT clinicians were informed of the 
study and requested to offer the opportunity to join the study to anyone on their caseload that 
appeared to have long term depression and did not have PTSD. Potential participants were 
informed about the study by their clinician within the IAPT service. They were given participant 
information sheets about EMDR and about the proposed research. If they wished to be referred 
their contact details were passed to the researcher and a meeting was arranged at a place and 
time convenient for the potential participant. At the meeting the research and EMDR were again 
explained, the participants were told what would occur and how that would differ from usual 
treatment. They were informed that they could leave the research at any time and this would not 
affect the care they received, they would go back to the IAPT service and receive the usual 
treatment with no penalty. Potential participants were offered the chance to ask questions of the 
researcher. If they were happy to continue they were asked to sign a consent form and then they 
were screened for the inclusion and exclusion criteria and informed immediately of whether or 
not they were eligible for the study or not, and if not why not. The referrer was informed of the 
outcome. Referrals and screening took place from August to December 2013. All participants who 
began the treatment were invited for interview. Figure 3.2.2 shows the flow of participants 
through the study, table 3.2.2 details participant demographics.  
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Figure 3.2.2 Flowchart of participant recruitment and retention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15 people 
screened 
2 have PTSD and are excluded – 
care from IAPT 
10 people 
start therapy 
13 people 
consented 
1 recovers – no longer meets DSM-IV criteria 
for depression (referred to mindfulness 
relapse prevention group) 
1 opt out (no response to letters) 
1 meeting criteria but no therapist available in 
the time frame (offered EMDR outside the 
research clinic) 
1 withdraws after 2 sessions due to home 
commitments – referred back to IAPT 
1 discharged after 9 sessions – unsuitable for 
further treatment – referred to Community 
mental health team (CMHT) 
8 people 
fully engage 
1 deteriorates and has to be discharged after 8 
sessions - referred to CMHT  
7 people complete treatment – all 
are classed as responders to 
treatment 
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Table 3.2.2 Participant demographics 
Age range 29-65 
Age mean 46 
Female 8/13  
In employment  8/13 
Age at first onset of depression - range 9-43 
Those under 18 at first onset of depression 7/13 
Number of episodes of depression - range 2-15 
Length of Current Episode of depression 1 month – 10 years 
Taking antidepressants at start of study 12/13 
History of antidepressant use 13/13 
History of at least 1 trial of a talking therapy 13/13 
Number of trials of talking therapies - range 1-6 
Previous talking therapies attended Cognitive behavioural therapy, computerised 
CBT, cognitive analytical therapy, counselling, 
bereavement counselling, workplace wellbeing, 
psychodynamic therapy, hypnotherapy, pain-
team psychology  
Diagnoses identified by the MINI:   
Major depressive disorder 13/13 
Recurrent MDD 11/13 
Melancholic MDD 5/13 
Dysthymia 7/13 
Panic disorder 4/13 
Agoraphobia 8/13 
Social phobia 8/13 
Generalised anxiety disorder 11/13 
 
Of the 13 participants 12 are white British and one is white European. Although this may seem to 
be unrepresentative it is not. All these clients were recruited from the south of Sheffield. Sheffield 
in its entirety is not a particularly diverse city, it is 80.8% white British according to the City 
Council’s website. However in the south of the city, in the electoral wards where these 
participants were recruited from, that rises to 92% white British. So to have one person in the 
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sample who is not white British is representative for the area studied. Table 3.2.3 shows the pre-
treatment outcome measure scores for the participants. 
Table: 3.2.3 Participant scores on the validated measures at the pre therapy screening 
appointment 
Participant HRSD BDI-ii PHQ-9 SASS GAF IES-r 
1 17 33 17 31 65 13 
2 27 50 24 24 40 52 
3 13 21 10 47 61 11 
4 25 48 24 31 68 50 
5 26 43 19 30 35 54 
6 13 26 10 44 62 19 
7 21 34 18 29 52 45 
8 22 28 17 26 38 33 
9 - - - - - - 
10 23 23 13 29 68 25 
11 10 24 10 43 65 15 
12 26 37 17 30 42 35 
14 19 21 9 24 55 54 
 
Participant 001, hereafter given the pseudonym ‘Alice’, was a healthcare professional. She had 
been suffering with recurrent depression of the melancholic type since the age of 15. She recalls at 
least five episodes of depression and was prescribed antidepressant medication for most of them 
including the current episode which is five months long at the start of treatment. She had taken 
several different antidepressants before and she had also had three years of psychodynamic 
therapy a few years ago. As well as depression she also screened positively for social phobia and 
generalized anxiety disorder. On the daily measure her energy levels are substantially worse than 
her low mood and level of interest because she also suffers from a chronic physical health problem. 
At screening she scored mild to moderate depression on the HRSD but on the BDI-ii her score 
indicated a severe depression and her PHQ-9 score indicated moderately severe depression. Her 
SASS score indicated impaired social functioning, the IES-r did not indicate that she was 
traumatised. 
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Participant 002, ‘Pauline’, had to give up work due to a physical health problem.  She met the 
criteria for double depression (current major depressive episode and long term dysthymia). Her 
depression had begun when she was 40 and she had experienced two chronic episodes of 
depression since that time. She was prescribed medication and had received two types of 
counselling in the past. The current episode had lasted for 18 months when she was screened and 
had not responded to counselling or antidepressant medication. She had several anxiety 
comorbidities including panic disorder, agoraphobia and social phobia. Her HRSD and PHQ-9 
scores indicated severe depression and her BDI-ii score, extreme depression. Her SASS score 
indicated impaired social functioning, the IES-r indicated that she was traumatised but did not 
have a criterion A event needed for a PTSD diagnosis.  
 
Participant 003, ‘Sophie’, was a healthcare professional. She met the criteria for double depression. 
She had experienced her first depressive episode at the age of 15 and had two episodes in total. 
She described her current episode as having lasted for ‘years’, she was prescribed antidepressant 
medication and had received counselling and two courses of CBT without remission. She did not 
screen for any comorbidities. Her HRSD score only indicated mild depression but her BDI-ii and 
PHQ-9 scores both suggested moderate depression. Her social functioning scores did not indicate 
any clinically significant impairment; the IES-r did not indicate that she was traumatised. 
Participant 004, ‘Robbie’, was a civil servant. He screened positive for double depression, He 
reported two very long episodes of depression beginning at the age of 10. He reported the current 
episode lasting for nine years. Robbie had also received three separate courses of CBT, he had 
been prescribed anti-depressants but stopped taking them as he didn’t think they helped. He also 
screened for social phobia and generalized anxiety disorder. His HRSD score suggested moderate 
depression, his PHQ-9 score, severe depression and the BDI-ii indicated extreme depression. His 
SASS score indicated impaired social functioning, the IES-r indicated that he was traumatised but 
did not have a criterion A event needed for a PTSD diagnosis. 
Participant 005, ‘Maxine’, was retired. She met the criteria for current and recurring melancholic 
type depression. She first experienced depression at the age of 23 and reported that she had been 
depressed six times in total. She said the current episode had lasted for three years. She was 
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taking antidepressant tablets and had received CBT at the start of this episode but although she 
found it of some help she remained depressed. She also screened positive for generalized anxiety 
disorder. Her HRSD and PHQ-9 scores indicated moderate to severe depression, the BDI-ii 
indicated extreme depression. Her SASS score indicated some impairment in social functioning, 
the IES-r indicated that she was traumatised but did not have a criterion A event needed for a 
PTSD diagnosis. 
Participant 006, ‘Martin’, was self-employed. He met the criteria for recurrent and chronic major 
depressive disorder. His first experience of depression was at the age of 43 and he had been 
chronically depressed for at least six years at the point of screening. He was prescribed 
antidepressants medication and had been given CBT and Cognitive Analytic Therapy in the past. He 
also screened for agoraphobia, social phobia and generalized anxiety disorder. He also expressed 
some obsessive thoughts that had the potential to be subclinical obsessive compulsive disorder. 
His HRSD and PHQ-9 scores indicated a moderate depression, although the BDI-ii suggested 
moderately severe. The SASS did not indicate any social functioning impairment; the IES-r did not 
indicate that he was traumatised. 
Participant 007, ‘Lewis’, ran his own business. He met the criteria for a current and recurrent 
melancholic depressive disorder. He had a six year history of depression and had suffered two 
episodes of depression. The current one had lasted for seven months at the time of screening. He 
was currently taking antidepressants. He had previously tried hypnotherapy and counselling for his 
depression. He met the criteria for panic disorder, agoraphobia, social anxiety and generalized 
anxiety disorder. Lewis also had a history of cannabis use but he stopped using six months before 
the study began. The HRSD indicated moderate depression, the PHQ-9, moderately severe 
depression and the BDI-ii severe depression. His SASS score suggested impaired social functioning, 
the IES-r indicated that he was traumatised but did not have a criterion A event needed for a PTSD 
diagnosis.  
Participant 008, ‘Andrew’, was an unemployed man with melancholic, recurrent and chronic 
depression. Andrew reported that his first episode of depression was at the age of 42 and he had 
three episodes. He reported the current episode had lasted one month but under the screening 
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assessment he met the criteria for dysthymia. He had tried counselling in the past with limited 
success. He was currently prescribed Mirtazapine but was determined to stop this against medical 
advice due to the side effects he was experiencing. He also screened for generalised anxiety 
disorder. Andrew’s depression rating scales scores all indicated moderately severe depression with 
impaired social functioning, the IES-r indicated that he was traumatised but did not have a 
criterion A event needed for a PTSD diagnosis. 
Participant 009, ‘Rebecca’ was an admin worker. She reported that her depression began in 
primary school but she could not remember more exactly than that. Primary school in the UK is 
from the ages of 5-11. ‘Rebecca’ was included in error at this stage as she met the criteria for 
dysthymia but not MDD. She never received EMDR and was referred to a mindfulness relapse 
prevention programme. 
Participant 010, ‘Sandy’, was a mature student. She met the criteria for current and recurrent 
depressive disorder and dysthymia. She first became depressed at the age of 17. She had since 
had four or five episodes but she was not able to be exact. She felt the current episode had lasted 
for about a year and had been on at least two different antidepressants and tried a course of 
counselling in 2000. Sandy reported that this counselling required her to record dream diaries 
which she did not find helpful. She also screened for agoraphobia, social anxiety and generalised 
anxiety disorder. Sandy’s depression scale scores all indicate a moderate depression with impaired 
social functioning, the IES-r did not indicate that she was traumatised. 
Participant 011, ‘Julie’, was a health care professional. She had current, recurrent and melancholic 
type depressive disorder. She reported that she had first become depressed as a teenager, around 
the age of 15, and she had been depressed on around 15 separate occasions since then. This 
episode had lasted approximately four months at the time of screening. She had tried several 
antidepressants in the past and previously received counselling. She also suggested a possible 
agoraphobia and reported a history of bulimia when she was much younger. This was no longer an 
issue. The HRSD indicated a mild level of depression whilst the PHQ-9 and BDI-ii both indicated 
moderate depression. The SASS score suggested no impairment of social functioning, the IES-r did 
not indicate that she was traumatised.  
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Participant 012, ‘Laura’, was a woman who was currently on sick leave from her admin job due to 
the depression. Laura screened positive for current and recurrent major depressive disorder. She 
states that she first became depressed at the age of 26 and has had four episodes of depression. 
The current episode is three months long and she is taking antidepressants for that. She has also 
accessed counselling and workplace wellbeing. She displayed a large amount of anxiety screening 
for panic disorder, agoraphobia, social phobia and generalised anxiety disorder. Laura’s depression 
rating scale scores all indicate a moderately to severe level of depression with impaired social 
functioning shown on the SASS scale, the IES-r indicated that she was traumatised but did not have 
a criterion A event needed for a PTSD diagnosis.  
Participant 014, ‘Daniel’ was a man who was currently unemployed due to ill health. He screened 
positive for major depressive disorder and recurrent MDD. He reported having first become 
depressed at the age of 15 and had rarely been well since then. He thought his current episode 
had lasted 10 years. He was currently taking antidepressants and had taken at least three different 
types in the past. He had also had four different periods of talking therapy including counselling 
and psychology from the pain-team. He also had been to two other therapists but he was unsure 
what type of therapy it was. He also had an interest in Neurolinguistic Programming (NLP), around 
which he had done a lot of reading. He was also an anxious person screening positive for panic, 
agoraphobia, obsessive-compulsive disorder and generalised anxiety disorder. Daniel’s depression 
rating scale scores indicate moderate depression on the HRSD and BDI-ii and mild depression on 
the PHQ-9 and the SASS indicated impaired social functioning, the IES-r indicated that he was 
traumatised but did not have a criterion A event needed for a PTSD diagnosis.  
3.2.9 Treatment 
After screening and the completion of the symptom questionnaires, participants were assigned to 
a therapist. EMDR was delivered twice weekly by therapists trained in EMDR by the EMDR 
International Association institute approved trainers. Although the Improving Access to 
Psychological Therapy (IAPT) team agreed to help recruit participants to the study they did not 
have sufficient numbers of EMDR therapists working for them for the study to use that service to 
deliver the treatment as well. Therapists were recruited through the Sheffield Health and Social 
Care NHS Foundation Trust. The Royal College of Nursing Foundation granted the researcher a 
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bursary of £2500. The School of Health and Related Research at The University of Sheffield also 
provided a data collection grant of £2000 to cover the cost of the therapists’ wages.  
The EMDR adhered to the manualised 8 stage protocol design by Francine Shapiro and approved 
by the EMDR International Association institute. To ensure the therapists were working to the 
standard EMDR eight stage protocol they were asked to complete a therapy process record. 
Although the Medical Research Council guidelines (Craig et al., 2008) recommend that treatments 
are modified to meet the needs of different populations the original EMDR ‘Standard Protocol’ 
was used. The protocol was designed for PTSD but it has been claimed (Shapiro, 2009a) to also be 
useful for treating depression. There are many varied protocols for EMDR but there is no 
depression protocol. Before making changes to the Standard Protocol it is necessary to discover its 
deficits in this population.  
After stage three of the protocol (identification of the traumatic memory), therapy was briefly 
interrupted so that this memory could be recorded and reaction to it tested using the memory 
narrative, SCR/HRV and Likert scales for distress. This testing took 15 minutes to one hour and was 
usually able to be done between sessions so the client did not have to wait to begin therapy again. 
Once this was done they returned to the therapist and completed the therapy and worked 
through the protocol. This was the only interference in the normal structure of the therapy 
process.  
The therapists had no other involvement with the research. The principal investigator did not treat 
the participants. Participants were offered up to 20 sessions as this is comparable to a course of 
CBT currently offered in the UK for depression, but also because Cuijpers et al (2010) found that 
for psychotherapy to be effective in chronically depressed clients at least 18 sessions are required. 
The actual number received was the decision of the therapist and based on clinical need. Therapy 
was delivered twice a week. Case studies have suggested EMDR may be successfully delivered in 
this way (Grey, 2011), partly because it does not have the homework component of CBT so the 
participant does not need time to complete it. It has also been reported that by increasing therapy 
from once to twice a week the effect size can be dramatically increased even when keeping the 
total number of sessions constant (Cuijpers et al., 2013). 
Participants could continue with any other medical input they normally received, as this could 
have changed over time and increased and decreased according to client need, including discharge 
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if this was appropriate, this continued with the only restriction being that they cannot begin any 
other psychological therapy during the experimental period. It was also necessary that the 
participants did not change their anti-depressant medication during the therapy period as this may 
have affected testing. It was decided beforehand that any participants that did require a change of 
medication would be removed from the study but none required this.  
3.2.10 Concealment and priming  
All the assessments (BDI-II, HRSD, SASS, GAF, IES-r, PHQ-9, Likert scales, HRV/SCR and content of 
memory) were done with or by the researcher and the therapists were not involved in the testing.  
There are two reasons for conducting a follow up session after three months. Firstly the therapist 
may inadvertently or deliberately prime the participant to report changes in memory when none 
have occurred. Priming is only really considered to be relevant for a few weeks after therapy has  
(Brewin, 2012) concluded, so if it did occur repeating the tests several months later would show a 
reversal to pretreatment test results. The second reason is to test the idea of reconsolidation. If 
the memory has changed and this is via reconsolidation it should remain stable. If it is not stable at 
three months then this suggests that the memory either did not change in the first place or it did 
but not via reconsolidation. 
3.2.11 Study 1 – The clinical impact of the intervention 
Aim: To investigate the clinical impact of EMDR upon long term depression 
RQ - 1 Is there an improvement in depressive symptoms and social functioning, and if so is it stable 
at follow up? 
RQ - 2 Are there any identifiable differences between the responders and non-responders which 
might be able to predict response in others? 
 
Participants underwent a range of symptom and functioning testing before and after therapy and 
at a follow up period of three months. The symptom and social functioning scales are a good 
indication of what has happened to the participant’s depressive symptoms.  
Non-responders to treatment can tell us about the different groups that may or may not benefit 
from different types of therapy. By comparing the responders and non-responders we may be able 
to discover who will be most effectively treated by EMDR for depression. It may be that non-
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responders have not fully processed their memories, or that it was not the memories that were 
the problem in the first place. 
Study 1 analysis 
The primary outcome for measuring impact was the Hamilton Rating Scale for Depression. To 
assess whether participants had made clinically significant and statistically significant changes the 
Reliable Change Index was used. Reliable change is a way of determining if the change you see is 
likely to be real or simply an artefact due to the unreliability of the instrument (Jacobson and 
Truax, 1991). A reliable change index (RCI) can be determined for each measure.  If the client’s 
score on the measure changes between the initial and end of therapy reading by more than the 
RCI, then we can be confident that in 95% of cases this change will be real and not due to error in 
the measure (i.e. it is statistically significant). The RCI was calculated for all of the scales. Due to 
the small sample size in this study, previously published means, standard deviations and internal 
consistency scores derived from larger samples were used to calculate the RCIs as they may be 
considered more reliable (see table 3.2.3). 
For all scales the literature was searched for published means and standard deviations. Where 
more than one population was found the one most like this study was used. Also found were 
published measures of internal consistency of the measure (Cronbach’s Alpha). These figures were 
then put into the Reliable Change criterion calculator (www.psyctc.org/stats/rcsc1.htm  accessed 
30.10.13 15.25). Where more than one Alpha score was found the lowest score was used this 
should make the RCI increase and thereby giving the most stringent criteria. Although test-retest 
reliability is considered preferable to Cronbach’s Alpha it could not be found for every measure 
and so Alpha was used throughout to have a consistent result. 
The formula for the standard error of change is: 
     SD1*sqrt(2)*sqrt(1-rel) 
where SD1 is the initial standard deviation 
sqrt indicates the square root 
rel indicates the reliability  
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The formula for criterion level, based on change that would happen less than 5% of the time by 
unreliability of measurement alone (i.e. the reliable change index), is: 
    1.96*SD1*sqrt(2)*sqrt(1-rel) 
This gives you a RCI which is the number of points on the measure to signify reliable change. 
Change can occur in either direction so change can be deterioration or improvement. Increasing 
SD or decreasing internal consistence will increase the RCI meaning more change is necessary to 
be sure it is reliable. 
Table 3.2.4 Reliable change 
Measure Published 
mean 
Published SD SEDI 
pretherapy 
mean 
Published α SE of 
change 
Reliable 
Change 
HRSD (Miller 
et al., 1985, 
Cusin et al., 
2010) 
21.2 6.2 20.3 0.88 3.04 5.95 
PHQ-9 
(Smarr and 
Keefer, 
2011, 
Kroenke et 
al., 2001) 
17.1 6.1 16.3 0.86 3.23 6.33 
BDI-ii 
(Brouwer et 
al., 2013) 
16.6 10.2 33.4 0.90 4.56 8.94 
IES-r (Coffey 
et al., 2006) 
39.5 17.2 32.0 0.86 9.10 17.84 
SASS (Bosc 
et al., 1997) 
29.65 8.73 33.1 0.74 6.30 12.34 
GAF (Jones 
et al., 1995, 
Söderberg 
et al., 2005) 
52.4 14.6 54.2 0.74 10.53 20.64 
 
Clinically significant change 
Although it is important to know that change is reliable it must be meaningful to the clinicians as 
well and therefore needs to be related to caseness and severity of illness. The RCI tells us if the 
change is statistically significant, it doesn’t necessarily tell us if it is clinically meaningful (Barkham 
and Mellor‐Clark, 2003). Many articles reporting a clinical measure will assign a cutoff level to 
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determine what levels of symptoms are clinically significant enough to be given a diagnosis. 
Sometimes they also suggest levels of change that can be considered clinically significant or an 
adequate response to treatment. This acknowledges that although a client’s symptoms may not 
disappear entirely this does not mean that a treatment has not made a major improvement to 
their life. 
Table 3.2.5 Clinically significant response 
Measure Caseness cutoff Clin sig response 
HRSD (Schramm et al., 
2011, Hamilton, 1960) 
<8 is nonclinical At least 50% reduction in 
score and score is now less 
than 15  
PHQ-9 (Kroenke et al., 
2001, Smarr and Keefer, 
2011) 
<10 is nonclinical At least a 5 point reduction 
BDI-ii (Smarr and Keefer, 
2011) 
No official level of caseness but some 
have suggested at least 16 points is 
required for diagnosis 
5 point decrease = minimal 
improvement 
10-19 = moderate 
20+ = large 
IES-r (Creamer et al., 
2003) 
33 or more indicates PTSD  
SASS (Bosc et al., 1997) 35 or less indicates impaired social 
functioning  
 
GAF No official level of caseness  
 
The other way to look at clinically significant change is to calculate if a client has moved from the 
clinical distribution to a normative population distribution.  There are three different ways to 
calculate this (Evans et al, 1998) but what is required is to know the clinical and normative 
distributions and that the measure is reliable enough that two standard deviations from the mean 
for both distributions do not overlap. Unfortunately this study had such a small sample that a 
reliable distribution is not possible and the published distributions for the GAF and IES-r have very 
large standard deviations. This makes using this method almost meaningless for this study with 
the measures chosen.  For this reason the standard cut off points used in previous studies and 
highlighted in table 3.2.4 will be used as a clinically significant benchmark. Using the RCI and 
clinical significance as a guide the pre and post therapy HRSD scores for each participant were 
plotted on a Jacobson Plot (Jacobson and Truax, 1991). 
The progress of the participants as measured by the repeated assessment measure was plotted 
graphically for visual analysis, as is standard in a SCED study (McLeod, 2003). Often in a single case 
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design such as this the data from the repeated measurement is autocorrelated, i.e. your mood 
score today is likely to be related to your mood yesterday. This phenomenon is widely accepted 
although its significance is not (Parker and Vannest, 2009). To avoid the possibility that 
autocorrelation could affect the analysis of the data it can be tested for (Manolov and Solanas, 
2008). Although quantifying SCED data in this way is not always necessary it is needed when 
attempting to provide support for evidence based practice and clinical effectiveness (Parker and 
Vannest, 2009). For each participant the autocorrelation was calculated. As the autocorrelation for 
each participant showed widely differing patterns, no obvious correction could be made as each 
would have needed different ones. However, as this data are looking at outcome rather than 
attempting to make a prediction it does not need to be subjected to a time series analysis 
(Campbell, 2012) and therefore the autocorrelation is less of a problem.  
A correlation analysis was done on the different daily measures to see if they were all measuring 
related concepts, their means were also examined. The raw data from the low mood measure was 
plotted, with raw data and a smoothed version to enable seeing the trends and levels more easily. 
The median  of seven days of data was taken and the moved on one day and take the median of 
the next seven days etc. (Franklin et al., 1996). This helped remove some, although not all, of the 
variability. However an autoregressive moving average model (ARIMA) was not used as there were 
less than 50 time points in the baseline phase and ARIMA is more appropriate to predictive time 
series rather than outcome time series like this one. Despite this a time domain rather than 
frequency domain was still considered the most appropriate as it is necessary to know if the levels 
of low mood changed over time during the treatment rather than just how frequently the 
participant was feeling low (Huitema and McKean, 1991). The differences between the baseline 
phase and the treatment phase were analysed with a Mann-Whitney U test as they were not 
normally distributed. The Mann-Whitney U test looks for the difference between the means of the 
whole of the two phases. One method for analysing SCED graphs to look for change is to see if 
there is a difference between them at different stages. The treatment phase was split in two to 
see if there were more treatment phase data points below the baseline mean at the end of the 
treatment phase rather than the beginning. If there are, this would indicate that even for those 
whose mean score was not different towards the end of treatment they became more consistently 
lower scoring. This corresponds to constantly lower mood. Finally, the number of points in the 
treatment phase that were below the baseline phase mean was calculated (Ma, 2006). This is 
another indication of a downward trend to lower levels of depression. 
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Jacobson plots were also completed for the secondary measures (BDI-II, HRSD, GAF, SASS, IES-r,). 
Paired t tests were used (as long as all assumptions are met) to see if there are any significant 
differences between the participants’ scores before and after the intervention. This was done on 
all measures (BDI-II, HRSD, GAF, SASS, IES-r,) although the HRSD is the primary outcome and the 
others are to support the primary outcome or provide possible explanations for unexpected 
results. This was done twice, once combining all results and once using only the responders. 
Correlations were carried out to see if the different measurements changed in relation to each 
other. Over the three studies this research will make use of several t tests as long as the 
assumptions are met. The assumptions for a two sample t test are that the data are continuous, 
the data are normally distributed, the variances of the two populations are equal, the two samples 
are independent and both are random samples from their population (O'Rourke et al., 2005). The 
assumption that is likely to pose a problem for this data is the normal distribution; this is because 
it is a very small sample size. Where necessary a non-parametric test was used instead.  
 
As these tests require data to have been gathered at the start and end of treatment, consideration 
must be given to those who drop out at various stages and are not able to provide end point data. 
Any participants who initially agree to join the study but then change their minds and do not start 
EMDR sessions with a clinician will be counted as a failure of research not a failure of the 
treatment and will be excluded from the analysis. Participants who begin but then drop out will be 
considered a failure of treatment and will be included. 
 
Following therapy, participants were classified into responders and non-responders. Remission 
was defined as a score of eight or lower on the 24 item HRSD, response was defined as at least a 
50% reduction from baseline and a final score of 15 or less on the HRSD (as used by Schramm et al 
and the ReVAMP trial). Responders to treatment had either a clinically important improvement in 
symptoms or a remission of their depression. Comparisons were made between the two groups to 
see if there were any significant differences between them at the pre-treatment phase in 
demographic data such as age range, mean age, gender, socio-demographics, age at onset of 
depression, number of previous episodes of depression, length of current episode and IES-r score 
pre-therapy. These data were specifically chosen because they have been identified by previous 
researchers as likely to impact upon response to psychological therapy (Saxon et al., 2008, Roth 
and Fonagy, 2005, Thase and Howland, 1994). The exception here was the IES-r. Although it has 
105 
 
not been identified previously, the importance of PTSD or at least traumatisation in the treatment 
of EMDR makes this an outcome of importance. 
Independent t tests were used (assuming test assumptions are met) to compare the differences in 
the before/after scores and the initial data in the responder and non-responder groups for change 
in HRSD, age, age at onset, number of previous episodes of depression, length of current episode 
and IES-r score. A chi square test was used to test to see if the gender makeup of the two groups 
was different. Due to the low numbers involved in this research it may be that the numbers in 
each group are too low to undertake meaningful statistical analysis. In this case the outcome will 
be descriptive instead. 
Outcomes were also grouped according to which therapist participants saw. These two groups 
were then compared using t tests (assuming test assumptions are met) to see if there was any 
significant difference between them. If there is this would indicate that therapist effect was key in 
determining who responded and who did not. 
Data quality is also reported in several ways. The amount of missing data for each participant for 
the daily measure is listed. Correlations of the ranked standardised measures were calculated at 
the start and end of treatment. This is to indicate if they are reporting the same relative severity 
for each participant. The PHQ-9 was also taken at several points during treatment. This was 
correlated with the daily low mood measure for those days for each participant to see if they are 
related. 
With the exception of the Reliable Change Index, calculations for all quantitative analysis utilised 
Microsoft Excel (Microsoft Office 2010) and SPSS 21 (IBM). 
3.2.12 Study 2 - Investigating possible mechanisms of action 
Aim: To investigate predictions of the AIP and previous EMDR research 
RQ - 3 Has the content of the target memory become less distressing and more adaptive, and if so 
is it stable at follow up? 
RQ - 4 Has the emotional impact of the target memory and the psycho-physiological response to it 
decreased? 
RQ - 5 Is there a relationship between the changes in symptoms and the changes in memories? 
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As was described in chapter two, there remains much discussion around possible mechanisms of 
action in EMDR. One of the key predictions from the AIP model is that in EMDR the client accesses 
a distressing memory and reprocesses it with more adaptive information so that in the future this 
memory is less distressing. The AIP also claims that this is the key way in which EMDR affects 
mental health problems as the memory of the distressing event is the trigger for the current 
difficulties and by changing the memory, the trigger is removed. These research questions aim to 
test these predictions.  
Study 2 analysis  
The memory descriptions were analysed by content analysis. The AIP model behind EMDR predicts 
that after treatment memories will be less distressing, less negative and more adaptive. Content 
analysis required the transcriptions to be coded for distressing, positive/adaptive and 
miscellaneous themes. As deciding what is a positive or negative theme could be subjective this 
was done by the researcher but also cross checked the scoring with someone else to ensure 
reliability of the coding. The ratios of the different themes were then compared before and after 
EMDR therapy to see if the EMDR has led to an increase in the amount of positive/adaptive 
themes being expressed. This was done using the Mann Whitney U test. Although a narrative 
description such as this could be analysed qualitatively in much more detail this is not necessary to 
answer the research question. The predictions of the model are clear that there should be a 
quantitative difference between before and after memories.  
Before and after comparisons of 4 Likert readings, HR, HRV and SCR where undertaken. Paired t 
tests (assuming test assumptions are met) were done to look for significant differences before and 
after treatment. The AIP predicts the response to the memory will be less emotional, less vivid, 
and more distant after treatment.  
Correlation analysis between before and after HRSD score, content analysis and HRV/SCR will 
show if these measures are changing in the same way. The AIP model predicts that as the 
depression (measured by HRSD) decreases then the content of the memory will become more 
positive and the heart rate variability will increase. Predictions of the direction of change in skin 
conductance response are debatable however, whatever the change direction, it should be 
consistent and correlate with the HRV, content analysis and HRSD if the model originally proposed 
by Gunter and Bodner (chapter 2) and expanded here (chapter 3) is correct. 
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In the interviews the participants were asked about the helpful aspects of EMDR and what 
happened to them during the Bilateral Stimulation. Were this elicited relevant information it was 
included again using a mixed methods matrix to introduce the comparisons and then expanded 
with quotes and explanation from the interviews. This will be helpful to answer questions about 
mechanism because the model is clear the bilateral stimulation is the key. Participants may be 
able to describe what did or did not happen to their memory during the bilateral stimulation. 
3.2.13 Study 3 - Acceptability 
Aim: To develop a framework to analyse EMDR therapy from a client viewpoint. 
RQ - 6 Do clients find EMDR to be an acceptable treatment for long term depression? 
Although we can tell how well EMDR affects the participant’s symptoms from the standardised 
scales, it is less straight forward to tell how it affected them. To try to understand EMDR from the 
point of view of the client interviews will be conducted two months after therapy has finished.   
Between the end of therapy and follow up the participants were invited back for a semi structured 
interview to discuss their experience of therapy, the interviews were conducted by an 
independent assessor. The interview topic guide was agreed in advance, it was based on the 
information gained from the HAT questionnaires, questions were on three main themes: 
1/ the participant experience of therapy – how did it compare to other interventions they have 
had? 
2/ experience of memories – did they report that they have changed with regard to content or 
impact? (It is possible that the memory will remain as it was but be less dominating – similar to 
pain in pain management therapy) 
3/ experience of depression – do they feel better? Have symptoms / functioning changed in a way 
that they recognise? 
By basing the questions on the HAT questionnaires, the interviewer can be more certain of 
covering the subjects that are most pertinent to the therapy experience without having to rely on 
the client’s memory of a therapy session that may have taken place many months earlier. A topic 
guide for the interviews is in the appendix. 
Study 3 analysis 
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A framework analysis approach was used to analyse the interview data. This involved five steps: 
familiarisation, identifying a thematic framework, indexing, charting and mapping and 
interpretation (Srivastava and Thomson, 2009). 
Familiarisation: getting to know the transcripts of the data, becoming immersed in it. 
Identifying a thematic framework: key to the framework analysis is the concept that although the 
research questions were designed around a priori issues, and these may form some of the key 
themes, it is also possible for unexpected themes to emerge from the data.  
Indexing: identifying portions of data that correspond to certain themes and coding these 
appropriately. 
Charting: indexed data are now removed from the transcript and placed in charts of corresponding 
themes linking key portions of data. 
Mapping and interpretation: Analysing key characteristics of the data set. 
This process has been described by Spencer, Ritchie and O’Connor (2003) and Bazeley and Jackson 
(2013) and contains eight steps to manage, describe and analyse the data. 
Data management: 
Step one - Go through each transcript, marking concepts and themes as you go through 
Draw up a framework or index of these themes 
Step two - Apply the index to each transcript (use Nvivo) 
Step three - Redo each transcript, ensure the coding is consistent 
Step four - Use Nvivo to create thematic charts and compare each subtheme for each client 
Descriptive analysis 
Step five - Detection - Review chart to find range of views across themes 
Step six - Categories – interpretation of themes, attempt to form categories that can incorporate 
and discriminate between different manifestations 
Step seven - Classifications – take categories to a higher level of abstract interpretation (consider if 
typologies are appropriate  
Explanatory analysis 
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Step eight – look for patterns and clustering of subgroups (for mixed methods this includes 
subgroups based on quantitative data) 
Predictions here are likely to be based on how well the person does in the therapy. Someone who 
does well will probably be more favourable towards the treatment than someone who remains 
depressed. Most reports of EMDR in PTSD give descriptions of change in the visual image of the 
target memory. It is therefore predicted that this will also occur when used with depression. The 
interviews were transcribed, then analysed on the latest version of Nvivo. 
3.2.14 Mixed Methods Analysis 
After the qualitative and quantitative data have been analysed separately they will be combined 
and reanalysed in a mixed methods format. This aim of this is to look for patterns and clusters of 
subgroups that were not apparent when the data was scrutinised separately. The primary method 
for this will be to use a mixed method matrix (O’Cathain et al., 2010), taking the tables created for 
the Framework analysis and adding in quantitative data to it. This allows data for each participant 
to be compared side by side, this is integration done at the level of analysis and is sometimes 
called integration through joint display (Fetters et al., 2013).  
Another method is triangulation; here the themes from the different methods are compared. This 
is done at the level of interpretation and looks specifically for areas of convergence, 
complementarity (expansion) and divergence in the datasets (O’Cathain et al., 2010, Fetters et al., 
2013).     
3.2.15 Procedure 
1. Clients referred to step three in IAPT (individual therapy) had an assessment with a therapist 
(CBT or counselling). This therapist identified clients who met the research entry 
requirements (require step 3 care, aged 18 or over with primary diagnosis of long term 
depression) and told them about the study. If client was interested in participating they 
completed the contact form which was returned to the research team. The client was given 
two information sheets. One specifically about EMDR and one about the research itself. 
2. The researcher contacted those who expressed an interest in participation and invited them 
for screening 
3. Screening with MINI, if volunteer met criteria following screen then they were given detailed 
explanation of the study. If they still wished to be a participant they signed the consent form 
and completed the battery of symptom scales (HRSD, BDI-ii, GAF, SASS, IES-r, PHQ-9). The 
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HAT scale and the daily scale were explained to them as was the importance of completing 
these. Any questions they had regarding the scales, testing, EMDR or anything else to do 
with the research was answered. 
4. Volunteers who meet the criteria and who signed consent form were assigned to an EMDR 
therapist (first 12 will be included). The therapists were bank workers brought in under the 
Sheffield Health and Social Care NHS FT (SHSC) governance procedures to deliver EMDR. The 
EMDR sessions took place at St George’s community health centre. Any volunteers who did 
not meet the criteria or decided not to participate were diverted back into the normal IAPT 
channels. The referring IAPT therapist was informed by email of the outcome to ensure that 
no one went untreated. 
5. Prior to beginning EMDR they had at least seven days of baseline period in which they 
completed the repeated measure every day. If there is a problem and the daily measures 
were not completed for the baseline period then the start of therapy was deferred for a 
week to allow time to collect the data. The participant met with the researcher and therapist 
to ensure they have understood the need to complete the research tools and if they needed 
any help in doing so. For example it was possible to send prompts by text message if people 
had difficulty in remembering to fill it in. 
6. EMDR followed the manualised standard protocol and therapists were asked to complete 
the ‘therapy process record’ to check adherence. 
7. After parts one to three of the protocol the participant returned to the University (or other 
arranged location) for pre-therapy testing. The memory narrative was recorded and the 
Likert scales and HRV/SCR readings taken. 
8. Client returned to EMDR therapist, two x 50 minute sessions per week. Up to 20 sessions in 
total as determined by clinical need and the client continued to complete the daily measure 
of symptoms. 
9. At each treatment session the client was asked to complete the PHQ-9 and HAT forms.  
10. At discharge or after 20 sessions, whichever came first, the client again met the University 
researcher to do the post-therapy testing and interviews (over at least two sessions). At the 
end of the treatment period they stopped the daily measure. 
11. At three months post-therapy the client was asked to do the follow up set of tests.  
  
111 
 
Chapter 4 – The clinical impact of the intervention 
 
4.1 RQ - 1 Is there an improvement in depressive symptoms and social 
functioning following EMDR for long term depression, and if so is it stable 
at follow up? 
 
Of the 13 participants recruited, three did not begin treatment (002, 009 and 014). The reasons for 
this are in the flow chart in Chapter 3.2. As they did not have any EMDR sessions they cannot be 
considered treatment failures and therefore their before therapy figures will not be included in 
the outcome data. Only one other participant did not provide after therapy outcome data, 
participant 008. He did begin therapy but he was discharged as the therapist deemed him 
unsuitable for treatment at the present time. After his discharge he did not respond to the 
researcher’s requests to meet for end measures. This was then treated as a drop out. As this is a 
failure of treatment his scores are included in the analyses. Table 4.1 shows the number of 
sessions received by all the participants who had at least one session with a clinician and how 
many of those sessions contained bilateral stimulation – the technique that separates EMDR from 
other therapies. 
Table 4.1: The number of sessions received by each participant and how many of those sessions 
contain bilateral stimulation (BLS) 
Participant Number of sessions Number of sessions 
using BLS 
1 17 12 
3 20 17 
4 20 16 
5 16 9 
6 9 1 
7 19 15 
8 9 0 
10 2 0 
11 20 10 
12 20 12 
 
4.1.1 Response on the primary outcome measure, the Hamilton Rating Scale for 
Depression 
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The HRSD was administered at the screening, after the final session and after a three month follow 
up. The figure (4.1) shows a Jacobson plot which shows the before and after scores and if any 
change is reliable, as measured on the reliable change index (RCI), and if it is clinically significant.  
Any point on the plot that is below the central diagonal line (red) is a participant who improved 
during the course of therapy. If that point is outside the tramlines (blue) then the change is 
reliable and if it is below the horizontal line (green) then the participant is now in remission. On 
the HRSD change can be clinically significant but not reach the point of remission, i.e. the 
participant has shown a major improvement in his or her symptoms but they are not yet well 
enough to be considered in remission, table 4.2 shows this in more detail.  
 
Figure 4.1: Jacobson plot for the HRSD 
 
 
 
 
Table 4.2: the change in HRSD and if that change was reliable and clinically significant 
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Participant HRSD Pre HRSD Post  Change Reliable? Clinically sig? 
1 17 3 14 Yes Yes – remission 
3 13 5 8 Yes Yes – remission 
4 25 9 16 Yes Yes - response 
5 26 3 23 Yes Yes – remission 
6 13 25 -12 Yes Yes but 
deteriorated 
7 21 5 16 Yes Yes – remission 
8 22 - - - Drop out 
10 23 11 12 Yes Yes - response 
11 10 2 8 Yes Yes - remission 
12 26 8 18 Yes Yes - response 
mean  20.3 7.89 11.4   
*a 6 point change is required for change to be considered reliable on the HRSD, for change to be 
clinically significant the participants post-score must be below 8 or have dropped by at least 50% 
and now be below 15. 
 
The table and Jacobson plot show that of the nine people to have before and after measures only 
one of those deteriorated and all the others meet the criteria for response. Of these five are in 
remission (001, 003, 005, 007 and 011) and three responded to treatment with at least a 50% 
reduction in HRSD score and are now rated as having mild depression (004, 010 and 012). The one 
person to have deteriorated (006) went from mild to moderate depression with an almost 50% 
increase in his score. Table 4.3 shows if participants maintained their gains over a three month 
follow up period. 
Table 4.3: HRSD score before and after the intervention and after the 3 month follow up  
Participant HRSD Pre HRSD Post  HRSD F/U Are benefits 
maintained? 
1 17 3 4 Yes 
3 13 5 6 Yes 
4 25 9 7 Yes 
5 26 3 7 Yes 
6 13 25 5 Improved 
7 21 5 4 Yes 
8 22 - -  
10 23 11 -  
11 10 2 5 Yes 
12 26 8 -  
mean  20.3 7.89 4.9  
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4.1.2 Repeated measures for individual participants 
As well as the standardised scales the participants completed a visual analogue daily measure on 
levels of low mood, energy levels and levels of interest in activities. Levels of low mood and 
interest were very similar as one may expect and correlated across each participant, see table 4.4 
in the appendix for details. However there were problems with the energy levels measure for this 
study. One of the clients had ME and one had an underactive thyroid, for this reason the energy 
levels questions were often marked as much worse than the low mood and lack of interest but 
may have not be associated with the depression. So even though the energy still correlates with 
the other measures its mean was generally much higher (table 4.5, also in the appendix). 
Therefore for the sake of consistency and to avoid the risk that physical health problems will 
confound the graphs the visual analysis has been provided for low mood only.  
Figures 4.2 to 4.10 show the change in daily low mood for each participant. The top half of the 
figure shows raw data, the lower half shows a seven day median smoothed data. In both instances 
the red vertical line shows when the treatment phase began and the green one shows when stage 
4 of the protocol began. The reason for this is that many people consider stage four, which is when 
the bilateral stimulation takes place, to be the key part of EMDR, it is certainly the part that makes 
it unique. Many early studies did not consider treatment to have begun until the eye movements 
started. Whereas for this study, any contact with the therapist is considered treatment as the 
therapeutic alliance (Klein et al., 2003) and the importance of non specific factors like treatment 
rationale and coping stategies (stage 2) (Ilardi and Craighead, 1994) are not to be underestimated, 
especially in depressed clients. However, by adding this second cutoff point on the visual analysis 
is allows the reader to compare these results with those of other researchers and to draw 
conclusions about the importance of the bilateral stimulation. Client 008 has no green line as he 
never started stage four. As can be seen in the upper portions of the figures there was very large 
variability in the mood ratings from day to day. For this reason the moving average (median) was 
calculated and also graphed. This shows a much smoother, although still highly variable, 
representation and makes it esier to see trends in the data. Although previous studies have 
suggested three day median smoothed data, this did not offer any visible smoothing so seven days 
was used instead (Franklin et al., 1996).  On all these graphs a higher number on the y axis equals 
lower mood so a downward trend will show improvement in mood.  The horizontal blue line 
shows the mean score in the baseline period. 
115 
 
Figure 4.2: low mood repeated data for participant 001 (Alice).  
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Figure 4.3: low mood repeated data for participant 003 (Sophie) 
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Figure 4.4: low mood repeated data for participant 004 (Robbie) 
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Figure 4.5: low mood repeated data for participant 005 (Maxine) 
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Figure 4.6: low mood repeated data for participant 006 (Martin) 
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Figure 4.7: low mood repeated data for participant 007 (Lewis)
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Figure 4.8: low mood repeated data for participant 008 (Andrew)
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Figure 4.9: low mood repeated data for participant 011 (Julie)
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Figure 4.10: low mood repeated data for participant 012 (Laura)
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There is clear downward trend during the treatment phase for all but participants 011, 008 and 
006.  Participants 006 and 008 showed significant worsening during the baseline phase and did not 
reverse that trend in the treatment phase. In both cases the clinician made a judgement that they 
should be discharged from the research and required referral to the CMHT. Participant 011 
appears to improve on the standardised measures but deteriorate on the daily score. This will be 
discussed in more detail below. 
The question of importance, and the reason for taking the repeated measurement, is can the 
improvement seen in the HRSD and the graphs be attributed to the intervention. Even in the 
smoothed data, some participants have extreme variability in their daily scores. Whilst this will not 
be a surprise to clinicians or researchers of depression it does make interpretation of the graphs 
more complex. Depression is a naturally fluctuating illness and over a period of three or four 
months such as in the research project, some people will improve regardless of any input. 
Traditionally in SCED visual analysis improvement in the baseline phase is considered to be part of 
natural variation and to be considered a sign that the participant would have improved anyway. 
However, in depression it is not quite as straight forward. The knowledge that the participant now 
has, that they are about to start treatment, the hope and expectation that this treatment may 
bring and the knowledge that their experiences are of interest and importance to someone (in this 
case the researcher) can improve mood. So although this is quite separate from the intended 
intervention it is not the same as natural variability.   
It is also not unusual for talking therapies to cause deterioration in a client’s mood before it starts 
to help them improve. In general people will avoid situations, experiences or memories that upset 
or distress them but in therapy that material is unavoidable. As a result mood scores often worsen 
at the start of a talking therapy (Castonguay et al., 2006) but it is how quickly that is reversed and 
how well as client is doing at the end that is of greater importance. Table 4.6 shows the 
percentage of treatment phase data points which are below the baseline mean for the whole 
period and the split into the first and second half of the phase. 
 
To investigate if the baseline and treatment phases were different an independent Mann-Whitney 
U test was conducted for each sample. The samples were not normally distributed so a 
nonparametric test was chosen instead of a t test, table 4.7 shows the results of these tests. 
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Table 4.6: Treatment phase data points below the baseline mean 
 Points below BL mean - total Total % First half 1st ½ % Second half 2nd ½ % 
001 85/159 53 39/79 49 46/80 58 
003 48/95 51 16/47 34 32/48 67 
004 31/78 40 10/39 26 21/39 54 
005 74/103 72 46/51 90 28/52 54 
006 4/47 9 3/23 13 1/24 4 
007 19/70 27 4/35 11 15/35 43 
008 3/27 11 3/13 23 0/14 0 
011 9/112 8 5/56 9 4/56 7 
012 82/101 81 39/50 78 43/51 84 
 
Table 4.7: Comparison of the baseline and treatment phases 
 BL mean BL SD Treat mean Treat SD 
001 49.35 21.25 41.91 21.29 
003 33.42 17.64 34.91 16.40 
004 37.43 17.61 48.13 23.13 
005 78.50 10.39 60.53* 18.90 
006 22.00 28.46 64.97* 27.05 
007 62.82 13.93 63.68 12.09 
008 63.63 16.03 74.36* 7.07 
011 56.54 14.24 66.46* 7.96 
012 51.46 26.84 29.89* 21.67 
⃰treatment mean is significantly different from the baseline mean at the 5% level. BL=baseline 
phase, Treat= treatment phase, SD= standard deviation of the mean 
Of those who improved on the HRSD, two had highly significant lowering of daily mood scores 
after the intervention, one decreased but not significantly, two stayed about the same and one’s 
mood score got significantly worse despite reported feeling better on every other scale (011). The 
two participants who deteriorated during the intervention had significantly higher mood score at 
the end of the treatment period, concurring with other estimates of their mood. 
 
Client 001 shows improvement in her low mood during the baseline phase, however, she was very 
keen to be in the research clinic and had emailed the researcher before she had been referred to 
discuss the project and asked to be referred rather than it being suggested by her health 
professional. The high variability in her data makes it hard to be sure of definite trends in the data 
even after smoothing. Her situation was further compounded by poor physical health that 
relapsed during the treatment period and she had to take several months of work.    
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Participant 003 shows consistent deterioration during the baseline phase which is followed by high 
variability during the treatment phase. As the treatment continues however, the variability 
becomes less and the median is consistently lower, indicating and more consistently improved 
mood. 
Participant 004 shows a similar pattern of consistent deterioration in baseline and then a variable 
treatment period. It does take this client longer to show the improvement of 003 but by the end of 
the treatment period he is reporting a more consistent mood.  
Client 005 had a highly variable but generally improving mood during the baseline period. This 
improvement continued during the treatment, to the extent that the client was considering 
finishing the treatment early. She took a couple of weeks off to go on holiday and said she would 
make up her mind when she got back and agreed to continue filling in the daily measures during 
this period. This was day 66. During the holiday she had what the therapist reported as a severe 
relapse, she returned early and asked to come straight back into the clinic. This was day 76. 
Following a return to treatment she once again improved consistently and reported that she 
thought the ‘relapse’ on holiday had actually helped her see she was not as well as she had 
thought she was and she was able to work on this in the coming sessions. What is interesting with 
client 005 is that she imposed this gap in treatment. Just before the break her low mood scores 
were very low indicating, as she reported, that she was feeling good. Within less than a week of 
treatment being withdrawn her mood scores become very high, higher even than the initial 
baseline at times. Then once she resumed treatment she followed a similar pattern as before of 
steady improvement. This could be seen as controlling for the effect of the intervention as she was 
reporting low depression scores in treatment and then very rapidly reported high scores once the 
treatment was removed. 
Client 006 showed substantial deterioration during the baseline phase. This in general continues 
during the treatment phase. Although he attempts to begin stage four and onwards he is judged 
by the clinician as not stable enough to continue. Client 006 was able to express in the interview 
afterwards that his deterioration was due to several external factors and he wished he had been 
able to continue with EMDR because he actually found it very helpful.   
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Participant 007’s baseline period has a lot of variability around a stable median, the first part of 
the treatment shows initial moderate improvement followed by deterioration as stage four is 
about to start. This is quickly reversed and the client is doing well by the end of the treatment 
phase. 
Participant 008 deteriorates severely during the baseline phase, going from less than 10 to nearly 
80 in the 6 week period. He does show some stabilisation during the start of treatment but 
unfortunately not enough for him to be suitable for treatment to continue and he had to be 
discharged. 
Client 011 has a large amount of missing data in her baseline period. Once the treatment starts 
she is much better at completing the daily measures. Client 011 is quite curious, she appears to be 
gradually deteriorating during the start of the baseline period, the only part that we have data for, 
during the treatment period this stabilises but does not improve on this measure. Despite this she 
does improve on the all other measures. This lady’s distress, although starting in childhood, was 
exacerbated by an unsupportive family. It could be that although she was developing a better 
understanding of her problems and no longer feeling guilty or abandoned her mood was still low 
due to also having a better understanding about how unhelpful her family had been and the 
pressures she is under. 
Client 012 also has a large amount of missing data during her baseline phase which makes it 
difficult to be sure about her mood during that period. However, her mood during the start of 
therapy is reasonably stable followed by a clear improving trend. Towards the end of treatment 
this appears to reverse slightly. However, the client reported a fear of endings. Right from the start 
of therapy she had been concerned about what would happen at the end. Once she reached the 
last few sessions, despite the fact that she had been feeling better on every scale she required 
large amounts of reassurance and work on dealing with ending the relationship with the therapist.  
When the huge variability in daily scores was first seen the possibility that this was a feature of 
depression was considered. If this is the case then the variability should reduce over time as the 
participants start to recover. Therefore means of the low mood measure and the associated 
standard deviations were calculated for each week of the research. A Spearman’s rho correlational 
analysis was run on the standard deviations versus time, the results of which are in table 4.8.  
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Table 4.8: Correlations of standard deviation of the daily measure over time for each participant 
 SD001 SD003 SD004 SD005 SD006 SD007 SD008 SD011 SD012 
Spearman’s 
rho week 
Correlation 
Coefficient 
-.534
**
 -.474 .050 -.191 -.733
*
 -.063 -.661
*
 -.266 -.324 
Sig. (2-tailed) .009 .064 .860 .448 .025 .846 .038 .257 .205 
N 23 16 15 18 9 12 10 20 17 
 
*. Correlation is significant at the 0.05 level (2-tailed).  **. Correlation is significant at the 0.01 level (2-tailed). 
As the table shows, with the exception of participant 001, the only participants whose variability 
significantly deceases are those whose mood actually deteriorated over time. Therefore this does 
not suggest that the variability was a symptom of worse depression or if it was it was not affected 
by the EMDR. The variability, especially in the baselines, did mean however, that the sample was 
not as homogenous as had been expected and therefore a meta-analysis was not competed.  
As is common in time series data the daily mood ratings are highly autocorrelated for all 
participants. For all the participants the first lag is positively autocorrelated but for some the later 
lags are negatively autocorrelated. This gives rise to the up and down nature of many of the 
graphs and suggests a pattern of a day or two of low mood will be quickly reversed and vice versa. 
It was also hypothesised that the intervention may help to reduce the amount of autocorrelation. 
Therefore the data for each client were split into separate columns, at least 50 data points in each 
column and the test run again. Participant 003 had significant autocorrelation in the first two lags 
for the first half of her data but no significant autocorrelation in the second half. For participants 
001 and 004 the first half did not have significant autocorrelation but the second half did. For 
participants 005 and 007 the autocorrelation was significant in both halves.  For participant 012 
once the data was split it no longer had enough power to identify any autocorrelation. Participant 
011 had enough data to split into three parts. The first and last were highly autocorrelated but the 
middle section was not. There does not appear to be any pattern within the data to suggest any 
change or otherwise in autocorrelation during the treatment phase.  
4.1.3 Outcomes on each of the secondary standardised measures 
Social Functioning 
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To investigate if there was also any improvement in social functioning, which is also a serious 
problem for people with long term depression, the Social Adaptation Self-evaluation Scale (SASS) 
and Global Assessment of Functioning (GAF) were used. Figure 4.11 shows the Jacobson plot for 
the SASS and GAF. Unlike the previous plot, improvement on the SASS and GAF is shown by a 
higher score. Therefore any point on the plot that is ABOVE the central diagonal line (red) is a 
participant who improved during the course of therapy. If that point is outside the tramlines (blue) 
then the change is reliable and if it is ABOVE the horizontal line (green) then the participant is now 
in remission. There is no cut off point on the GAF indicating ‘caseness’. Table 4.9 details the data in 
the graphs. 
Figure 4.11: Jacobson plots for SASS and GAF 
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Table 4.9: The change in SASS and GAF and if that change was reliable and clinically significant 
Participant SASS 
pre 
SASS 
post 
Change Reliable Clin 
sig 
GAF 
pre 
GAF 
post 
Change Reliable 
1 31 39 8 N Y 65 75 10 N 
3 47 49 2 N N 61 75 14 N 
4 31 36 5 N Y 68 68 0 N 
5 30 36 6 N Y 35 85 50 Y 
6 44 27 -17 Y Y 62 25 -37 Y 
7 29 38 9 N Y 52 65 13 N 
8 26 -    38 -  Drop out 
10 29 62 33 Y Y 68 62 -6 N 
11 43 48 5 N N 65 79 14 N 
12 30 69 39 Y Y 42 69 27 Y 
mean  33.1 38.1 10.0   54.2 67 9.4  
Reliable change on SASS = 12 and on GAF =21 and clinically significant change on the SASS= a score 
above 35. 
 
Of the nine people with before and after scores, six of these had impaired social functioning on 
the SASS before treatment began. All of these six improved their scores so that it was now above 
the SASS’s threshold of 35, however only two improved by such a margin that the improvement 
can be considered reliable and only one of those engaged with the treatment programme. The 
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GAF does not have a green line because it does not have a cut-off point for caseness nor does it 
have a published definition of clinically significant change. Its RCI is so large (see the blue tramlines 
on the graph) that even an improvement of 20 points cannot be said to be reliable. This raises 
questions about how meaningful the GAF is and how useful it is in a clinical situation. However, of 
the eight people who improved on the HRSD five improved on the GAF, only two of these can be 
considered reliable change due to the very large reliable change index (RCI) for the GAF. Table 4.10 
shows if any gains in social functioning were maintained after three months. 
Table 4.10: SASS and GAF scores before and after the intervention and after the 3 month follow up 
period 
Participant SASS 
Pre 
SASS 
Post  
SASS 
F/U 
Are benefits 
maintained? 
GAF 
Pre 
GAF 
Post  
GAF 
F/U 
Are benefits 
maintained? 
1 31 39 41 Yes 65 75 85 Yes 
3 47 49 48 Yes 61 75 68 No 
4 31 36 32 No 68 68 68 No improvt 
5 30 36 40 Yes 35 85 82 Yes 
6 44 27 41 Improved 62 25 75 Improved 
7 29 38 52 Improved 52 65 78 Improved 
8 26 - -  38 - -  
10 29 62 -  68 62 -  
11 43 48 44 No 65 79 75 Yes 
12 30 69 -  42 69 -  
mean  33.1 38.1 42.6  54.2 67 75.9  
 
Traumatic Stress 
 
The revised version of the impact of event scale is a validated self-report measure to measure 
traumatic stress. As EMDR is an efficacious treatment for post-traumatic stress disorder the 
participants were screened to ensure they did not have this diagnosis. None of the participants 
had witnessed a ‘Criterion A’ event, or if they had they had not responded with fear and 
helplessness. Despite this, seven of the 13 participants (four of those who started treatment) 
scored 33 or above on the IES-r indicating traumatic stress; they were traumatised by their past 
experiences. It was key for the research to ensure that EMDR was capable of treating depression 
not just trauma. Figure 4.12 shows the Jacobson plot for the IES-r and table 4.11 details this data. 
The Jacobson plot for IES-r once again shows improvement as a decreasing score just as the HRSD 
did. 
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 Figure 4.12: Jacobson plot for IES-r 
 
Table 4.11: The change in IES-r and if that change was reliable and clinically significant 
Participant IES pre IES post Change Reliable? Clinically sig? 
1 13 4 9 N N 
3 11 5 6 N N 
4 50 13 37 Y Y 
5 54 12 42 Y Y 
6 19 68 -49 Y Y 
7 45 20 35 Y Y 
8 33 -   Drop out 
10 25 24 1 N N 
11 15 1 14 N N 
12 35 13 22 Y Y 
mean  32 17.8 13.0   
Reliable change on IES= 18 and clinically significant change = a score dropping below 33 
 
Four of the nine people with before and after scores had scores on the IES-r indicative of traumatic 
stress before they started EMDR. All of these four improved so they can no longer be described as 
such, this change was reliable and clinically significant. The one participant who deteriorated did 
not have traumatic stress when he started but his scores indicate he was traumatised afterwards. 
Three participants showed a decrease in their IES-r score but it cannot be categorised as clinically 
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significant because their starting score was under the threshold for trauma or reliable change as 
their starting score was lower than the tramlines are wide. The tramlines representing the RCI are 
almost as wide for the IES-r as they are for the GAF. Change is only reliable if it is more than 18 
points but these three participants had a starting score of less than 18 so they cannot improve 
reliably. Table 4.12 shows if any of the gains from the treatment phase were maintained by the 
end of the three month follow up period. 
Table 4.12: IES-r score before and after the intervention and after the 3 month follow up  
Participant IES-r Pre IES-r Post  IES-r F/U Are benefits 
maintained? 
1 13 4 8 No 
3 11 5 12 No 
4 50 13 15 Yes 
5 54 12 0 Improved 
6 19 68 28 Improved 
7 45 20 22 Yes 
8 33 - -  
10 25 24 -  
11 15 1 20 No 
12 35 13 -  
mean  32 17.8 15  
 
Self-rated Depression Scales 
The primary outcome for this section was the Hamilton Rating Scale for depression; this is a 
clinician rating scale. There has been some debate about the use of this scale when the clinician is 
not blind to the research aims. To counteract that claim two participant rated scales, the BDI-ii and 
the PHQ-9 were also completed. Figure 4.13 shows the Jacobson plots for these scales and table 
4.13 details the data. As with the HRSD and IES-r, on both the PHQ-9 and BDI-ii an improvement is 
shown by a decreasing score which will be BELOW the diagonal red line.  
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Figure 4.13: Jacobson plots for BDI-ii and PHQ-9  
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Table 4.13: Change in BDI-ii and PHQ-9 and if that change was reliable and clinically significant 
Particip
ant 
BDI 
Pre 
BDI 
post  
Chan
ge 
Relia
ble 
Clin sig PHQ 
pre 
PHQ 
post 
Chan
ge 
Relia
ble 
Clin sig 
1 33 10 23 Y Y 17 7 10 Y Y 
3 21 2 19 Y Y 10 3 7 Y Y 
4 48 29 19 Y Y 24 11 13 Y Y 
5 43 9 34 Y Y 19 4 15 Y Y 
6 26 5 24 Y Y 10 25 -15 Y Y 
7 34 17 17 Y Y 18 6 12 Y Y 
8 28 -    17 -   dropout 
10 23 28 -5 N N 13 14 -1 N N 
11 24 0 24 Y Y 10 6 4 N N 
12 37 17 20 Y Y 17 5 12 Y Y 
mean  33.3 18 19.4   16.3 9 6.3   
Reliable change on the BDI-ii=9 and on the PHQ-9=6 and clinically significant change on the BDI-ii 
=a 10 improvement and the PHQ-9= a 5 point improvement 
 
Of the eight participants that showed improvement on the HRSD, seven also showed reliable and 
clinically significant improvement on the BDI-ii and PHQ-9. The only one that did not was the 
participant who left the programme after two sessions and therefore cannot be considered to 
have received EMDR. The one participant who deteriorated on the HRSD also had reliable and 
clinically significant deterioration on the BDI-ii and PHQ-9 as well. Table 4.14 shows if any gains 
from the treatment phase where maintained through to the end of the follow up period. Benefits 
have been described as still maintained if the client is still non-clinical in their score. 
Table 4.14: BDI-ii and PHQ-9 scores before and after the intervention and after the 3 month follow 
up period 
Participant BDI 
Pre 
BDI 
Post  
BDI 
F/U 
Are benefits 
maintained? 
PHQ 
Pre 
PHQ 
Post  
PHQ 
F/U 
Are benefits 
maintained? 
1 33 10 6 Improved 17 7 4 Improved 
3 21 2 8 Yes 10 3 6 Yes 
4 48 29 27 Yes 24 11 7 Improved 
5 43 9 2 Improved 19 4 5 Yes 
6 26 5 25 No 10 25 13 Improved 
7 34 17 8 Improved 18 6 7 Yes 
8 28 - -  17 - -  
10 23 28 -  13 14 -  
11 24 0 12 Yes 10 6 4  Improved 
12 37 17 -  17 5 -  
mean  33.3 18 12.6  16.3 9 6.6  
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4.2 RQ - 2 Are there any identifiable differences between the responders 
and non-responders which might be able to predict response in other? 
4.2.1 Participant effects 
Of the nine participants who received more than two sessions of treatment there were only two 
negative outcomes. The two groups of responder and non-responders are therefore not powered 
to be able to answer the question statistically. Therefore, the differences between the participants 
who achieved remission will be compared to those who only achieved a response and those who 
did not respond is described in key demographics before a description of the non-responders is 
given. 
At the end of treatment 001, 003, 005, 007 and 011 were in remission, 004, 010 and 012 
responded to treatment but did not see a remission in their symptoms. 010 left after two sessions 
and did not receive anything that could be described as EMDR so will not be included in the rest of 
this section. As there are so few participants in the each group formal statistical analysis could not 
completed but table 4.15 shows the spread of data in the key demographic areas highlighted in 
chapter 3.2. 
It is difficult to see any clear pattern in the data in table 4.15 to help understand who may benefit 
from EMDR for long term depression and crucially who would not. From the median data it 
appears that the remission group have much lower initial IES-r scores than the other groups. This 
is interesting because an initial concern was that EMDR would only treat depressed clients who 
had a high IES-r score meaning they were highly traumatised. The average scores suggest that the 
opposite is true although when the spread of the raw data is taken into account it does not appear 
to be too important. The remission group contains the clients with both the highest and lowest 
initial IES-r score.  
The clearest difference between the remission group and the responder group is the initial HRSD 
score. The responder group has a much higher score at the start indicating a much more severe 
depression. However, this does not mean that EMDR was not suitable; they still show a clinically 
significant response. However, it may be that they needed a longer treatment period to go into 
remission.   
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Table 4.15: The demographic characteristics of each group 
  remission response non-response 
N  5 3 2 
Initial HRSD raw 17, 13, 26, 21, 10 25, 23, 26 12, 22 
mean 17.4 24.7 17 
median 17 25 17 
Change in HRSD  raw 14, 8, 23, 16, 8 16, 12, 18 12 
mean 13.8 15.33 12 
median 14 16 12 
Age range  31-65 29-34 41-44 
Current age raw 32, 31, 65, 44, 64 29, 43, 39 58,55 
mean 47.2 42 43 
median 44 39 42.5 
Gender mix  4 f, 1 m 2 f, 1 m 0 f, 2 m 
Sociodemographics  4 C1, 1 retired 2 C1, 1 student 1 C1, 1 E 
Age at onset raw 15, 15, 23, 38, 15 10, 17, 26 43, 42 
mean 21.2 17.67 42.5 
median 15 17 42.5 
Number of previous 
episodes  
raw 5, 2, 6, 2, 15 2, 4, 4 1, 3 
mean 6 3 1.5 
median 5 4 1.5 
Length of current 
episode (months)  
raw 5, 75, 36, 7, 4 108, 12, 36 72, 1 
mean 24.8 52 36.5 
median 7 36 36.5 
IES-r score pre-therapy  raw 13, 11, 54, 45, 15 50, 25, 35 19, 33 
mean 28 37 26 
median 15 35 26 
 
The three participants with the highest number of previous episodes all achieved remission and 
the next two highest achieved a response. However with the longest length of the current episode 
was split between the groups. Of the four people who reported their current episode had lasted 
less than one year, three were in the group that achieved remission. As chronic and recurrent 
depression are considered to be different conditions (Klein and Santiago, 2003) this is important to 
investigate in a larger sample as it could be that recurrent depression is more responsive to EMDR 
than chronic depression.  
Responders v non-responders 
Participant 006 relapsed and had to be referred to the community mental health team (CMHT) for 
home visits as he could not leave the house. Whether or not this was a serious adverse effect of 
the treatment was considered in some detail. It was decided it was not, as this pattern of 
agoraphobia in relapse is typical for this participant and was not unexpected in a relapse situation. 
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The participant was also clear that the relapse was caused by factors external not the treatment 
programme, which he found helpful and wished he could have continued.  
The other negative outcome was participant 008. He attended nine sessions, almost half of those 
on offer, but had difficulty engaging with the treatment programme. He never got as far as stage 
four (processing) in the standard protocol of EMDR. His mental state was becoming more unstable 
throughout the sessions and again it was decided that the CMHT was a more appropriate 
intervention for him at that time. 
Both were middle aged men who had developed depression in their early 40’s. Both had current 
and recurrent Major Depressive Disorder and dysthymia. Although one had melancholic type, the 
other did not. One scored highly for anxiety, the other did not. One was long term unemployed, 
the other was self-employed. Both relapsed substantially during the baseline phase and both 
seemed to have problems relating back to their relationship with their mothers, although one’s 
mother was abusive, the other’s was smothering. Both had markedly differing starting scores on 
the HRSD, PHQ-9, IES-r, SASS and GAF. 
In comparison to the rest of the participants, these men were of average age for the group. At the 
start of the study there were four men and eight women, however, although only male 
participants had poor outcomes this is of the ten who actually started treatment. Two women did 
not start and another stopped after two sessions.  Not only that, but the other two men in the 
study did very well, so it is unlikely that gender is a key factor here. 
As mentioned above, the scores of the non-responders on the standardised measures were so 
different that it is not possible to group them and compare them to the other participants. One 
link the non-responders have is their age, however, older, younger and similar aged participants 
responded well to the treatment.  
It is more likely that this was a time in their lives when talking therapy was not appropriate due to 
external factors and their lack of support. Talking therapies require significant input from the 
participant and as 010 discovered, when there is a lot going on in your world that is not always 
possible. This may also have been the reason behind the failure of 002 to start. She was offered 
several appointments to begin treatment but refused them saying, ‘I’ll take the next one’. Maybe 
it just was not the right time for her either.  
139 
 
No assessment was considered at screening to discover if the potential participants had the 
resources available to undertake therapy. It was assumed that as they had been seen by at least 
one IAPT worker and that 1:1 therapy had been recommended that was an indication that therapy 
was suitable at this time. This assumption may not have been correct. IAPT has a high dropout rate 
(Griffiths and Steen, 2013) and here several participants either did not start treatment at all of 
dropped out quickly. Even the ones who did remain in treatment commented on the logistical 
difficulties of attending. A wider roll out of EMDR would need to consider elements such as when 
and where people can attend, how often and if they need other support as well.   
 
4.2.2 Therapist effects  
There were three therapists in the research clinic. Therapist 1 saw participants 001, 005, 006, 011 
and 012. Therapist 2 saw 003, 004 and 007 and therapist 3 saw 008 and 010. The two participants 
with negative outcomes, 006 and 008, had different therapists. Therapist 3 will be excluded from 
this analysis as 008 has no end of therapy data and 010 only completed two sessions of treatment. 
This does raise the question of why this therapist was not able to engage these two participants in 
the treatment programme but the sample size is so small it is difficult to offer robust explanations. 
The change in HRSD for each client was grouped by therapist and the two groups showed no 
significant difference at the 5% level using a Mann-Whitney U test. 
The two therapists who saw participants to the end of treatment and have before and after 
measures were compared. There was no significant different between the two groups (p=0.79). 
The one outlying score (for participant 006) was removed and the analysis conducted again, there 
was still no significant difference between the two (p=0.63). From this it can be concluded that 
there is no significant difference between the therapists in terms of the outcomes of their clients 
on the HRSD.  
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4.3 Data quality  
 
 correlation between PHQ9 and repeated measure 
 Correlations between standardised measures 
 Missing data from repeated measure 
 
4.3.1 Correlation between PHQ9 and repeated measure 
 
The PHQ-9 and low mood repeated measure were both repeated during the treatment phase and 
both are attempting to measure the participants’ low mood. If they are both truly measuring the 
same phenomenon over the same time period, they should be highly correlated. 
Figure 4.14 shows a scatter plot of PHQ-9 scores and the corresponding daily low mood score. 
 
 
Figure 4.14 shows the data from all participants and it suggests an upward gradient meaning that a 
higher PHQ-9 score corresponded with a higher daily low mood score which is what one would 
expect if the two the measures were truly measuring the same thing. However, there is a large 
amount of scatter in the graph so correlation analysis was undertaken for each client and for the 
group (table 4.16). 
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Figure 4.14: The score on thePHQ-9 and plotted against 
the corresponding daily mood score for that day 
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Table 4.16: Correlations (Spearman’s) between each participant’s low mood repeated score and 
their PHQ-9 score. Both taken only on the day of the treatment session for comparison 
Participant   PHQ-9 and low mood repeated 
measure score for each session 
001  Correlation coefficient 
Sig (2 tailed) 
N 
-.187 
.523 
14 
003  Correlation coefficient 
Sig (2 tailed) 
N 
.491* 
.033 
19 
004  Correlation coefficient 
Sig (2 tailed) 
N 
.300 
.211 
19 
005  Correlation coefficient 
Sig (2 tailed) 
N 
.433 
.122 
14 
006  Correlation coefficient 
Sig (2 tailed) 
N 
.943** 
<0.01 
6 
007  Correlation coefficient 
Sig (2 tailed) 
N 
.369 
.194 
14 
008 Correlation coefficient 
Sig (2 tailed) 
N 
.280 
.542 
7 
011 Correlation coefficient 
Sig (2 tailed) 
N 
.599* 
.014 
16 
012 Correlation coefficient 
Sig (2 tailed) 
N 
.697** 
<0.01 
19 
Meta of all clients  Correlation coefficient 
Sig (2 tailed) 
N 
.490** 
<0.01 
112 
*Correlation is significant at the 0.05 level (2-tailed) 
**Correlation is significant at the 0.01 level (2-tailed)  
 
The meaning of this is difficult to determine. For some people there is a clear link between the two 
measures for others there is not. It could simple be that the sample sizes are too small for the 
majority of individuals for the analysis to be confident of a pattern. It could be that the PHQ-9 is 
not as reliable for this complex client group as it is for general primary care clients. It was 
remarked by the therapists that even when the clients were scoring very low on the PHQ-9 and 
indicating remission that they felt this was not accurate and they still needed a lot more input. 
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It could be that the repeated measure was flawed. It could be something much more subtle. 
Clients with depression and especially long term depression are known to have selective memory 
for negative experiences. It could be that the repeated measure, because it only looked at low 
mood, continued to show this negative outlook even as other symptoms improved.  
It is suspected that these two scales are measuring different things. The PHQ-9 scale asks clients to 
rate items based on the last two weeks. The repeated measure was only asking for how the client 
felt at the moment of completing the measure. This makes it likely that the two will get different 
scores for two reasons. Firstly, it is quite plausible that a person’s mood this instant is not 
necessarily related to their mood over a two week period. Secondly, the PHQ-9, to be accurate, 
requires that the client can remember accurately how they have felt for the last two weeks and be 
able to average that into one reading. As is clear from the repeated data that the participants in 
this study have quite labile mood and there is a wealth of literature documenting the memory 
biases and general poor memory of people with depression (Brewin et al., 1999, Watkins, 2002, 
Barry et al., 2006).     
4.3.2 Correlations between standardised measures 
 
Table 4.17: showing the rank orders of severity of symptoms on the pre therapy measures 
 best symptoms         worst 
HRSD 11 3 6 1 7 8 10 4 5 12 2 
BDI-ii 3 10 11 6 8 1 7 12 5 4 2 
GAF 10 4 11 1 6 3 7 12 2 8 5 
PHQ-9 3 6 11 10 1 8 12 7 5 4 2 
SASS 3 6 11 1 4 5 12 7 10 8 2 
IES-r 3 1 11 6 10 8 12 7 4 2 5 
 
Table 4.17 shows the rank orders of the different scales; with the exception of participants 10 and 
4 most people’s scores are consistent. Correlations on these data (table 4.18, appendix) show that 
the depression rating scales (HRSD, BDI-ii and PHQ-9) were, as expected, highly correlated as was 
the IES-r to all three depression scales (HRSD, BDI-ii and PHQ-9). Surprisingly the GAF showed no 
correlation to any other scale. The other social functioning scale (SASS) however, was correlated 
with HRSD, PHQ-9 and IES-r.  This is a very small data set so it cannot be assumed that the GAF 
truly does not bare any relation to the other measure but it may in this group it is not an accurate 
measure of distress.  
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The BDI-ii shows higher severity of depression symptoms than the other depression 
measures at the end of treatment. This seems to be that the different emphasis of the 
different questionnaires. The HRSD only asks about two negative thought styles, low 
mood and guilt, and the rest are about physical symptoms whereas the BDI-ii asks 16 
questions about thought pattern and mood and only 5 about physical symptoms. There 
were a couple of participants who clearly still have negative thought patterns that 
remain untreated although other areas of their depression have improved.
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4.3.3 Missing data from repeated measure 
 
Table 4.22 shows the amount of missing data for each participant across both phases of the study 
Participant Length of 
baseline 
(days) 
Number of 
data points 
% 
missing 
data BL 
Length of 
treatment 
(days) 
Number of 
data points 
% missing 
data T 
001 17 17 0 159 120 25 
002 - - - - - - 
003 12 12 0 98 95 3 
004 21 21 0 85 85 0 
005 18 18 0 107 94 12 
006 9 9 0 48 36 25 
007 12 12 0 78 52 33 
008 41 41 0 28 28 0 
009 - - - - - - 
010 12 0 100 47 0 100 
011 66 25 62 112 97 13 
012 34 20 41 101 94 7 
014 - - - - - - 
 
Participants 002, 009 and 014 never started and therefore do not have a baseline period or a 
treatment period and no data, missing or otherwise. 
Participant 010 had her first session just before the Christmas holiday and as she had not done the 
recordings during the baseline phase it was decided that she could start them over the holidays 
and start with treatment when she got back. At the second treatment in January she had not 
completed them again and then cancelled several sessions. A joint meeting was arranged with the 
participant, researcher and therapist to discuss the issue. As it transpired 010’s home life was so 
turbulent that she was not in a position to take part in therapy and definitely not the extra work 
required by the research. She was discharged by the clinic and referred back to IAPT for treatment 
when things became more stable. For the other participants much of the missing data comes from 
towards the end of the treatment period.  
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Chapter 5 – Investigating possible mechanisms of action 
 
5.1 RQ - 3 Has the content of the target memory become less distressing 
and more adaptive, and if so is it stable at follow up? 
 
The Adaptive Information Processing model states that EMDR activates and changes the target 
memory taking it from distressing to adaptive through the use of bilateral stimulation. To 
determine if any changes actually occurred in the target memories the participants described their 
first target in detail before and after therapy. Content analysis was used to analyse the level of 
positive and negative statements in the memory descriptions, this is described in table 5.1. 
Counted were the total number of statements (pre total, post total), the number of negative 
statements (pre neg, post neg), the number of positive statements (pre pos, post pos) and the 
word count for both before and after the intervention. The negative and positive numbers were 
also converted to a percentage of the total.  
Table 5.1: Content analysis of the memory descriptions by participant 
 
pre 
total 
pre neg 
(%) 
pre pos 
(%) 
word 
count 
post 
total 
post neg 
(%) 
post pos 
(%) 
word 
count 
1 63 27 (42.9) 3 (4.8) 1221 29 5 (17.2) 0 (0.0) 336 
3 29 9 (31.0) 1 (3.5) 403 25 4 (16) 2 (8.0) 336 
4 265 38 (14.3) 12 (4.5) 4329 70 23 (32.9) 9 (12.9) 976 
5 36 
11 
(30.6) 1 (2.8) 365 23 5 (21.7) 2 (8.7) 205 
6 24 7 (29.2) 0 (0.0) 191 11 3 (27.3) 0 (0.0) 108 
7 58 15 (25.9) 3 (5.2) 1030 28 2 (7.1) 3 (10.7) 255 
11 32 3 (9.4) 1 (3.1) 475 41 2 (4.9) 2 (4.9) 422 
12 73 22 (30.1) 2 (2.7) 911 35 7 (20.0) 0 (0.0) 342 
mean 72.5 
16.5 
(26.7) 2.88 (4.0) 1115.6 32.75 
6.37 
(18.39) 2.25 (6.9) 372.5 
 
From the table it appears that there are some differences between the pre and post treatment 
time periods so a comparison of the groups was undertaken. As these are very small samples and 
not normally distributed nonparametric analyses were used throughout the chapter. Mann-
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Whitney U tests revealed there was no significant difference in the percentage of negative 
statements, the percentage of positive statements, the number of positive statements or the total 
number of statements across the two time points. There was a significant reduction in word count 
and in the number of negative statements. 
Surprisingly the number of total statements is not significantly different despite a large difference 
in the means. Closer examination of Table 5.1 suggests that this is because although some 
participants had very large changes many did not. Word count is significantly lower suggesting that 
the statements get shorter after the treatment rather than there being fewer of them. The 
situation with the negative statements is more complicated. The number of statements is 
significantly fewer as the word count goes down which may be expected. However, as the total 
number of statements has not reduced this suggests that the number of negative statements has 
changed in relation to the total number. However, the percentage of negative statements has not 
changed significantly. It is likely that this study does not have enough power to properly unpick 
this. 
The AIP model states that the number of negative statements should go down and the number of 
positive statements should go up. This is only partly supported by the findings. The working 
memory model says the statements should become more neutral; this was supported by the 
findings. This relates closely to some of the statements made in the interviews and will be looked 
at further in chapter 7.2. 
5.2 RQ - 4 Has the emotional impact of the target memory and the psycho-
physiological response to it decreased? 
As detailed in Chapter two, some researchers have shown a decrease in psychophysiological 
responses during the EMDR session. However, whether or not this relaxed state lasts outside the 
session has not been measured. Research suggests that clients with depression have decreased 
heart rate variability so it can be expected that an improvement in depression should lead to an 
increase in HRV. Previous research on EMDR in PTSD clients has seen skin conductance response 
decrease. SCR is lower in depressed clients than in healthy controls, unlike anxiety which raises 
SCR. Again it can then be expected that successful reduction in depression symptoms should be 
accompanied by an increase in SCR. These readings are taken at the same time as asking them to 
describe the distressing target memory; this can be expected to be distressing, at least at first, so it 
should raise the heart rate. If the AIP is correct then after treatment the memory will no longer be 
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distressing and therefore will not raise the heart rate so the reading after the intervention should 
be lower than the one taken before. Table 5.2 shows the before and after psychophysiological 
responses and if there was a change.  
 
The AIP also makes predictions about other effects of the treatment on the target memory. 
Previous research on PTSD clients and health participants has suggested the bilateral stimulation 
reduces the strength of emotion produced by the memory. It also reduces the vividness of it, 
makes the memory more complete and increases the distance of it. Table 5.3 displays the findings 
from the SEDI participants. If the AIP is correct the after memories will be higher on the 
completeness score but lower on the emotionality, vividness and distance scores.   
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Table 5.2: The psychophysiological response generated by the target memory, before and after therapy and if there was a change 
 Pre SCR 
uSiemans 
(SD) 
Post SCR uSiemans 
(SD) 
Diff Pre HRV 
RMSSD 
(SD) 
Post HRV RMSSD 
(SD) 
Diff Pre HR bpm 
(SD) 
Post HR 
bpm 
(SD) 
Diff 
1 
496.75 
(75.46) 271.13 (40.75)  -225.62 29.58 (45.28) 61.25 (117.9) 31.67 
82.67 
(9.97) 
73.97 
(22.26) -8.7 
3 
494.52 
(33.36) 2786.08 (178.73)  2291.56 36.13 (64.32) 48.24 (124.7) 12.11 
73.57 
(12.28) 
59.28 
(21.9) 
-
14.4 
4 396.55 (53.16) 
  1722.88 
(184.61) 1326.33 40.56 (57.05) 37.29 (91.2) 
 
-3.27 
72.28 
(18.85) 
61.88 
(17.79) 
-
10.4 
5 109.75 (10.98) 334.66 (25.44) 224.91 22.68 (54.95) 56.58 (123.0) 34.05 
68.92 
(10.08) 
73.27 
(24.31) 4.35 
6 366.28 (13.02) 274.93 (6.02) 
 
-91.35 23.53 (87.98) 54.39 (125.1) 30.86 
83.84 
(16.76) 
65.53 
(20.36) 
-
18.3 
7 349.05 (9.22) 378.34 (16.16) 
 
29.29 35.65 (49.33) 50.86 (86.7) 15.21 
66.93 
(7.35) 
75.96 
(26.97) 9.03 
11^ 267.19 (42.2)  - - 43.36 (86.38) - - 
67.46 
(17.18) - - 
12 401.98 (66.97) 405.28 (96.33) 3.3 31.43 (41.27) 37.5 (66.5) 6.07 
73.46 
(8.62) 
67.71 
(11.65) 
-
5.75 
mean 360.26 (38.05) 881.9 (78.29) 521.64 32.87 (60.82) 49.44 (105.0) 16.57** 
73.64 
(12.64) 
68.23 
(20.75) 
-
5.41 
SCR=skin conductance response measured in uSiemans, HRV= heart rate variability measured in the root mean square difference of successive 
NN intervals (RMSSD), HR = heart rate measured in beats per minute, SD= standard deviation, Diff= change from pre to post therapy.  
**significant difference at the 1% level (2 tailed t test) 
^Client 011 does not have any post therapy measures due to equipment failure  
149 
 
Table 5.3: The emotional reaction generated by the target memory, before and after therapy and if there was a change  
 Emotion 
Pre 
Emotion 
post 
diff Vividness 
pre 
Vividness 
post 
diff Completeness 
pre 
Completeness 
post 
diff Distance 
pre 
Distance 
post 
diff 
1 51 -  87 -  115 -  65 -  
3 32 51 -19 32 35 -3 15 19 -4 49 33 16 
4 167 35 132 84 64 20 4 55 -51 149 106 43 
5 86 16 70 151 103 48 151 33 118 151 16 135 
6 117 101 16 135 134 1 102 67 35 156 134 22 
7 51 17 34 135 135 0 118 120 -2 68 18 50 
11 136 18 118 136 35 101 137 35 102 137 38 99 
12 153 120 33 134 62 72 100 76 24 116 54 62 
mean 99.1 51.1 48.0 111.8 81.1 30.6 92.8 57.9 34.9 111.4 57 54.4* 
^All scores are mm along a visual analogue scale, measured from the left so a lower number indicates less extreme emotion, vividness, 
completeness or closeness of the image. 
*significant difference at the 5% level (2 tailed t test) 
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Mann Whitney U tests were performed to determine if the skin conductance response, heart 
rate variability and heart rate were different after the treatment. As expected the heart rate 
variability of the participants significantly increased following the intervention. This suggests 
that the autonomic withdrawal associated with depression has been lessened during the 
research period. Despite the very large mean increase in skin conductance response this was 
not significant. This is likely to be due to the large variations in the small sample size. At the 
post treatment recording clients 003 and 004 had very high skin conductance response 
readings. As they did not have unusual readings at the pre-therapy time point it could be a 
machine error in the reading. However, they were not done at the same time and client 007 
actually had his end of therapy recording done in the middle of the other two. A lengthy 
consultation was undertaken with the makers of the equipment (Vilistus) to try to find an 
explanation for the unusual readings. Despite several attempts to replicate the effects of short 
circuits and other possible artefacts that could cause an unexpected reading, no score as high 
as this was reached by the researcher or Vilistus. The team at Vilistus reported never having 
seen such a high reading. This remains unexplained. The equipment failure that occurred in the 
case of 011 was different. In this case only 3 seconds were recorded before the equipment 
failed. As expected the heart rate decreased following treatment, however this was not large 
enough to be significant. 
The Likert scales covering emotionality, vividness, completeness and distance were attempting 
to test the AIP predictions that following EMDR the target memories will provoke less emotion, 
appear less vivid, be more complete and appear further away. The Likert scales for emotion, 
vividness and distance moved in the direction predicted by the AIP but only distance was 
significant. The memories got less complete following the intervention but this was not 
significant. 
Client 006 is the only participant who deteriorated during the study to also have before and 
after scores for the psychophysiological responses and the Likert scales. Although he barely 
changes his scores on the Likert scales which is to be expected. He surprisingly improved on 
the psychophysiological measures. He has the highest reduction in heart rate, he is one of 
three with a very large increase in heart rate variability and has a substantial decrease in skin 
conductance response suggesting a reduction in distress. This may however, be a reflection of 
the fact that SCR is not a suitable measure when working with depression rather than 
suggesting that at some biological level he was improving.   
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5.3 RQ - 5 Is there a relationship between the changes in symptoms and 
the changes in memories? 
The AIP claims that the way in which EMDR reduces pathology, whether that is depression, 
PTSD or any other mental health problem, is by reducing the distress associated with the 
target memories. It is clear from chapter four that the participants in the study have in general 
seen a reduction in their depressive symptoms over the course of the research period. We 
have also seen pulse rate go down, and heart rate variability and skin conductance response 
go up. For most people the memories are now less emotional, less vivid and more distant.  
This is all consistent with the AIP; however, have they changed in relation to each other, have 
they changed in any consistent way. Table 5.4 shows a correlational analysis between the 
change in HRSD, the content analysis (word count and number of negative statements) and 
HRV. These measures were chosen as the HRSD and content analysis were the primary 
outcome measure for research questions 1 and 2. Word count and number of negative 
statements were both found to have changed significantly. There was also substantial change 
in the HRSD as can be seen in the Jacobson plots. Heart rate variability is a key indicator of the 
psychophysiology and as this was also found to be significantly changed following treatment it 
was decided to include this as well. 
Surprisingly, although all the outcome measures in table 5.4 changed significantly and in the 
direction that was predicted they have not changed in a consistent pattern over the different 
measures. The exception is word count and change in the number of negative statements in 
the memory description but this is likely to be the case, if the number of words decreases the 
number of negative words also decreases. It would be interesting to see this repeated with a 
larger sample size to see if this is a genuine phenomenon or just a lack of power. 
Table 5.4: Correlations between the change in HRSD, heart rate variability, word count and 
number of negative statements in the memory report.  
 Change 
HRSD 
Change 
wordcount 
Change 
HRV 
Change 
numneg 
Spearman's 
rho 
Change HRSD 
Correlation Coefficient 1.000    
Sig. (2-tailed) .    
N 8    
Change word 
count 
Correlation Coefficient .566 1.000   
Sig. (2-tailed) .143 .   
N 8 8   
Change HRV 
Correlation Coefficient .090 -.250 1.000  
Sig. (2-tailed) .848 .589 .  
N 7 7 7  
Change 
numneg 
Correlation Coefficient .552 .898
**
 -.198 1.000 
Sig. (2-tailed) .156 .002 .670 . 
N 8 8 7 8 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Chapter 6 - Client views on the acceptability of EMDR for long 
term depression 
 
RQ - 6 Do clients find EMDR to be an acceptable treatment for long term 
depression? 
The interviews took place around 2 months after the end of therapy. This was deliberate to 
ensure that real life had a chance to become normal and not revolving around therapy and to 
reduce the chance of being primed by therapists. The interviews lasted approximately 45 
minutes and were undertaken with seven participants, five of whom achieved remission at the 
end of therapy, one was a responder and finally one who had deteriorated during EMDR. Ten 
people had started EMDR, one only had two sessions and never got past the assessment stage 
so was not interviewed as she had not truly experienced EMDR. One did not respond to letters 
and answer machine messages to meet up for the interview. Finally the other participant who 
deteriorated could not be interviewed. Although it would have been very helpful to get his 
views his mental state was such that it was agreed that he would not be contacted without the 
permission of his care coordinator and this was not forthcoming. The interviews focussed on 
three subject areas, the participant experience of therapy, their experience of memories and 
their experience of depression, the topic guide is in the appendix. Within the area of 
participant experience of therapy there were five themes, helpful aspects of EMDR, unhelpful 
aspects of EMDR, comparing EMDR to other therapies, the relationship with the therapist and 
the friends and family test. Within participant experience of memories two themes emerged, 
identification of the target memory and the experience of processing. The experience of 
depression contained two themes covering their current feelings of depression and whether or 
not other people had noticed change. There were three emerging themes to have come from 
the interviews and these covered the motivation to attend therapy, the stigma of depression 
and post traumatic growth.   
6.1 Participant experience of therapy 
Among those who were contactable and agreed to be interviewed, the overall consensus was 
that EMDR was very helpful. 
‘I think it was really helpful’ (001) 
 
‘It was brilliant really’ (005) 
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All seven participants made similar comments, all denied it had been unhelpful or damaging, 
however they were not necessarily convinced by some of EMDR’s more unique aspects. 
‘The person who came in and the person who came out is different. That’s fact. There’s no 
disputing that. Now you can dispute the how’s and which’s and where’s in between but the fact 
is I came out better than I went in, a lot better and it’s continued on from there.’ (007) 
 
‘The therapy that I had worked, which of the bits of it it was it’s been useful whatever, even 
if that is just having therapy twice a week, who knows’ (003) 
 
6.1.1 Helpful aspects of EMDR 
Both when asked in the interview about what was most helpful and also on the HAT forms it 
was frequently the preparation and relaxation exercises that were well thought of by the 
participants. 
‘that light stream was brilliant’ (005) 
 
‘(therapist) did quite a lot of stuff with me around like having like a team of people. At the 
time I found it really annoying. When she first did it I just thought oh no, I can’t be doing with 
this. (Laughter) I’m not doing all this imaginary nonsense but I think actually it did make me 
kind of more open to being kind of aware of who is in my life that I can rely on and people that I 
trust and being more open with people.’ (001) 
 
It was universally considered to be very helpful to have got to the root of the problem. 
‘You know and I was able to understand a lot of my, you know my background and 
everything, why I am as I am I suppose.’ (005) 
 
‘this [EMDR] is the sort of thing that is going to tackle my deep-seated problems’ (006) 
 
Whilst the participants talked about understanding the things that had happened in their past 
they also talked about accepting there was a problem at all. 
‘it has made me aware that they were problems and that in itself has been quite helpful.’ 
(001) 
It was also helpful to get emotional at times and access the feeling that had been suppressed. 
‘For me it was really really good because it located the feelings in a big way, in a way I’m 
not, well I just don’t think I have probably ever done it before’ (011) 
 
6.1.2 Unhelpful aspects of EMDR 
One theme that ran through the interviews was one of individuality and the need for a person 
centred approach. Although everyone was pleased with EMDR in general there were some 
aspects that divided the group, they were mostly logistical, and could be accommodated if 
services were able to be a bit more flexible. This included the location of the therapy, most did 
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not mind where it was, some preferred St George’s to their GPs, others would have preferred 
their GP’s, but one participant found that St George’s sparked severe anxiety that impacted on 
several sessions. This would have been avoided if therapy could have been offered somewhere 
else. 
‘I liked it being away from the GP. Yeah GP’s would have felt too busy or something too 
much, not the right atmosphere. It was a nice atmosphere it was quiet.’ (011) 
 
‘it would have been more convenient at (GP surgery name)’ (005) 
 
‘it probably wasn’t very helpful me having to go to that place, just because I just found the 
whole experience really stressful so I think and it got better because (therapist name) bless her, 
let me go in the back door. But I think that sometimes I would get myself so wound up about 
having to sit there and potentially see somebody I knew that that’s probably kind of got in the 
way a bit’ (001)  
 
The number and length of sessions also came up. Most people had achieved remission by the 
end of 20 sessions but not everyone. An ability to alter the range of sessions to suit the needs 
of the client would be helpful. For many people the 50 minute session was long enough, some 
mentioned how tiring EMDR can be and did not want a longer session. For others the sessions 
were so emotionally difficult that they would have preferred a longer session so they had more 
time to calm down before leaving.  
‘Therapy sessions ought to be a little bit longer may be an hour rather than 50 minutes, I 
mean we always went over. I think it needs to be a longer session if it’s a deep-seated problem 
like mine it needs to be longer.’ (006) 
 
‘I would say I would need more than 20 yes. Yeah because I think it was just getting to it’ 
(011) 
 
Most of the participants really like this format of two sessions a week; however it was difficult 
for some to get the time off work. 
‘yeah it is more frequent than you would normally get but I suppose that focuses you better 
for and I mean if you had that many sessions once a week it would be a very protracted process. 
Although it might have been easier to get the time off work, but you might not feel you got the 
results the same way. The difficulty is how draining it is.’ (003) 
 
‘I’m glad it was twice a week. I think once a week wouldn’t have been enough and I would 
have felt that the progress was too slow. Whereas twice a week you could pick up on 
something quite quickly’ (007) 
 
‘I think I would have preferred it once week so it would have gone on longer’ (011) 
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6.1.3 Comparison with other treatments 
All the participants in this study had received at least one type of psychotherapy before joining 
the research. In the main this was either CBT or counselling as these are the ones typically 
offered by the health service for depression. It is clear that most people did get something out 
of their previous therapy experiences, validation of their issues, coping strategies and 
recognising unhelpful thinking styles were all listed as beneficial. 
‘it was like errm like psychodynamic therapy so I suppose it was a lot less structured and 
went on for a lot longer errm yeah it wasn’t as focused but yeah the same themes were 
definitely there. It was less focused and more just going with what is on your mind at the 
moment rather than having any kind of plan. Errm whereas, I guess there was more of an 
intention with the EMDR. That we are going to do this and that and you knew that you were 
following the process. I think they have probably both got their, I don’t know, yeah there’s good 
things to both of them.’ (001) 
 
‘trying to challenge some of the negative thoughts well it was more when I realised that the 
kind of negative thoughts I was having I wouldn’t even say out loud, and that’s when I realised 
quite how, I hadn’t even noticed how unpleasant I was to myself and I thought about some of 
the things I was saying to myself.’ (003) 
 
‘it’s good to recognise unhelpful thinking styles but don’t think they go into enough to teach 
you how to deal with it. And to do things with it so it’s very surface. I think it’s very good for 
you know things that have occurred recently that aren’t too in-depth.’  (004) 
 
‘I had the hypnotherapy before and that has helped me to errm give me the tools to try and 
calm down in anxiety attacks or try and calm myself, little things too like the breathing thing.’ 
(007) 
 
However, there were problems. CBT is highlighted for not recognising the client’s past as an 
important factor, many participants here described it as ‘for surface things’ or ‘fine if you have 
mild depression but not if it’s deep seated’. There is a definite view that long term problems 
cannot be solved without getting to the bottom of the issue. Which was one of the reasons 
participants liked EMDR. The other issue with CBT is that although the strategies and thinking 
styles are valued by participants trying to put them into practice when you are severely 
depressed they considered almost impossible. CBT was not the only therapy to have been 
unhelpful to the participants here. CAT and psychiatry also raise ire from 006 and 011 
highlights the problem with some private therapy keeping client for far longer than they want 
to be there. 
‘the problem with CBT it’s almost feels like you’re, you’ve got to be responsible for 
everything and I think if you don’t get a good therapist it can almost feel like you are being 
blamed for what’s happening all the time and was I’d never had before was something that 
looked at underlying reasons because CBT is all here and now stuff.’ (003) 
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‘that (CBT) didn’t really address the fundamentals of errm my personality and why I am like I 
am. Errm it’s gave you strategies for managing it but they were very hard strategies if you are 
really depressed which is what I was. Very very hard but I did do, I really tried’ (005) 
 
‘I’ve had most therapies, the worst one was psychoanalysis, CAT, the therapist doesn’t say 
anything really. I had a very good one to start with who would look at me and look saddened or 
disappointed or happy or, but the next one I had, she left and then the next one I had sat there 
at an oblique angle so I could barely see her. And just didn’t say anything ever and that was 
just awful.’ (006) 
 
‘psychiatry doesn’t work and psychiatrists don’t know what they’re doing. My experience of 
psychiatrists is completely negative, they just say try this comeback three months, try this one 
oh it doesn’t work try this one. Hopeless.’ (006) 
 
‘she could have had me going there for five years and I didn’t want that.’ (011) 
 
Despite deteriorating during EMDR, 006 still preferred it to the numerous other treatments he 
had received in the past. 
‘if I was to meet a person in a similar position to me, the one I would go for rather than 
psychiatry or CBT or CAT or any of the other therapies that is the one I would go for, or 
medication, including medication I would go for EMDR first.’ (006) 
 
6.1.4 The relationship with the therapist 
All the participants emphasised the importance of a good relationship with the therapist. They 
all felt the therapists they saw for EMDR made them feel comfortable and that this was 
essential for EMDR to progress smoothly. This was demonstrated in different ways, some 
spoke of ‘validation’ or feeling able to ‘open up’. One explained that tapping was very intimate 
so whilst she felt fine with her therapist she is not sure how she would have found the same 
situation with a male worker (003).  
6.1.5 The friends and family test 
Ultimately the research question was to discover if the participants consider EMDR to be an 
acceptable form of therapy for long term depression and they certainly indicated that they do. 
They have given a lot of detail about what happened to them during therapy, what they think 
has been helpful and the parts of the treatment that were very difficult to go through. This is 
valuable information for clinicians and researchers alike. Crucially EMDR passed the ‘Friends 
and Family test’. Increasingly, NHS services are asking their clients ‘would you recommend this 
service to your friends and family?’ All seven interviewees, including the one who deteriorated 
during treatment, said they would definitely recommend EMDR. Some acknowledged that 
other therapies had given them some tools but no therapy invited as much praise as EMDR did. 
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6.2 Participant experience of target memories 
6.2.1 Identifying target memories 
Initially the idea of identifying target memories was very difficult for the participants either 
because they did not have any obvious targets or that they did but were not sure they could 
talk about them. 
‘that was hard because I have no obvious negative things.’ (003) 
 
‘yeah very difficult. Having to speak about something that had only ever gone on in my own 
mind from being quite a young age, something that is quite a sensitive issue ‘(004) 
 
 ‘Having to recall those memories was painful errm and they of course sparked off other 
memories that were equally painful.’ (006) 
 
‘I was worried at the beginning that my trauma wasn’t going to be the right trauma. Partly 
because it was, I had perhaps not seen it as trauma before in the way that you would as if you 
had had a car accident. So I wasn’t quite sure whether I would fit the bill errm but that, it did.’ 
(011) 
 
6.2.2 Experience of processing 
The participants preferred to have their eyes closed to help them to bring up the memory. This 
meant that they could not use the eye movements during processing but usually used tapping 
instead. 
‘so initially we tried to do it with me following eye movements but errm I couldn’t think and 
have my eyes open at the same time (laughter) errm so we used the buzzers which worked like 
loads better for me.’ (001) 
 
‘with the eye following you can’t close your eyes’ (007) 
 
During the interview it became apparent that 004 had an extremely vivid visual experience 
during processing. 
‘I could feel something changing it was like my eyes were following the tap in some kind of 
way, like bouncing side to side while it was happening. I was thinking I could feel the physical 
sense that something was happening. How that would work I don’t know. But it has.’ (004) 
 
‘it was almost as though I could feel my mind searching (laugh). I almost felt like I was in a 
big room filing cabinets, I’m like (makes noise like flicking through papers), like a machine just 
rattling through, oh that’s significant, oh that pops up, oh I didn’t realise that. And it’s almost 
as if these things were misfiled. I’m reading through things and I didn’t expect to see this just 
lying around, it’s almost as though, okay what’s that doing here. Why is that out? Not with 
everything else it’s almost like it’s out of place or not put away properly.’ (004) 
 
‘I was becoming aware of things, some of the things have never even come up in CBT. Some 
of the things I didn’t even think with that big a deal and they turned out to probably be the 
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most significant thing there. Errm, the realisation from that was quite profound for me really. 
(004) 
 
it would bring the emotion to the forefront’ (004) 
 
Although he was the most vivid in his descriptions he was not the only one to “see” changes in 
his target memories. 
‘I would be thinking of a picture of something but then it would move onto yeah yeah. 
That’s it.’ (005) 
 
‘yes and when the eye movements were being done it was (daughter’s) face who was 
constantly popping up, reassuring not saying anything but, just reassuring.’ (006) 
 
Not everyone is quite so visual in their imaginations however and not all the participants had 
this reaction. 
‘yeah like it felt different, it seemed different but I don’t know exactly how.’ (001) 
 
‘nothing I can put my finger it’s difficult because over time eventually your body tires itself 
out so, eventually you’re probably going to stop or at the least do something different.’ (003) 
 
‘That is a different image. It’s like I’m not, what keeps coming in, it doesn’t matter.’ (007) 
 
‘I can’t say no I’ve never thought about that, I think that it was I was listening more to what 
(therapist name) was saying.’ (011) 
 
Several participants mentioned that the bilateral stimulation seemed to cause a change of 
state in their mind. 
‘when you had actually been doing the processing, sometimes I felt quite weird. A bit kind of 
sickie or spaced out or something’ (001) 
 
‘trance like’ (007) 
Participant 011 described that most of the time she lived in her ‘intellectual head’ and that 
during EMDR she was able to get into her ‘emotional head’ which was something she had 
never done before. Interestingly these are the same participants who did not have a very 
visual image change in their memories but have clearly had a profound experience.  
These experiences were not confined to the therapy session. 
‘weirdly some of the things that happened not necessarily in the session, kind of after the 
sessions at night and stuff like I would have quite vivid dreams errm and also I would start to 
remember things. But not like bad things, quite nice things that I had may be not given any, 
that hadn’t popped up before. Just like nice memories from being a child and that was really 
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nice to, I felt like it’s given me access to those again all something but may be because I had I 
don’t know gone to memories that were nearby or whatever I don’t know’ (001) 
 
She said this was incredibly helpful because during the session they would focus on something 
negative that happened at a particular age, and then later she would access these positive 
memories. She felt that it ‘restored balance’ to her childhood, reminding her that although 
there were unhappy incidents, there were some really good ones too. 
During processing these target memories changed, each person appears to have experienced 
this differently but the end result is the same, the memories have gone from being incredibly 
traumatising to not mattering. 
‘I’ve controlled it subconsciously I’ve not sort of got any physical strategies for doing it, it 
has somehow not happened. It’s up here (taps head), it’s switched it.’ (005) 
 
‘but errm so the memories don’t bother me now. Errm I mean they weren’t memories until I 
did this, they were my childhood really. So they are just there now and I can understand it.’ 
(005) 
 
‘That is a different image. It’s like I’m not, what keeps coming in, it doesn’t matter.’ (007) 
 
6.3 Participant experience of depression 
6.3.1 Do they feel better? 
According to the participants EMDR was in parts very difficult, but generally a very positive 
experience. However, the aim of all therapy is to ensure lasting changes, to reduce the 
symptoms of depression and have a positive impact in the wider lives of the clients. The other 
key point is that the Hamilton rating scale of depression indicated that the participants did 
very well in therapy and most are in remission, however, do they agree with that assessment? 
‘I feel like different to how I felt before I started the EMDR.’ (001)   
 
‘a huge ball and chain has been loosened, it’s not completely gone but I don’t feel like I’ve 
got the weight of it any more. I feel like it’s still there I’ve still got marks, scars but don’t feel 
like I’m dragging around this weight.’ (004) 
 
‘taking me before the course and me after the course it’s almost like a different person.’ 
(007) 
 
Clearly the participants feel that things have moved in a very positive way, they were also very 
clear about what specific parts of their lives have changed. Again this is expressed by the 
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participants in different ways, some talk about how the memory no longer has such an effect 
on them, others talk more about reducing day to day stress in their lives. 
‘I certainly think depressive memories can sometimes have a traumatic effect on you, they 
certainly did in my case. I was almost visually traumatised. Every night I was having intrusions. I 
can’t remember having one for a while, I might have had one in a few weeks’ (004) 
 
‘there were two, two really big things for me I have always felt that everything that has 
happened has always been my fault, I’m the one that is caused it, it’s been my fault, on the 
other really big thing was that nobody ever really liked me and why did people want to be 
friends with me. Both of those really went straight back down to my childhood and that was 
how I was made to feel right from being little. So my whole and you know you’re not a nice 
person, your own self-image and those things that I actually know now were weren’t true. So 
they actually helped me to look at people and myself very differently.’ (005) 
 
‘I was always highly stressed, quite wound tight in a way. Like a coiled spring you know the 
compressed spring. Errm whereas I don’t feel as compressed these days.’ (004) 
 
‘I try not to rush in so much, I try not to let things build up and get me down I try to slow 
things down much more, I think about things in a different way.’ (007) 
 
The AIP model differs from CBT in that it considers negative thoughts to be a symptom of the 
pathology (caused by the unresolved memory), rather than the cause. 005 had previously had 
a failed course of CBT but here managed to change her thinking style even though this was not 
worked on directly during the treatment. 
For others it’s about resolving issues in the past and moving on or how they cope better when 
a crisis does strike. 
‘if you don’t believe in yourself then you are not being fair to yourself as you going to 
experiences in your life. You are going to be critical all that time, rather than think well actually 
I did that quite well considering’ (011) 
 
‘To leave me feeling better, I’m at work having a laugh with people. I don’t think, I do take 
things to heart sometimes, I do start to self-criticise and to beat myself up but I’m able to sort 
of bounce back quickly from it, like within the half-hour or hour not be affected for weeks. So 
again a massive significance. I think personally I’ve seen some significant changes.’ (004) 
 
As well as being better able to cope with the memories that were the target of therapy, or 
reduce stress and depression in their daily lives there were statements that appeared to go 
beyond healing and into positive growth. Participants began talking of acceptance, insight into 
themselves and their relationships with others and a need to look after yourself if you are to 
remain healthy. 
‘I’m trying to be more accepting of yeah emotional responses.’ (003) 
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‘you forget that you’ve got to maintain yourself like you’re a car, if you don’t it’s going to let 
you down. Errm and I think that I had neglected to give myself time and I think this therapy 
helped me realise that.’ (004) 
 
‘you know you’re not a nice person, your own self-image and those things that I actually 
know now were weren’t true. So they actually helped me to look at people and myself very 
differently. Errm and one of the really big things has been the relationship with my eldest 
daughter, that was really really helped me understand my relationship with her.’ (005) 
 
 ‘I don’t have to forgive her actually. She was horrible and I have to accept that’ (006) 
 
 ‘I’m actually going through some sort of challenge in my life at the moment which is about 
saying what your needs are, what your wants are.’ (011) 
 
Like many people with long term depression these participants had difficulty with many of 
their relationships, whether it was with family, existing friends or making new ones. Again 
everyone commented on how their view of relationships has changed and the tangible effect 
that is having on their interactions with others. 
‘it was like I was more willing to errm connect with people or something and I think that has 
kind of continued I have been less avoidant of sort of my relationships I suppose. I think it 
makes me feel more like more kind of optimistic about the possibility of kind of making new 
relationships.’ (001) 
 
‘I do feel as if I am in control a lot more of my emotional feelings really and I understand 
why I have been like this all my life. It’s had a massive impact on the way I view friendships.’ 
(005) 
 
‘My relationship with my daughter is so much better because I laugh and I joke with her 
now.’ (007) 
 
‘you’ve got a lot of people expecting things from you… but internally I think it’s about that 
asking for what you want which is really quite fundamental.’ (011) 
 
6.3.2 Have others noticed? 
Several people commented on how others had noticed change in there mood and behaviour. 
‘I had supervision and I was just like I’ve got my last session like the review thing today and 
she [manager] was asking about do I know the results from other people or anything, had 
everybody else had such a positive response and that kind of thing’ (003) 
 
‘In fact my friend said ‘how do you get this’.’ (005) 
 
‘All I could do is say what other people see in me now how much better they all see me.’ 
(005) 
 
‘even people who know me just say I look different, just the way I will smile more, or my 
eyes are different’ (007) 
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‘I’m not saying that I’m completely cured, my wife would say ‘I don’t know any change’, but 
I feel a change.’ (004) 
 
Although 004’s wife did not think he had made much improvement he disagreed. He put this 
disagreement down to the fact that ‘she didn’t know the half of it’. 
 
6.4 Emerging themes 
6.4.1 Motivation 
All talking therapies ask for a significant investment from clients, it can be hard work and 
different people will find the motivation to continue in different places. 
‘I think the thing that was really useful for me was that it was the research project. And so I 
was much more willing to accept this was kind of weird (laughter) like what’s going on here oh 
well just go with it because there is almost like a higher purpose to it and if it was just for my 
benefit I don’t know if I if I do have err. I think I would have been more, what is this all about, 
why am I doing this, is this a good use of my time, it’s a big use of my time etc etc. Whereas if 
there was going to be something practical that came out of it whether it worked for me or not 
than was more useful I think than, yeah having the additional reason to do it was helpful for 
me.’ (003) 
 
6.4.2 Stigma 
The issue of getting time off work also linked to the issue of mental health stigma and about 
talking about depression to employers and colleagues. Despite initial fears the participants 
their employers were very supportive, allowing them time off work, not only for the therapy 
but also for the research appointments as well, some people’s colleagues were not as open 
minded. 
‘I’ve not had that much choice, I’ve had to tell them what was going on eventually, but I feel 
able to talk about and I’ve got a really good support network at work.’ (003) 
 
‘very fortunately (employer) were very very good. They let me have the time to do it’ (004) 
 
‘one of the hardest bits was tiptoeing round colleagues. Trying to bat off questions, I just 
told them it was physio linked to research. Because when something is physical it’s easier to 
talk about, people understand it. I sit next to somebody who you mentioned owt about 
depression or anxiety and he screws his face up and that is his first reaction, ‘people, what’s 
that about blah blah blah’, really negative about it. So to be sat next to somebody like that who 
is fishing for information about where you have been, what you’ve been doing, blah blah blah, 
who has that opinion, was quite a difficult experience,’ (004) 
 
Unfortunately it’s not just members of the public who have difficulty understanding 
depression.  
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‘I honestly hope that GPs get more awareness of these things’ (004) 
 
Here 004 is not just talking about depression but also about getting the right treatment. 
Despite not responding well to CBT and actively asking for something else, he was given CBT 
on three occasions. 
‘I’ve always known that the therapies I’ve had in the past errm, through IAPT have been CBT 
based. I’ve known very early on into that it wasn’t for me. errm, yet trying to get other people 
of the power to refer you to these things to understand that you have got a bit of an idea about 
what you are, where you are, you’ve studied a little bit of something, and you’ve got all bit 
more awareness than a lot, and you know something is not right for you but you don’t know 
what it is. Trying to get that across and trying to get that has been something that took the 
best part of seven or eight years.’ (004) 
 
This clearly frustrating experience only came to an end when his latest CBT therapist heard 
about this research programme and asked him if he would like to try something different. 
Service managers in the NHS are currently claiming to respect clients as experts by experience, 
that they know their condition better than anyone else, but because there is very little 
flexibility in the system this expertise has little chance to be expressed.  
6.4.3 Positive growth 
There is a field of study around post therapeutic gains sometimes referred to as positive 
psychology or post traumatic growth. This refers to the benefits of treatment over and above 
‘getting back to normal’. The participants made several references to areas that were not 
directly worked on the therapy but nonetheless have seen behavioural or attitudinal change. 
They talked about being more accepting of themselves, their emotions and their histories. The 
also mentioned having a new found confidence to apply for a promotion (004) or to ring 
friends (001,005) which they would not have considered doing before.  
There was also a recognition that it is important to look after yourself. Whether that is eating 
properly (005), building in some relaxation time (004) or leaving stress at work and not taking 
it home with you (007). 
‘you forget that you’ve got to maintain yourself like you’re a car, if you don’t it’s going to let 
you down. Errm and I think that I had neglected to give myself time and I think this therapy 
helped me realise that.’ (004) 
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6.5 Interlinking themes 
The separation into themes for qualitative analysis runs the risk that interactions between 
themes are missed. The themes here are clearly interlinked. The relationship with the therapist 
relates to the identification of the memory and feeling comfortable enough for that to be 
possible. A good relationship with the therapist was highlighted many times as important and 
allowed them to feel secure and validated. They felt comfortable enough to explore parts of 
their pasts they had not revealed to anyone else, even previous therapists. They also felt 
comfortable enough to use tapping for processing. This requires the client and therapist to be 
in closer proximity than in most therapy and to have physical contact. 
The processing also linked to the themes of helpful and unhelpful aspects of the therapy 
because although it was considered helpful overall, there were some difficult aspects to 
overcome. Not just identifying the memory but also processing it. All the participants found 
the eye movements difficult and tapping could have caused issues if the participant had not 
had such a good relationship with their therapist. 
There are links between identifying the memory, thoughts on their depression and positive 
growth. Getting to the bottom of the reason for their depression was universally considered 
helpful. By developing an understanding of their pasts and feeling that there was a good 
reason for their depression, helped them to feel validated and more accepting of self. This 
allowed them to move passed the depression and adopt behaviours and attitudes more likely 
to led to a healthier outlook such as being more engaged with friends and family, accepting 
emotions, making time for relaxation and leaving stress at work.   
The friends and family test linked to the things other people had said about their depression. 
There were cases of friends asking to be part of the research or asking about how it was going 
for the others as they had seen such a change in their friend. This is a level of endorsement 
that cannot be underestimated.  
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Chapter 7 Integration Chapter – Mixed methods 
Although the quantitative and qualitative methods have provided interesting results a true 
mixed methods study recombines this data and reanalyses it to discover if there is more to be 
learnt. The three main questions of the study remain, did EMDR have an impact on depressive 
symptoms, does the data support predictions of mechanism of change and did the participants 
find the treatment acceptable? However, this chapter will draw on mixed methods to answer 
these questions.  The quantitative and qualitative data can be combined at different stages. 
The data for the three key research questions will be combined at the stage of analysis using a 
mixed methods matrix (O'Cathain et al., 2007). This will look at the data on an individual level. 
Data can also be combined at the group level at the interpretation stage using the 
triangulation protocol (O'Cathain et al., 2007). This will take the different types of data and 
look for convergence, divergence and expansion of understanding between them.    
7.1 Impact 
In depression diagnosis is heavily based on the subjective reports from the clients themselves, 
it is important that the clients agree with the assertion that they have improved over the 
course of treatment. In a client focussed service, with an emphasis on recovery, if the client is 
not satisfied that they have improved then they cannot be said to have improved sufficiently. 
Table 7.1 is a mixed methods matrix allowing close comparison of how much the participants 
changed on the primary outcome measure of the research (the Hamilton rating scale of 
depression - HRSD) and the views the clients expressed during the interviews.  
006 recognises issues but also benefits that EMDR had for him 
‘I know now something that I knew then but didn’t realise it had had such a spectacular 
effect and that is the use of triggers that set me off on a train of negative thought and I wasn’t 
sure whether errm and I’m still not sure whether me recounting all of these experiences from 
my history was errm useful.’ (006) 
004 acknowledges that he is ‘not cured’ but had a ‘ball and chain lifted’. He thinks his wife 
hasn’t seen much difference because she ‘didn’t know the half of it’. He was very candid about 
the changes he has seen and the ones he hasn’t. He did not reach remission during the 20 
sessions of therapy but he had one of the highest scores on the HRSD at the start and he did 
make very large gains, he had the third largest improvement on that scale. 
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Table 7.1: views of clients and their change on the HRSD  
 HRSD 
change 
Views of change Views of others 
001 14 
(remission) 
‘at the moment like I feel like 
things feel clearer or they 
feel bit more hopeful 
definitely’ 
 
003 8 (remission) ‘I’m trying to be more 
accepting of yeah emotional 
responses’ 
‘my boss commented on it today you 
see… I had supervision and I was just like 
I’ve got my last session like the review 
thing today and she was asking about do 
I know the results from other people or 
anything, had everybody else had such a 
positive response ‘ 
004 16 
(response) 
‘I’m not saying that I’m 
completely cured, … but I feel 
a change’ 
‘my wife would say ‘I don’t know any 
change’’ 
005 23 
(remission) 
‘there has been a massive 
shift in how I am’ 
‘my friend said ‘how do you get this’ ‘All 
I could do is say what other people see 
in me now how much better they all see 
me’ 
006 12 
(deteriorate) 
  
007 16 
(remission) 
‘I felt a lot more relaxed or 
like a weight off my 
shoulders kind of thing. I 
definitely came out of the 
sessions feeling better than 
when I went in.’ ‘it’s like a 
new beginning’  
‘people who know me just say I look 
different, just the way I will smile more, 
or my eyes are different’ 
 
011 8 (remission) ‘Its acceptance really its 
acceptance that something 
happened’ 
 
 
011 is probably the largest discrepancy. According to the HRSD she moved into remission 
during treatment. However, during the course of treatment she realised how much pressure 
her family put on her and how little support she received in return. This is obviously very 
distressing and means she is going ‘though a difficult period’ right now. She may not be 
clinically depressed but it could be argued she is not psychologically balanced. She was also 
lacking in confidence during the interview. At times she reverted to talking about herself in the 
third person and when she was asked if she thought she needed more sessions she skirted 
around the issue until the interviewer gave her permission to say yes. She also said she 
thought getting EMDR was a ‘treat’ implying it was a luxury rather than a treatment for her 
mental health. 
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This lack of confidence was also seen in 006, who deteriorated during treatment, he felt that 
he should not be contributing to the development of EMDR for depression because he was not 
important. He referred to the recurring image of his mother’s disapproving face and her voice 
telling him that it was ‘not his place’. 
005 and 007 were the most enthusiastic about EMDR using phrases like ‘brilliant’ (005) and 
‘it’s like a new beginning’ (007). 005’s only negative comment was that she was saddened by 
finding EMDR so late in her life and wondered how things would have been different if she had 
received it as a young women, a view echoed by 011. 
001 and 003 are both young healthcare professionals. Although both did well in treatment, 
and acknowledged that, they were not as enthusiastic as 005 and 007. This is possibly in part 
due to very high expectations from the start ‘I wanted there to be one thing from the past that 
was stopping me from being happy and that I could go and fix that memory and then be happy’ 
(001). This is not likely to be the case especially when suffering from a chronic health condition. 
003 has clearly made impressive progress but some potential issues remain. 003 has difficulty 
expressing emotion and views crying as being wrong and something that should be fought, 
whilst she now admits to ‘trying to be more compassionate toward my emotions’ she still 
keeps a diary noting all the times she is ‘not coping’.  
With the notable exception of 011, the HRSD matches remarkably well with the views of the 
clients. The participants also had views on issues that might affect improvement during EMDR. 
It is clear that when dealing with complex cases a large number of sessions might be necessary. 
004 made impressive improvements and given more sessions he may have moved into 
remission as well. 011 eventually admitted that she would like more sessions, although she 
would have been happy to have 20 but more spread out rather than having the twice a week. 
Other issues that were mentioned were not spending enough time in preparation so you could 
not cope with the strong emotions brought up in the session. This was brought up by 006 who 
admitted that he ‘thought he could cope but couldn’t’. The effect of outside factors was 
acknowledged by several people, 004 noted that if you were stressed by work it was hard to 
get into a session as you spend most of it relaxing. 
7.2 Mechanism 
The EMDR grey literature contains very vivid descriptions of processing when the image of the 
memory the client is holding in their head changes dramatically and helps them to take out the 
emotion so they can put the incident behind them (Shapiro, 1995, Shapiro, 2005, Shapiro, 
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2009a). However, the peer-reviewed literature is sparse when it comes to client descriptions of 
what is happening to them during processing. 
 
Here 004’s interviews were full of metaphors and similes and his descriptions of EMDR are no 
different. 
‘the tapping? I could feel something changing it was like my eyes were following the tap in 
some kind of way, like bouncing side to side while it was happening. I was thinking I could feel 
the physical sense that something was happening. How that would work I don’t know. But it 
has.’ (004) 
 
‘it was almost as though I could feel my mind searching (laugh). I almost felt like I was in a 
big room filing cabinets, I’m like (makes noise like flicking through papers), like a machine just 
rattling through, oh that’s significant, oh that pops up, oh I didn’t realise that. And it’s almost 
as if these things were misfiled. I’m reading through things and I didn’t expect to see this just 
lying around, it’s almost as though, okay what’s that doing here. Why is that out? Not with 
everything else it’s almost like it’s out of place or not put away properly. And I think that’s what 
EMDR is about isn’t it, it’s about trying to find stuff that you’ve not processed or filed away in 
storage correctly that’s bothering you. Errm, because it’s not been dealt with, it’s like 
unfinished business type stuff. Errm, and so I’d thought that was helpful’ (004) 
 
‘It has a buffering effect. So when I was tackling XY and Z it felt like it buffered things around 
those things. So it kind of had a wider impact. I think it kind of had a ripple effect really’ (004) 
 
‘I feel like burden has been lifted the vividness of the image is not anywhere near, it’s very 
greyed down, sort of like lacking colour really. At the time, it wasn’t like fluorescent vivid you 
know some kind of wappy crazy thing, it was just like a very clear, crystal clear I’m there its 
happening right under my nose kind of situation where as now it’s like I’m further back from it, 
sometimes I can barely see it, it’s not like I’m right distant instead of being in the room 
sometimes I maybe stood outside the room through the window but the window is steamy. It’s 
a bit like that sometimes. So and the emotional sort of errm value attached to it is, it’s much 
less damaging, it’s much less, it doesn’t really, it’s not got that fire it had before it’s very sort of 
tame. I hope it stays like that’ (004) 
 
He has clearly benefited from the EMDR and the effect on his particular target memory has 
been quite profound. These descriptions could be out of one of the training books but are not 
from any of the verbal or written material that he was given during the research. This does not 
stop him from having done his own research but he did deny this in the interview. When 
talking about lots of different themes 004’s language remains metaphorical and full of vivid 
description. It seems likely that he is a very visual type of person in the way he imagines and 
describes his world. 
However, as Chapter six described not everyone had the same vividly visual experience. There 
seemed to be a split in the group, three had a visual experience and three had a ‘trance like’ 
experience, one had a more abstract experience where she was convinced there had been 
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change but had no words to describe what that change was.   
Table 7.2 contrasts the type of experience described by the participants with the key changes 
in the content analysis to unravel if there is a difference in the way EMDR has affected the 
target memories and the responses that they induce or it is just that some people have very 
visual imaginations and some people do not. 
003 doesn’t even mention the target memory in the interview, even when asked about it, it 
seems to have so little importance there is no need. She rationalises that the memory, which 
was from when she was a teenager, is linked to an ego state response and that she is now 
‘trying to connect with that person’ rather than ‘fighting it all the time’.  
Table 7.2: Content analysis v descriptions in interviews 
 Change in 
total 
word 
count 
Change in 
neg 
statements 
Change in 
pos 
statements 
Experience 
type 
Reports of change 
001 -885 -22 -3 Trance ‘it seemed different but I don’t 
know exactly how’ 
003 -67 -5 +1 Abstract ‘Nothing I can put my finger 
on’ 
004 -3353 -15 -3 Visual ‘the vividness of the image is 
not anywhere near, it’s very 
greyed down, sort of like 
lacking colour really’ 
005 -160 -6 +1 Visual ‘I would be thinking of a 
picture of something but then 
it would move on’ 
006 -83 -4 0 Visual ‘when the eye movements 
were being done it was 
(daughters)’s face who was 
constantly popping up, 
reassuring not saying anything 
but, just reassuring’ 
007 -775 -13 0 Trance ‘It’s like I’m not, what keeps 
coming in, it doesn’t matter’ 
011 -53 -15 -2 Trance ‘definitely the feelings 
changed’ 
 
Those describing ‘trance-like’ experiences appear to have generally larger reductions in 
negative statements, but there does not appear to be any pattern in the changes of word 
count or positive statements. Indeed the change in positive statements did not occur as 
expected at all. The AIP model states that the memory should become positive or adaptive 
(Solomon and Shapiro, 2008). In most cases here this did not happen. The memory became 
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irrelevant. The memory remains, it is still there and most people acknowledged that it was an 
unpleasant thing but it is no longer of importance (It’s a different image…it doesn’t matter – 
007). It is in the past and that is where it belongs. The AIP clearly predicts the number of 
positive statements in the memory narrative to increase and it has not. Despite this the 
participants report having generally benefited from the EMDR treatment. They express many 
positive statements in regards to their lives and their futures but not towards the memory. 
 ‘the memories are there, I don’t think they will ever go, because that’s memories…... it 
wasn’t nice but then it wasn’t very clear, it was like looking through steamed glass……I don’t 
think it’ll ever go but I don’t think it had the impact it did.’ (004) 
In this respect these interviews raised more questions than they answered. 
Table 7.3 reports each participant’s HRV and Likert responses and the reported levels of stress 
and impact of the memory in comparison with the type of experience they had during 
processing to investigate any links here. 
Table 7.3: Mixed methods matrix of changes in emotional response to the memories on 
different measures 
  Likert scale change Exp 
type 
Reports of 
 HRV 
change 
Emotion Vividness Completeness Closeness change 
001 +++     Trance ‘it seemed 
different but I 
don’t know 
exactly how’ 
003 ++ More  No 
change 
No change Less Abstract ‘Nothing I can 
put my finger 
on’ 
004 - Much 
less 
Less Much more Much 
less 
Visual ‘the vividness of 
the image is not 
anywhere near, 
it’s very greyed 
down, sort of 
like lacking 
colour really’ 
005 +++ Much 
less 
Less Much less Less Visual ‘I would be 
thinking of a 
picture of 
something but 
then it would 
move on’ 
006 +++ Less No 
change 
Less Much 
less 
Visual ‘when the eye 
movements 
were being done 
it was 
(daughters)’s 
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face who was 
constantly 
popping up, 
reassuring not 
saying anything 
but, just 
reassuring’ 
007 ++ Less No 
change 
No change Less Trance ‘It’s like I’m not, 
what keeps 
coming in, it 
doesn’t matter’ 
011  Much 
less 
Much 
less 
Much less Less Trance ‘definitely the 
feelings 
changed’ 
HRV change – slight decrease (less than 10 µS), + slight increase (less than 10 µS), moderate increase (10-30µS), +++ 
large increase (more than 30µS) Likert change – no change - difference is +/- 10mm, less – difference is 11-50mm, 
much less – difference is over 51mm. Empty cells denote missing data. 
Those describing a visual type experience appear to have experienced a greater distancing 
effect but it is impossible to be sure as the numbers of participants involved are so small. The 
changes in the other descriptors of the memories do not appear to have any relationship to 
experience type. This is perhaps surprising as it would be logical to hypothesise that those with 
the visual type of experience would be more likely to notice changes in descriptors like 
vividness as this is a very visual term. 
The key response here is that something has changed, what it is is not really that important 
because the memory does not matter anymore. Only 004 has the flowing, vivid descriptions 
that are considered to exemplify EMDR in the text books, most of the other participants did at 
least as well as 004, both on the HRSD and by their own reports and yet did not describe their 
experiences in such a way. As EMDR has made attempts to distance itself from hypnosis it 
(Shapiro, 1993) could be that there has been selective reporting and this trance like state is 
common but not discussed. 
7.3 Acceptability 
Of the 10 people who began EMDR as part of the research project, three were discharged early 
(i.e. before the clinician felt they had made sufficient improvement to end treatment). All 
three were discharged on the advice of the clinician, one was unable to manage the research 
commitments rather than the EMDR and two had deteriorating mental health and needed 
community mental health team care. Therefore no one left the treatment programme because 
they did not want to continue receiving EMDR once they had started it.  
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One participant dropped out between the end of treatment and the interview / follow up 
sessions (012). This participant did not respond to any attempts to contact her so it is unclear 
why this was. However, at the end of the treatment period she requested details of how to 
receive EMDR outside the research project, so it would appear that it was the research 
appointments, not the EMDR appointments, which she did not want to be a part of. 
During the interviews the participants were asked some direct questions to discover their 
attitude to possible issues with EMDR: 
 Would you recommend EMDR to family or friends in a similar position to you? (The 
friends and family test) 
 Was there anything unhelpful or damaging in the EMDR? 
Table 7.4 shows a comparison between what participants said about unhelpful aspects of the 
treatment and whether they would recommend EMDR to their friends and family. 
Table 7.4 shows that all participants said they would recommend EMDR to friends and family, 
in fact two actually did, they asked if there was any space left in the research clinic as they 
knew someone who wanted to be involved. This is a clear endorsement of the participant’s 
view of EMDR as an acceptable treatment and also that at least some of them improved so 
much that this was visible to family and friends who then wanted to do the same. 
Table 7.4: Interview responses to the Friends and family test and questions about unhelpful 
aspects of EMDR 
 F&F Unhelpful 
001 ‘yeah definitely yeah’ ‘only thing in terms of the actual sitting in the room… I 
just found the whole experience really stressful’ 
003 ‘yes, in fact I have a friend 
who wants to do it’ 
‘only that it was exhausting’ 
004 ‘definitely, all the way.’ ‘sometimes depending what was happening outside of 
here with me and I be stressed out I might be tired, …on 
the occasions where I found it hard to relax for no reason 
really, it wasn’t anybody’s fault, it wasn’t anything I was 
doing I don’t think it certainly wasn’t anything (therapist) 
did’ 
005 ‘oh I would yes, yes 
definitely. In fact my friend 
said ‘how do you get this’.’ 
‘There was nothing that was unhelpful’ 
 
006 ‘yes I would given the 
option.’ 
‘I was doing quite well in the therapy, in the sense that I 
understood it, just the fact that I was doing well may 
have contributed to my downfall’ 
007 ‘yes definitely. I have, yes. I 
mean that course that I did 
‘no I have no memory of anything unhelpful.’ 
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really did sort of change me, 
well changed my life really.’ 
 
011 ‘yeah I would, I would 
recommend it’ 
‘Nothing’ 
 
The biggest complaint about EMDR was that it was so tiring it was difficult to do anything 
afterwards. It was also mentioned that it was hard to get into a session if you were stressed; it 
meant spending a long time in the session relaxing so you were in the right frame of mind to 
continue. Only two participants deteriorated during the project. One of these could not be 
interviewed due to his mental state. The other was interviewed and despite not doing well he 
held EMDR in high regard and made it clear that he would use it again in the future if he got 
the chance. 
‘if I was to meet a person in a similar position to me that is the one I would go for rather 
than psychiatry or CBT or CAT or any of the other therapies that is the one I would go for, or 
medication, including medication I would go for EMDR first.’ (006) 
      
7.4 Triangulation of interpretation 
Triangulation aims to use the different information coming from different sources of data to 
look for convergence, divergence and expansion in understanding. A triangulation protocol 
(O’Cathain et al., 2010) looked at the group data from the quantitative and qualitative 
methods, this is summarised in table 7.5. 
Although there was some divergence at the individual level there is little to be found at the 
group level. The qualitative and quantitative data regularly converge and help to expand our 
understanding of the findings from the individual methods. 
7.5 Conclusions 
Although there were very small numbers in this project there are still some important findings. 
Of the nine participants that had more than two sessions of therapy seven had statistically 
reliable and clinically significant improvements in their depression symptoms. This is 
highlighted both on the HRSD results but also in the comments made by the participants in the 
interviews. Improvements were so marked in certain cases that family and friends of the 
participants wanted to join the project. For the majority the gains seen at end of treatment 
were maintained (or even better) at follow up. 
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Some, although not all, of the predictions of the AIP model were seen. However there were 
significant discrepancies in certain areas. Not least the trance like experience of three of the 
participants. The reason for this remains unexplained as it was so unexpected the questions 
required to investigate the phenomenon further were not asked at the start of treatment.  
The value of using mixed methods in this study has been to use data from different sources to 
expand on the understanding of using EMDR with depressed clients. 
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Table 7.5: A triangulation protocol matrix for the Sheffield EMDR and Depression Investigation   
Quantitative data Qualitative data Convergence/Divergence/Expansion 
Impact of EMDR   
Clin sig & Stat rel* 
improvement in HRSD 
Report feeling better but 
with qualifications 
Convergence and expansion 
Improvement on IES Memory no longer 
matters 
Convergence 
Improvement on social 
functioning 
Report improved 
relationships 
Convergence 
Consistent 
improvement seen 
from about halfway 
through treatment 
Reported that EMDR 
helped but mentioned 
phase 2 interventions 
more than phase 4 
Convergence and expansion 
Mechanism of change   
Increased distance 
from the memory 
Memory reported as no 
longer important  
Convergence 
Decreased vividness/ 
completeness/ 
emotionality 
  
Increased heart rate 
variability 
  
Decreased heart rate 
and skin conductance 
response 
  
 Visual and trance like 
experiences  
Expansion 
Acceptability of EMDR   
No drop out from 
therapy 
Friends and family 
recommendations 
Convergence 
Only two did not 
engage 
EMDR reported 
favourably in comparison 
to other therapies 
Expansion 
*Clinically significant and statistically reliable improvement in Hamilton Rating Scale for 
Depression Score 
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Chapter 8 Discussion 
 
This thesis has described a feasibility study to investigate if EMDR has the potential to be a 
treatment for long term depression.  Eight of the nine participants with before and after 
treatment data points showed clinically significant improvement and statistically reliable 
change on the primary outcome measure (Hamilton Rating Scale for Depression); this was 
reflected in the secondary depression measures with eight on the BDI-ii and six on the PHQ-9 
showing clinically significant improvement and statistically reliable change. Five of them had 
non-clinical levels of depression after treatment. Of the ten who began the intervention three 
did not receive a full course of EMDR. One dropped out as she did not have the time to attend 
therapy twice a week, one participant was discharged by the therapist as she was concerned 
the participant was not engaging with the treatment and proceeding could be detrimental to 
him. One participant dropped out due to a relapse in agoraphobia and could not leave the 
house to attend therapy. The first went back to IAPT; the other two were referred to the local 
community mental health team.  
 
This indicates that it is feasible to design and implement an EMDR intervention for depression 
which is acceptable to service users and potentially effective. This would need to be 
investigated further in larger studies with more diverse populations and compared to the 
effects of CBT. This study used 20 sessions of EMDR. With CBT or counselling in IAPT a course 
of treatment can be between five and twenty sessions for depression (BABCP, 2012). It would 
also be possible to investigate whether EMDR can be successful at a lower dosage. If EMDR 
requires 20 sessions it could be considered as a treatment for those who have previously not 
responded to shorter treatments of CBT and counselling. All the participants in this study had 
previously received at least one and up to six courses of psychotherapy but remained 
symptomatic, which indicates EMDR may be suitable for this hard to treat client group. 
 
Encouragingly the participants were enthusiastic about EMDR at the interview and all would 
recommend it to family or friends in a similar situation. Despite being a small study some of 
the data investigating mechanism of change was very interesting. The study data supports the 
theory that EMDR works via taxing the capacity of the working memory. It also suggests that 
although the AIP assertion that EMDR can be used to treat more than just PTSD may be correct, 
the AIP itself may not be complex or nuanced enough to explain how EMDR works in 
depression.  
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8.1 Strengths and limitations of the Sheffield EMDR and Depression 
Investigation  
Despite being a small study it has several strengths: it addressed the research questions that it 
set out to investigate. The quality of the data collected was good, it included a good number of 
replications giving it greater validity and there was very little drop out between the end of the 
study and the follow up. 
 
Whilst all efforts were made to make the study as rigorous as possible it has some limitations. 
As with any PhD study there was a lack of resources in terms of finance, duration and 
manpower. In fact additional funds had to be secured from the Royal College of Nursing 
Foundation and the University of Sheffield’s School of Health and Related Research to be able 
to pay for the therapists to deliver the treatment. Without these generous grants the research 
would not have gone ahead. Duration was also a problem; the time limited nature of PhD 
courses and a delay in receiving NHS R&D approvals resulted in a follow up period of three 
months. At least six months, preferably a year or more would have been more appropriate 
when working with long term depression but this was just not possible. A PhD is also a solo 
project, ideally it would be better to have at least two people deciding inclusions and 
extracting data for the systematic reviews and cross checking the coding for the content 
analysis. However, there was no one available to complete this task so it was done by the 
author alone. Arguably this is also an issue for the framework analysis on the interview data. 
On the other hand, one could also argue that as any identification of themes necessarily 
incorporates the researchers own feelings and beliefs as well as those of the interviewees, this 
cannot be replicated in the same way as quantitative coding, nor should it be attempted 
(Bazeley and Jackson, 2013). This is a feasibility study and as such is small in size and did not 
have the power required for some of the secondary analyses. However, the primary questions 
were answered within the remit of a feasibility study.   
 
Another limitation of the study is the potential for bias from the allegiance of the researcher. 
The author is an EMDR therapist and despite all attempts to achieve equipoise there remains 
the potential that this study is influenced by the researcher’s allegiance (Luborsky et al., 1999). 
Although, both critical and subtle realism and post-positivism recognise that true objective 
measurement is impossible, it should nonetheless be strived for and methodological rigour can 
reduce the chance of bias (Maxfield and Hyer, 2002). Even when the researcher takes all 
possible measures to achieve this they are not the only people involved in the data collection. 
There are also the participants. Once again due to a lack of resources the data collection and 
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analysis was done by the lone PhD student. So not only did the researcher know the 
participants, the participants knew her. The participants were of course aware of the aims of 
the research, they had all received a client information sheet and had the chance to ask 
questions, and they as much as anyone wanted the EMDR to be successful. It could be 
assumed that this was purely selfish, they wanted to get well, and who could blame them? 
However, it was soon discovered that there might be another motivation behind the 
dedication to data collection that many of the participants showed. The therapists started 
reporting that at the end of a session the participants would start filling in the Helpful Aspects 
of Therapy forms and they would start asking questions such as ‘Is this enough?’ or ‘Is this 
what Emily needs?’ It was also noted at the memory recordings they would describe their 
memories and then say ‘Is that ok?’, this especially occurred at the end when the recordings 
were much shorter. There are numerous recordings of the researcher saying ‘It is your 
memory, if that is how you see it that is great’. It began to appear that a desire to help the 
researcher was a powerful motivator for the participants. This was confirmed by some of the 
interviews when the idea of helping someone else was mentioned again. This is not entirely 
unexpected when working with people with long term depression, many had issues around 
worthlessness and that they should not do things for themselves. Thus some may have started 
or stayed in therapy for the researcher. As almost everyone improved significantly it is not a 
concern that they were unintentionally coerced into something harmful but it could mean that 
the data quality is better than it would have been and that there may have been more 
dropouts if the participants had only been in therapy to help themselves. It is difficult to see 
how this could have been approached differently, the participants needed to be aware this 
was a research study, they needed to meet the researcher to be screened so a relationship 
was formed from the beginning and as previously mentioned there was no one else to do 
these jobs. 
 
In 2005 Horner and colleagues published a paper on using single case designs to identify 
evidence based practice. Within that paper they listed 21 quality indicators for single subject 
research under the headings of description of participant and settings, dependant variable, 
independent variable, baseline, experimental control and internal validity, external validity and 
social validity. The main issue where this study does not reach the standards set by Horner and 
colleagues is for the independent variable to be ‘systematically controlled and under the 
control of the experimenter’ (Horner et al., 2005). In this study the baseline period was 
decided by how quickly a therapist became available and not formally randomised. Although 
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this means it is not a true experimental design, it was clinically more appropriate as 
randomisation could lead to impossible situations such as a baseline being specified as too 
short and a therapist not being available or it being too long and a therapist was available but 
was waiting for the computer allotted baseline period to be up, this would entail preventing a 
participant from accessing treatment unnecessarily and was considered unacceptable. This 
was mediated slightly in that a one week baseline was mandatory; however in the end 
everyone’s baseline was longer than this.  
 
Although under ideal circumstances SCED can make causal inferences this study did not meet 
those ideal conditions. Weaknesses here involved non-random, unstable baselines and using 
an AB (rather than ABAB) design due to the time restraints mentioned above and crucially the 
irreversible nature of the intervention.  
 
The baselines all contained at least nine data points, some as many as 41. The key use of a 
baseline in single case experimental design is to offer a prediction of how the long term illness 
would progress over time if no intervention occurred. For this to be of most use the baseline 
needs to be stable. Unfortunately in this study the measure of daily low mood varied widely 
from day to day and for many of the participants there were indications of trend either in 
worsening or improving low mood during the baseline phase. For this reason conclusions of 
cause and effect are not possible as the baselines were unable to predict with confidence how 
low mood may or may not change without the intervention. This is also an issue for the 
mechanism of change questions. For the data to be able to relate to mechanism of change it 
must be assumed that any change occurred due to the intervention. Despite this weakness, 
the design is sufficient to answer the primary research question, because this was a feasibility 
study and it did not aim to investigate efficacy. 
 
The conclusions of this study must be that the results indicate change occurred, but it cannot 
be certain that this was due to the intervention. Larger, randomised and controlled studies will 
be able to confirm or disprove any preliminary conclusions from this study.  
 
Although this thesis contains a systematic research review in its second chapter, I was unable 
to perform a meta-analysis because only one randomised controlled trial investigating EMDR 
and depression was discovered. This trial looked at a subpopulation of those with depression 
who also had had a myocardial infarction. The study was of low quality had no active 
180 
 
comparison group. No conclusions about the efficacy of EMDR to treat depression can be 
concluded from this review. The review highlights the need for high quality studies of EMDR to 
treat depression including feasibility studies, RCTs and dismantling studies. 
 
When it comes to mixing methods, the way to assess quality is still being discussed (Creswell et 
al., 2011), however O’Cathain and colleagues have suggested the GRAMMS approach to good 
reporting in mixed methods studies (O'Cathain et al., 2008): 
Good Reporting of a Mixed Methods Study (GRAMMS) 
(1) Describe the justification for using a mixed methods approach to the research question 
(2) Describe the design in terms of the purpose, priority and sequence of methods 
(3) Describe each method in terms of sampling, data collection and analysis 
(4) Describe where integration has occurred, how it has occurred and who has participated in 
it 
(5) Describe any limitation of one method associated with the presence of the other method 
(6) Describe any insights gained from mixing or integrating methods 
 
Items (1), (5) and (6) are very clearly interrelated. The justification for using mixed methods is 
that by mixing and integrating quantitative and qualitative methods, the limitations of each 
can be mitigated and far more can be learnt than by using one method alone. For example in 
this study although standardised scales like the HRSD, BDI-ii and PHQ-9 are essential for 
comparison to other studies and to add to the research evidence on the impact of 
psychotherapy approaches, in a client centred health service can we truly say that a client is 
better unless they agree? The scales measure what symptoms the client reports but only by 
talking to them can we know if this actually translated into some noticeable difference in their 
lives. It can therefore be argued that the limitations of quantitative and qualitative methods 
and the insights that can be gained by combining them are the justification for mixed methods 
approaches.  
 
Despite these limitations this PhD has been a tremendous learning experience and has 
produced some interesting results. Lessons learnt include a better understanding of how long 
and potentially problematic the bureaucratic side of research can be and not underestimating 
the need to leave plenty of time for ethics and research and development permissions, 
recruiting staff and recruiting participants. This took almost a year and meant that the follow 
up had to be truncated which was not ideal. This study’s findings could have been more 
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informative if participants had been asked in more detail about their experiences of their 
traumatic memories, the memory recording only contained the visual image but they could 
also be asked about what they heard, smelt, and felt. This may have been able to give better 
insight into the differences between the trance and visual change experiences reported by the 
participants. Although the EMDR Standard Protocol worked reasonably well there were some 
issues and modifications could be made to improve its use in treating depression (see section 
8.6), including a Delphi consensus on what constitutes good practice in the preparation phase. 
More systematic recording of the therapists’ experiences during the intervention could also 
bring insights into which parts of the protocol work for people with depression. 
 
8.2 The impact of EMDR on long term depression 
Many EMDR proponents claim it can be used for far more than just PTSD (Shapiro, 2005, 
Shapiro, 2009a). The primary aim of this research (research question 1, chapter 3.2) was to 
investigate if it had potential to be a treatment for long term depression. These results indicate 
that it does indeed have potential. Eight out of ten starters improved on the Hamilton rating 
scale for depression, that improvement was clinically significant and statistically reliable. The 
average scores on all scales continued to show improvement between the end of treatment 
and follow up. It is impossible to know from this data if this is due to time or treatment but is 
nonetheless encouraging. On the social functioning scales, nine improved on the SASS and 
eight improved on the GAF however, these were not statistically reliable due to the very large 
reliable change index for those scales.  
 
The clinician rated, self-rated and daily measures of depression all show the same pattern of 
the majority of clients improving over the research period, usually by substantial amounts. 
However, there are some discrepancies. The clinician rated scale (the HRSD) is heavily 
weighted to questions on biological symptoms such as sleep patterns and eating behaviours, 
the self-rated scales (PHQ-9 and especially the BDI-ii) are more focussed on thinking styles. All 
of these ask for an answer representative of the last two weeks. Whereas from the daily low 
mood score we can see that this fluctuates a lot over that period. This raises questions over 
the best way to measure symptoms of depression, self-rated or clinician rated, focus on 
biology or cognition and rating today or the last two weeks. These different measures, all claim 
to be valid scales for clinical depression (Dozois et al., 1998, Miller et al., 1985, Kroenke and 
Spitzer, 2002), but they are all asking different things. Can they really be measuring the same 
illness? The DSM-IV and the PHQ-9 (which is essentially a list of diagnostic criteria) are heavily 
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reliant on the medical model (see chapter 1) whereas Beck who wrote the BDI is focussed on 
the cognitive model of depression, Hamilton’s rating scale gives more weight to somatic 
symptoms (Cheung and Power, 2012). The two week requirement for many of the scales is 
based on the diagnostic criteria for depression (APA, 2003), considering the daily fluctuations 
in mood seen here it seems reasonable to attempt to base a diagnosis on a longer time period. 
Although factor analyses comparing the BDI with the HRSD show that both scales appear to be 
measuring the same underlying concept (Brown et al., 1995, Hotopf et al., 1997) more recent 
research has cast doubt on that (Cameron et al., 2011). Although the BDI-ii and the PHQ-9 
have good convergence (Titov et al., 2011), this is less good with the HRSD and the BDI-ii 
appears to consistently rate severity much higher than other scales (Cameron et al., 2011, 
Titov et al., 2011). 
 
The impact of event scale results show that those who were classified as traumatised before 
the treatment were no longer traumatised at the end and this remained true at follow up. 
Although it could be predicted that EMDR would be successful at treating trauma (van der Kolk 
et al., 2007), it was more surprising that so many participants scored so highly for trauma 
when they screened for not having PTSD. This may highlight the difference between PTSD 
criterion A events (those events sometimes referred to as ‘big T trauma’ in the EMDR literature) 
and negative life events (also called ‘small t trauma’ in the EMDR literature). Negative life 
events may not be life threatening but they can still have a profoundly damaging effect on a 
person’s mental state. The AIP states that the memory of these events can fail to be fully 
processed regardless of whether or not the event is life threatening (Shapiro, 1995). It also 
predicts that it is these memories that cause negative thinking styles and that by processing 
the memory, the negative thinking style can be altered. This was reported by several of the 
participants here.  
 
The reason for using a single case experimental design was to follow the participant closely 
and then to be able to plot their progress over the course of the baseline and treatment 
periods. None of the graphs shows an immediate obvious effect at the onset of EMDR but 
three (003, 005 and 012) show a strong reduction in low mood from about half way through 
the sessions, another shows a moderate relationship (001). Two graphs show no real change 
over the time period (004 and 007) and three show low mood getting worse, however two of 
these (006 and 008) are the two participants who were referred to the CMHT. The final one 
was the participant (011) who continued to struggle with family issues right to the end and 
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requested details of how to access EMDR privately once the follow up period was complete. 
Even the participants who showed a marked change on their daily low mood scores do not 
show that until at least half way through the treatment phase. Once improvements are made 
they are fairly consistent but there is no immediate effect. Although 20 sessions over a three 
month period does not make EMDR a long term treatment it is also not the rapid acting 
treatment it claims to be for PTSD (Van Etten and Taylor, 1998). However, long term 
depression is not likely to be as rapidly treated as a single trauma, adult onset PTSD due to the 
likelihood of complex and multiple childhood traumas and the nature of depression to be 
incorporated into self-schemata (see chapter 1).   
 
This research also hoped to identify people who may not be likely to benefit from EMDR 
(research question 2, chapter 3.2). However, as only two participants failed to improve this 
was not possible. When looking at the differences between those who responded to treatment 
but failed to reach remission it is clear that they started treatment with a much higher score 
on the Hamilton rating scale for depression. Although they achieved among the highest 
reductions in symptom score on this scale it was not enough to reach remission. This would 
indicate that they may have just required more sessions due to the initial severity of their 
illness rather than that they did not respond well to EMDR. This observation and the two 
clients who asked how to access EMDR outside the NHS after the research was complete 
indicate that EMDR may need a longer intervention period for long standing and severe 
depression. There are mixed reports about the effectiveness of an increased number of 
sessions in psychotherapy.  A recent meta-analysis that looked at psychotherapy for 
depression concluded that there was little evidence for increasingly the number of sessions 
past 15 or 16 (Cuijpers et al., 2013), however when the same research group focussed purely 
on psychotherapy for chronic depression they did find a need for more sessions (Cuijpers et al., 
2010b). Neither of these studies included EMDR as one of the psychotherapies. As EMDR 
focusses on past traumatic events rather than current thinking styles it is possible to argue that 
a person with many traumas will need more sessions than someone with few to achieve the 
same effect. One thing the Dutch analyses did show is that increasing the intensity of the 
therapy (more sessions per week) was an important factor in improving effectiveness (Cuijpers 
et al., 2013). In this study sessions were, as often as possible, twice a week. Many of the clients 
said they found this helpful as it ‘carried on the momentum’. 
 
184 
 
This adds to a growing body of literature that EMDR has distinct potential to treat depression 
(Hofmann et al., 2014, Grey, 2011, Bae et al., 2008). It also shows that EMDR does not 
necessarily need to be an adjunct to another therapy but can be used as the standard protocol 
describes. Further research will be needed to see if that is the best way to treat depression but 
it is certainly possible. In Hofmann’s work in Germany (2014) the participants received an 
average of seven sessions (range 3-16) of EMDR along with around 38 sessions of CBT. As the 
start of the standard protocol involves history taking and preparation and stabilisation it can 
be assumed that this was done, at least in part during the CBT sessions before the therapist 
moved on to the more experimental EMDR. Although it is not clear from the paper, seven 
sessions of EMDR probably means seven sessions of bilateral stimulation. In the Sheffield study 
bilateral stimulation was given in 10-16 of the sessions, the other 4-10 sessions involving other 
aspects of the protocol such as history taking, stabilisation and reviews. As these other aspects 
are not unique to EMDR and stabilisation techniques may include cognitive, behavioural or 
mindfulness techniques they are comparable to CBT sessions. This study questions the need 
for so many additional sessions. By using only standard protocol EMDR this study appears to 
have seen results equivalent to the German study but in half the number of sessions.   
 
8.3 Indications of the mechanism of change   
Research questions 3 and 4 (chapter 3.2) aimed to investigate some of the specific predictions 
of the AIP model about the mechanism of change in EMDR. The descriptions given of the 
target memories do change over the study period but not in the ways described in the 
literature. Firstly, the AIP model (Solomon and Shapiro, 2008) expects the number of negative 
statements in the memory description to decrease after treatment which makes sense if the 
aim of the treatment is to remove the distress from the memory. This was seen here. The AIP 
also states that the number of positive or adaptive statements should increase. This is because 
the client can now see the positive in the situation. This did not occur. What was seen was that 
the sentences became shorter and more matter of fact. There was little emotion at all in the 
final descriptions. They did not go from being distressing to being adaptive, they went from 
being distressing to unimportant. Again this discrepancy could be due to the differences 
between PTSD and depression. The AIP model is heavily based on PTSD and has developed 
alongside EMDR as it has developed as a treatment for PTSD. As these memories were of 
negative life events not life threatening terror, perhaps a more adaptive response to them is to 
say ‘actually that situation seemed important when I was 8 but it isn’t’ rather than to try to 
invoke some inspirational message from it. 
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The AIP model also predicts that these adaptive changes can lead to positive psychological 
growth. There is an argument that this was seen in many of the participants here. Although 
they did not refer to their pasts in a positive light they did start to look more positively on their 
futures. This was manifested in different ways but included having the confidence to apply for 
jobs or take the initiative in interacting with friends and family.  
 
The emotional and neurological response to the memories was more in line with predictions 
from the AIP. Heart rate variability significantly increased, skin conductance response 
increased and heart rate reduced although not significantly. The emotionality of the memory, 
its vividness and completeness all decreased (not significant) and the closeness of the memory 
significantly decreased (i.e. it felt further away). The only one of these that contradicts the 
previous literature is the completeness of the memory. Previous explanations would have 
expected that to increase. However, as with the length of the memory narrative this could be 
due to the difference between the way memories are recalled in PTSD and depression. It has 
previously been shown that these physiological changes occurred during processing but until 
now there was no evidence that EMDR had a lasting effect on these memories as well.  
 
The reduction in word count is opposite to what was found by Foa et al (1995). Foa and 
colleagues did work specifically with rape victims who had developed PTSD (Foa et al., 1995), a 
very different population from this study. Here there were no criterion A events reported. It 
could be that there is something specific about rape memories or even criterion A memories 
that makes them different. It could also be the difference between PTSD and depression. In 
PTSD there is a desire on behalf of the client to supress the disturbing memory due to its 
horrific nature and what it says about the world (Dalgleish, 2004). In depression, on the other 
hand, the client is more likely to ruminate on the memory and what it says about them (Nolen-
Hoeksema, 2000). It is possible that the rumination in depression has made the memory long 
and detailed and as it becomes less important it loses those details, whereas in PTSD the 
avoided memory becomes less distressing so the client is able to describe it in full. 
 
For research question 5, the study had investigated if there were any correlations between the 
way symptoms changed and the way memories, or responses to memories, changed. No 
significant relationships were found although most measures did move consistently in the 
expected direction. The lack of significance in these relationships and in changes to memories 
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and responses to memories could be due to a lack of power in this study. This was always likely 
to be a problem with such a small sample size but as these were secondary research questions 
the number of participants was not changed for them.  
 
8.4 The acceptability of EMDR as a treatment for depression 
The final research question (research question 6, chapter 3.2) aimed to investigate if the 
clients thought EMDR was an acceptable treatment for depression. All the interview 
participants said that they would recommend EMDR to their family or friends if they were in a 
similar situation to themselves. Two actually did ask if there were any spaces left in the 
research programme as they knew someone who wanted to join and two participants how to 
get EMDR outside of the study so that they could continue to receive EMDR after the follow up 
period was complete. Only one participant had difficulty engaging with the treatment 
programme and ultimately had to be referred elsewhere. No one dropped out of the 
treatment programme. This indicates that EMDR had a high level of acceptability among 
participants in this study. 
 
It is difficult to compare this to other research as acceptability and client views of EMDR are 
rarely reported. If they are they are usually reported as dropout rate rather than interview 
data. The Cochrane review of treatment for PTSD found that there were no differences 
between dropout rates in EMDR or tfCBT/exposure treatment arms (Bisson and Andrew, 2007). 
However, tfCBT for PTSD is a different treatment to CBT for depression. 
 
The clients were also asked about what they thought had been helpful and unhelpful during 
the treatment. Many of the techniques used during the stabilisation phase were noted as 
helpful, the light stream, safe place and supportive figures. Most people also said they found it 
helpful to get to the root of their problems and resolve their issues. Although no explicit 
thought challenging occurs in EMDR it is clear that the participants’ negative thinking styles 
had changed anyway. Some described this as ‘like a switch in my head’. This supports the AIP 
assertions that the problem memory is the cause of the negative thinking style and is the key 
to changing it (Solomon and Shapiro, 2008). 
 
Some of the unhelpful aspects were purely logistical, such as difficulties having time off work 
or the location of the therapy sessions. Others were more directly related to the treatment 
modality, such as the tiring nature of the therapy and the difficulty using eye movements. 
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Ironically, if the working memory model of EMDR is correct then the tiredness shows that it is 
working (Van Den Hout et al., 2011). Identifying the target memories was also identified as 
difficult. Some found it demoralising as they had hoped to find one distinct memory that they 
could work on and then ‘be happy’. When finding the memories was hard or did not appear to 
be immediately relevant this was distressing. This highlights the need for sensitivity on behalf 
of the therapist but also sufficient education in the earlier parts of the protocol to try to ensure 
the client has realistic expectations.  
 
The response to the treatment in the interviews was very positive. This raises the question of 
bias in the sample. Generally people are likely to think favourably on something which has 
helped them, so the fact that most of the participants responded well to treatment could be a 
factor. One of the two people who deteriorated during treatment was also interviewed and he 
also liked EMDR (006). One possibility is that the researcher had formed a relationship with the 
participants and they knew that she had a vested interest in the project. This could mean that 
participants were more positive than they would have been to someone they did not know. 
However, they were able to identify some aspects they did not like suggesting they were able 
to express negative opinions during the interviews if they had them. 
 
8.5 Integration of the data   
Trance v visual change 
Just as the key qualitative themes are linked, so are the key mixed methods themes. The 
impact EMDR had on depression is caused by its mechanism and both lead to whether or not it 
would be considered as acceptable by the participants. Almost all these participants saw a 
clinically significant and statistically reliable improvement in their depression. This alone makes 
it likely that they would feel favourably towards the intervention, especially as they had all 
received failed therapy before. However, the manner of the treatment also matters. Many 
found it hard going in places, whether it was coming up with the target memory or the 
exhaustion that followed processing. The interviews revealed some interesting descriptions of 
the way EMDR works and what participants think of it. Eye movements, generally thought of as 
key to EMDR and taught to trainees as the stimulation of choice, were universally disliked. 
Despite this it still had a positive impact on symptoms.  
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One interesting aspect that was uncovered by the interviews was the two distinct modalities of 
experience during the processing. For some of the participants this was the vivid visual change 
in the memory image that is commonly seen in EMDR textbooks (Shapiro, 1995). However, for 
the others there was a trance like experience. This was wholly unexpected and has not been 
commonly described in the EMDR literature. When comparing the two groups there is no 
obvious difference in their other data. Both groups preferred tapping to eye movements, both 
did equally well when it came to symptom reduction and changes in response to the memories. 
It could be that these participants were particularly unusual in this respect. It could be that it is 
specific to the treatment of depression and thus has not been seen in PTSD studies. It could be 
that it is a common phenomenon but that it remains unreported. This could be because no 
one is asking clients what happens to them during processing.  Or it could be because they are 
asked but when the response does not fit the model answer the therapists do not raise it as 
they lack the confidence to challenge the orthodoxy. It is likely that the numbers involved here 
are too small to be able to discern any difference between the groups and that further study 
on larger numbers is required, which takes into account a range of measures and interview 
data including the primary mode of memory (visual, somatic, auditory). If the primary mode of 
the memory is not visual then it is arguable that the change that occurs in it will not be visual, 
especially if the working memory model is considered. For a visual change the memory must 
be held in the visuospatial sketchpad but a memory could be primarily reliant on the 
phonological loop, this could be expected to change the experience of sound during processing 
but not the visual image (Baddeley, 2009). The mode of the memory was not investigated in 
depth before the EMDR treatment in this case.    
 
EMDR has been linked to hypnosis before (Lilienfeld, 1996). The similarity of moving a hand in 
front of the client’s face and for example the moving pocket watch used in induce a hypnotic 
state has been made. So it could be theorised that the trance like state is in fact a hypnotic 
state induced by the eye movements. However, these participants did not use eye movements, 
they used tapping and that draws fewer parallels with the hypnotic procedure. Also there has 
been a study which looked at the brain scans of those undergoing EMDR and they were 
different from those undergoing hypnosis (Nicosia, 1995). In 2001 the American Journal of 
Clinical Hypnosis published a special issue on the ways EMDR and hypnosis could be combined, 
they were clear in their introduction to the issue that although these approaches have 
similarities they also have several differences (Frischholz et al., 2001). These differences 
include hypnosis begins by inducing relaxation, whereas EMDR deliberately attempts to 
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connect to the anxiety, hypnosis attempts to create a single highly focussed state whereas 
EMDR maintains duality of focus between the negative and positive and hypnosis promotes a 
state of fantasy and imagination whereas EMDR attempts to keep the client grounded by 
coming back to the room and the body’s physical sensations (Frischholz et al., 2001). Despite 
their differences they are regularly used together and this special issue contained seven papers 
discussing how they could be combined.      
 
One technique that links EMDR and hypnosis is ego state therapy. Ego state therapy can be 
done in two ways, working with the conscious mind and helping the client to understand why 
what happened as a child can relate to how they respond to situations in the present. This is 
commonly used in the preparation phase of EMDR (Forgash and Knipe, 2008). The second way 
is by using hypnosis to regress the client to repressed ego states (Wade and Wade, 2001). This 
is not done as a matter of routine in EMDR as EMDR training does not include hypnosis but 
some of the literature reporting a combination of EMDR and hypnosis uses ego state therapy 
in this way. It could be that when including ego state work in EMDR it promotes a state where 
the client moves between ego states and the processing happens to a child ego state causing a 
trance like experience for the adult in therapy. However, this can be viewed as a type of 
dissociation and a dissociating client is expected to do less well in EMDR but that does not 
appear to be the case here.   
 
The reconsolidation model of EMDR 
An integrated model of EMDR was suggested in chapter 2 (figure 8.1), along with suggestions 
to test the model.  
Figure 8.1: An extended integrated model of memory retrieval and reconsolidation as a 
mechanism of change in EMDR – The reconsolidation model of EMDR. 
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This working memory model of EMDR assumes that boxes 1 and 2 are true, that old memories 
can be brought from the long term memory into the working memory and that in doing so this 
causes the memory to lose stability. Box 3 states the crux of the theory, that bilateral 
stimulation is a task that taxes the capacity of the working memory at the crucial moment 
when the distressing memory is held within.  
 
As a method of therapy it is then expected that this taxing of the working memory will produce 
a reduction in the emotionality and vividness of the image (Figure 8.1 box 4, research question 
4). Lilley and colleagues (2009) showed that this was the case in people with PTSD but only 
during the task. This research found that the emotionality and vividness of the memories did 
decrease and stay decreased but not significantly. This could be due to low numbers or that 
there is no significant reduction. Other work on the neurophysiology of EMDR has shown that 
we should also expect changes in the biological responses to these memories (Figure 8.1 box 5, 
research question 4). Here heart rate variability increased significantly and remained improved, 
indicating the participant’s parasympathetic system is less withdrawn (Camm et al., 1996). The 
skin conductance response of the participants is difficult to interpret. On average there was an 
increase but this was not significant due to high variability within the sample. This included 
two very unusual readings, removing these gives a very slight reduction in SCR. As the 
expected change in SCR was unclear (people with depression have lower SCR so a reduction in 
Memory brought to mind, 
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Memory 
• (Baddeley et al, 2009) 
Retrieval causes the memory to 
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depression should increase SCR however, anxiety when recalling trauma leads to a higher SCR 
so reduced anxiety provoked by the memory should lead to lower SCR), it is likely that the 
variability of the readings are due to the complexity of the situation. As many of the 
participants had anxiety as well as depression it is possible that SCR is not a suitable measure 
in this population and concentrating on HRV (which moves in the same direction regardless of 
anxiety or depression) may be a more suitable measure. 
The addition of positive and adaptive messages into the memories is where these results most 
differ from what was expected (Figure 8.1 box 6/7, research question 3) (Solomon and Shapiro, 
2008). Although the memories definitely became less distressing there is little evidence to 
support a more adaptive view of them. Short of ‘they are no longer important’ the participants 
did not have anything more to say of them. There are two theories as to why this is. Firstly, as 
depression memories differ from PTSD memories it could be that the AIP model of positive 
adaptation is not relevant in this case. Nothing more than ‘letting go’ may be necessary for 
non-life threatening memories. A key adaptive scenario would be for a client to acknowledge 
that they did live through the car crash and they are now safe. This is just not necessary in the 
sorts of memories targeted here. A second view is that standard protocol EMDR is not very 
good at installing positive and adaptive thoughts.  
 
If EMDR does indeed work using working memory taxation as a mechanism then there is a 
problem in the EMDR Standard Protocol. According to working memory disruption by holding 
the image in mind at the same time as the distraction task, the capacity of the working 
memory is overstretched and the image becomes less disturbing, less emotional (van den Hout 
et al., 2012). The problem with the EMDR protocol is that is also tells therapists to use the 
bilateral stimulation to install the positive cognition. This would then mean the client holds the 
positive image in mind and taxes the working memory. This would have the effect of reducing 
the emotion associated with the positive not enhancing it (van den Hout et al., 2012).  
 
There is increasing support for the working memory account of EMDR in the literature (Jeffries 
and Davis, 2013, Altink et al., 2012, Hornsveld et al., 2011, van den Hout et al., 2012) . There is 
also more evidence that the interhemispheric interaction account of EMDR may be incorrect 
(Hornsveld et al., 2011, Samara et al., 2011). This is important as the interhemispheric account 
is the one usually taught in training for EMDR but is not supported by the evidence. By using 
bilateral stimulation with positive images EMDR may even be damaging results. It is also 
important when it comes to the type of bilateral stimulation provided and if it actually needs 
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to be bilateral. Some researchers have found that vertical eye movements have the same 
effect as horizontal ones (Gunter and Bodner, 2008). EMDR training states that eye 
movements, taps or tones can be used but eye movements are preferred (Shapiro, 2009b). As 
taps and tones are passive they are less taxing to the working memory and therefore less likely 
to have an effect as eye movements (de Jongh et al., 2013), although as van den Hout and 
colleagues (2012) discovered the level of complexity must be tailored to the client.  
 
Another technique used in EMDR is the ‘butterfly hug’, originally developed to work with 
groups of traumatised children; it is now being used to deliver EMDR via online video call and 
in group therapy. In the butterfly hug position the client crosses their arms over their chest 
and uses opposite hands to tap their shoulders alternately (Artigas and Jarero, 2009). This is 
not bilateral stimulation as you tap your left shoulder with your right hand so both sides of the 
body are stimulated simultaneously. However, it has still had some success (Jarero et al., 2006) 
and is now recommended as an acceptable technique by EMDRIA. Although the butterfly hug 
is not bilateral stimulation, it is a task which would tax the working memory, more so than 
being tapped by the therapist or electronic tappers. The latter is a passive task like listening to 
tones but the butterfly hug requires more concentration. Many EMDR therapists are using a 
technique that does not support the interhemispheric interaction model but does support the 
working memory model. 
 
If vertical eye movements and the butterfly hug are as successful as horizontal eye movements 
then it becomes less likely that the inter-hemispheric account can be true. But if it is working 
memory taxation that is behind EMDR then there are potentially other tasks that can be added 
to the techniques used in EMDR. Memory researchers have shown that counting and 
arithmetic tasks can also disrupt the working memory. Van den Hout and colleagues (2012) 
also found that mindful breathing, a component of Mindfulness-Based Cognitive Therapy, also 
taxes the working memory. Another recently developed therapy with links to working memory 
may be Emotional Freedom Technique (EFT) (Craig, 1995). Although EFT bases its current 
theory of mechanism of change on ‘Qi lines’, it may be much less mystical. In EFT the client is 
expected to bring to mind the issue they wish to deal with and then tap their hand or head in a 
certain pattern. The pattern is based on pseudoscientific notions of acupuncture and Qi but 
the pattern is unlikely to be what is important (Waite and Holder, 2003). By bringing to mind 
the distressing event and completing a complex tapping sequence the client is taxing their 
working memory. It may be that these third wave therapies are based, not on habituation to 
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distress and realisation that the situation is not as bad as imagined, but on an entirely different 
neurological process, taxing the capacity of the working memory. This gives these therapies 
that have been accused of pseudoscience a sound theoretical base and also a different mode 
of working which may help those who do not respond well to the traditional cognitive 
behavioural model of therapy.        
8.6 The EMDR Standard Protocol as a treatment for depression 
The EMDR Standard Protocol is more flexible than its name implies. It is a list of stages, some 
more prescriptively described than others (Shapiro, 1995). There is no guidance on how long 
each section should take relative to others. In one sense this is helpful as it means the 
therapist can adapt their approach to the needs of the client, however it also makes it difficult 
to be sure a standardised procedure has been used in the research environment. The Standard 
Protocol contains eight stages: (1) history taking, (2) preparation, (3) assessment of the 
memory, (4) desensitisation, (5) installation, (6) body scan, (7) closure and (8) re-evaluation. 
The idea is to move in a generally linear pattern through the phases but this is not a 
requirement and going back to do more history or preparation is permissible. Phases 1, 7 and 8 
are not unique to EMDR, discovering the reason why a client has come to therapy, closing 
down a session before the issue is completely resolved and then re-evaluating the situation at 
the next session are common to all approaches. Phase 2 is where the client is prepared for the 
memory processing to occur. EMDR can bring up some intense emotions, quite fast and so it is 
recommended that adequate resourcing is done beforehand to help the client cope. Phases 3-
7 are the ones most commonly associated with EMDR as a technique, rather than EMDR as a 
therapy, because this is the build up to and then use of bilateral stimulation, first with the 
trauma memory, then with the positive cognition and finally with body sensations.  
Most of the participants in this study did very well which would suggest the Standard Protocol 
is adequate for treating depression. However, the interviews with the participants and 
numerous conversations with the therapists during the intervention did reveal some problems. 
For the clients this was primarily around three areas, anxiety about not having a memory of a 
traumatic event and therefore the treatment would not work for them, anxiety about knowing 
what the memory was and being reticent to talk about it and finally the fact that the sessions 
were physically and emotionally draining (chapter 6). Although the AIP states that everyone 
who has psychological issues must have a trauma memory that can be uncovered and can be 
treated (Solomon and Shapiro, 2008), it was not known at the start of this study if that would 
apply to depression. In the end everyone did find something to work on and this was generally 
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very helpful. Integrating this finding into information for future participants may help set their 
minds at ease. 
The therapists were most concerned with phase two, the preparation and resourcing phase. 
This phase has little guidance about appropriate techniques. Two suggested approaches are 
the safe place and the light stream (Shapiro, 1995) but what is actually done is left to the 
therapist’s judgement about what the client needs. This is where most of the differences 
between therapists occur. All EMDR therapists are qualified mental health professionals before 
they undertake their EMDR training. However, this qualification could be in social work, 
psychiatry, psychology, CBT, nursing or pretty much any other accredited profession. This leads 
to a wide range of backgrounds, skills and preferred techniques learnt from other roles. An 
EMDR therapist may take a very different view of resourcing if their background is social work 
to another therapist trained in psychodynamic psychotherapy. The therapists in this study 
were concerned about how much they could or could not do in phase two and still be adhering 
to the protocol. Although the light stream and safe place were helpful, they were never 
sufficient. The methods employed varied from client to client but included, light stream, safe 
place (including the addition of nurturing, protective and inner wisdom figures where 
necessary (Parnell, 2013)), ego state strengthening, compassionate mind, psycho-education, 
relaxation (including simple breathing meditations). It was agreed that anything that involved 
key concepts from other therapies (such as behavioural activation or hypnosis) should not be 
used in the research although may be used in clinical practice. 
This experience suggests that if EMDR for depression is to be taken further, then clearer 
guidance on helpful resources is necessary. Research is needed into what resources are better 
for depressed as opposed to PTSD clients, or if, in fact, it makes a difference. Despite the 
growing evidence base for EMDR there is still a paucity of dismantling studies that help 
therapists make decisions about which techniques they should or should not be using (Leeds, 
2009) and whether or not they should be using bilateral stimulation to install them (van den 
Hout et al., 2012). At the very least some consensus across the discipline would be helpful to 
guide therapists until the research is done.   
 
8.7 Recommendations for research 
This small feasibility study has shown that EMDR has potential to be able to treat long term 
depression. Larger studies, preferably randomised controlled trials where EMDR is compared 
to an equal number of CBT sessions, are required to fully investigate its clinical use. 
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Medical research council guidelines (Craig et al., 2008) recommend building on knowledge. 
The next step should be a pilot RCT to check randomisation, dropout rates and effect size 
before moving on to a larger trial. 
Close attention should be paid to identifying those who do not respond to EMDR and trying to 
discover why. 
The mechanism behind EMDR is still not fully understood. Further investigations into client 
experience during bilateral stimulation may help here. These should include brain imaging 
where possible and further investigation of the trance v visual image experience during 
processing.  
To ensure the acceptability of EMDR, client views should be sought during clinical trials. Clients 
here were pleased with EMDR but they were few in number and their views need to be 
replicated in a larger population. 
A dismantling study to understand the efficacy of different resources in phase two and how to 
install them is needed. 
This research showed some support for the theory that EMDR does change the emotional 
content of traumatic memories; however similar studies are needed to see if this also happens 
in CBT and counselling when depression is successfully treated. 
8.8 Implications for practice  
Although this study has indicated that EMDR has the potential to be a treatment for long term 
depression it was not an adequate test of the efficacy or effectiveness of the therapy. As such 
EMDR should not yet be considered a first line, evidenced based treatment for depression. 
However, if a client has already received the first line treatments and not improved, EMDR 
could be considered. The client must be informed that EMDR is not a proven treatment for 
depression but does have potential. 
Where possible, sessions should be available twice a week if the client is able to attend. 
During training novice EMDR therapists should not be taught that EMDR works via 
interhemispheric interaction when evidence increasingly points away from that theory and 
towards working memory as a mechanism of action. 
The use of bilateral stimulation with the positive cognition and resourcing is not supported. 
This study has raised some interesting questions about trauma in depression and the beneficial 
use of the IES-r with clients who do not have PTSD.  
8.9 Conclusions 
This small study has shown that EMDR has the potential to be a treatment for long term 
depression with seven of the eight participants who received EMDR to at least the 
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reprocessing stage achieving clinically significant and statistically reliable change on the 
Hamilton rating scale for depression. When interviewed participants spoke favourably of 
EMDR and although it seemed strange to them to do some of the imaginal work and bilateral 
stimulation they found it helpful. One key message that was repeated was that it was helpful 
to look into their past at why they were depressed not just using coping strategies to deal with 
the depression.  
 
Due to the size of the study it was not able to provide conclusive results on any potential 
mechanism of change but it did add support to the growing body of research suggesting that 
the taxing of the working memory as the mechanism behind EMDR. A new phenomenon was 
described, that of the bilateral stimulation causing a trance like state. This has not been 
previously noted in the EMDR literature and warrants further investigation. 
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Participant information sheet 
Sheffield EMDR and Depression Investigation (SEDI)    
We would like to invite you to take part in a research study. Before you decide you need to 
understand why the research is being done and what it would involve for you. Please take time 
to read the following information carefully and discuss it with others if you wish. Ask if there is 
anything that is not clear or if you would like more information. Take time to decide whether 
or not you wish to take part.  
What is the purpose of the study? 
We are researchers from the University of Sheffield and the NHS. We are carrying out this 
research to investigate new ways of treating longer term depression with psychotherapy. Eye 
Movement Desensitisation and Reprocessing (EMDR) is a therapy that has been used 
extensively with people suffering from Post-Traumatic Stress Disorder (PTSD). It is said to work 
by helping people manage their distressing memories. People with depression often have 
memories of distressing events from their past and we hope to find out if EMDR can help them 
and if it works in the same way as in people with PTSD. There is information about what EMDR 
is on the additional information sheet. 
Usually people with depression will be offered Cognitive Behavioural Therapy (CBT). CBT has 
been shown to work for a lot of people with depression but not everyone which is why we are 
looking for a new treatment. Although EMDR is recommended for people with PTSD it is 
currently an unproven experimental therapy for depression. The purpose of this research is to 
see if it may help people with depression too.  
Why have I been invited to take part? 
You are being invited to take part because you have experience of longer term depression.  We 
are asking all people with longer term depression who have just been referred to Sheffield 
Health and Social Care NHS FT’s Improving Access to Psychological Therapies (IAPT) South East 
Team and assessed as suitable for one to one therapy to consider taking part. 
Do I have to take part? 
It is up to you to decide. We will describe the study and go through this information sheet, 
which we will then give to you. We will ask you to sign a consent form for this part of the study 
to show you have agreed to take part in it. You are free to withdraw at any time, without 
giving a reason. This would not affect any regular services you receive.  
What will happen to me if I take part? 
Initially we will ask you to meet a researcher to determine whether you can be included in the 
study by asking you some questions about your mental health. If we can include you and you 
agree, you will be placed in the study. 
By agreeing to take part in this study you will be choosing to have this experimental treatment 
INSTEAD of CBT. 
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You will be asked to complete some questionnaires and talk about some specific unpleasant 
memories before the research project begins, at the end and 3 months after. These 
questionnaires should take no longer than one hour to complete. We would like to record your 
recollections of your memories to see if they change over time and therapy. These recordings 
will be transcribed and analysed by the researcher. 
After the questionnaires there will be a short wait, so that we can measure your symptoms 
before the start of therapy then you will receive up to 20 sessions of EMDR depending on how 
many you need. You will be asked to complete a quick rating scale every day. This is so we can 
see how you are progressing. We will may also need to review your medical notes (held by 
Sheffield Health and Social Care NHS FT). 
What are the possible disadvantages, risks or benefits of taking part? 
We do not think that the psychotherapy or completing the questionnaires will cause you harm. 
However you may experience strong thoughts or feelings. This often happens in therapy but 
sometimes it can be unpleasant. For some people these may be remembering past events or 
new feelings or thoughts about the person asking you questions. If you do feel uncomfortable 
about completing any of the questionnaires or during therapy we will stop what we are doing 
and ask you what you need to feel comfortable.   
We hope that your participation will help you to manage your depression more effectively in 
the future. However as this is an experimental treatment, it may not help you; if this is the 
case then you will be able to return to IAPTs for CBT after the research is complete. The results 
of your involvement will also help us design and provide services to people with long term 
depression in the future.  
What if there is a problem? 
If you have a concern about any aspect of this study, you should contact the research 
supervisor, Glenys Parry. Her contact details are at the end of this Information Sheet. 
In the unlikely event that you are harmed by taking part in this research project, there are no 
special compensation arrangements. If you are harmed due to someone’s negligence, then you 
may have grounds for a legal action but you may have to pay for it. Regardless of this, if you 
wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study, then you can contact the Principal 
Investigator for this research study, Emily Wood. Her contact details are: Telephone: 0114 
2222975; email: e.f.wood@sheffield.ac.uk; postal address: University of Sheffield, ScHARR, 
Regent Court, 30 Regent Street, Sheffield, S1 4DA. 
Alternatively, if you would like to speak to someone independent of the research you can 
contact the local Patient Advice and Liasion Service (PALS).  They can be contacted on 0114 
271 8768 or email: faye.mellors@shsc.nhs.uk. 
Will my taking part in the study be kept confidential? 
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Your therapist will continue to communicate with other members of the mental health team 
and your general practitioner about your care as usual. 
All additional information you give the researchers will be confidential, kept safe and later 
destroyed. A transcriber will be used to type up the audio-tapes or notes and they will sign a 
statement to ensure confidentiality. No one else apart from the researchers in the study will 
see your information, for example your doctor or anyone from any other health services will 
not see the information. The only exception is if you tell the researcher that you are at risk of 
serious harm to yourself or others. In this situation, the researcher would discuss this with 
your NHS worker to ensure you get any help that you require. If needed, immediate action will 
be taken, but you would be told about this first. 
Regulatory authorities may look at your consent form to check that the study is being carried 
out correctly. Your name, however, will not be disclosed outside the research office. 
All research information will be kept in a locked cupboard in a locked office and then 
destroyed 5 years after the study ends. This is in case the University wants to monitor the 
quality of the research.  
What will happen to the results of the research study? 
The results will be analysed by the researcher and a report will be written about the research 
study. No information which could identify you or anyone else would be contained in the 
report. Please let us know if you would like to be sent a summary of the findings of the study, 
and we will send one to you. 
Who is organising and funding the research? 
The study is being organised by a PhD Student the University of Sheffield and the NHS. It will 
form part of her PhD thesis. It is part of a larger programme of research that is taking place, 
called CLAHRC (Collaboration for Leadership in Applied Health Research and Care) and it is 
funded by the National Institute of Health Research (NIHR). See http://clahrc-sy.nihr.ac.uk/ for 
more information.  This particular part of the study is focusing only on longer term depression 
(see http://clahrc-sy.nihr.ac.uk/theme-iquests.html). 
Who has reviewed the study? 
Before any research goes ahead it has to be checked by an independent group of people (a 
Research Ethics Committee). They make sure that the research is fair and that people’s safety, 
rights, wellbeing and dignity are protected. 
Further information and contact details 
If you want to talk to someone about the study please contact Emily Wood, PhD student. She 
can be contacted at ScHARR, University of Sheffield, Regent Court, 30 Regent Street, Sheffield, 
S1 4DA; email: e.f.wood@sheffield.ac.uk  
Telephone: 0114 2222975. Emily can direct you to Glenys Parry, who is supervising this part of 
the study, if necessary. 
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Invitation to interview letter 
Emily Wood MMedSci RMN 
PhD Student in Psychological Therapies 
Mental Health Group, Health Services Research 
School of Health and Related Research (ScHARR) 
University of Sheffield 
Regent Court, 30 Regent Street 
Sheffield S1 4DA  
 
Tel: (+44) (0) 114 2222975 
Fax: (+44) (0)114 2724095 
Email: e.f.wood@sheffield.ac.uk 
 
 
Date 
 
Dear ------- 
 
Thank you for taking part in the research so far, investigating the use of EMDR to treat long 
term depression. 
 
As we spoke about before I wish to interview you to find out your views on EMDR, what it was 
like to receive EMDR and if you think it has been a helpful treatment. I anticipate that the 
interview will take around 1 hour.  
 
You do not have to take part in the interview however, if you would be willing to answer my 
questions or you have any questions about what the interview will include then please contact 
me on the above details and we can arrange a time and place that is convenient to you. 
 
Kind Regards 
 
 
 
Emily Wood  
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Sheffield EMDR and Depression Investigation Interview Guide 
 
Context 
 
As you are aware the EMDR therapy that you received a couple of months ago is experimental. 
Although it has been approved for post-traumatic stress disorder, it has not been fully 
investigated for use with depression. 
 
As well as finding out how the EMDR did by using the questionnaires I asked you to complete 
at the start and end of the therapy I am also really interested in finding out what you thought 
about the treatment. 
 
You may remember that after each session you completed a form listing helpful or unhelpful 
parts of the sessions. I have made a summary of those forms and may refer to that today if it is 
related to our discussion. 
 
If at any point you want a break, want to stop or just don’t want to answer a particular 
question then that is fine, just say. 
 
Everything you say will be analysed as part of the research project, so it will be recorded. I will 
also take notes. I will anonymise anything you say that may be able to identify you.  
 
I want to ask you some questions to get an idea of how the EMDR has affected you. 
 
This is all about your experience so there are no right answers here I just want to know how 
you feel. If you say something I am interested in I will ask you some follow up questions so I 
can fully understand. 
 
Are you happy to continue? 
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SEDI Topic guide 
 
How was the EMDR for you? 
 
How have things changed since EMDR? 
 How do you feel now? 
 Do you feel ‘better’? 
 
What was it like going to St George’s? 
 What was it like going twice a week? 
 
Thinking about the actual EMDR, can you tell me about any helpful bits? 
 Compare answer to HAT form summary 
 
Can you tell me about any unhelpful bits? 
 
Can you tell me about other treatments you have had? 
 How does EMDR compare to them? 
 
What was it like to have to pick out the upsetting memories? 
 
What was it like to use the eye movements/tapping? 
 
Do you think that memory has changed in any way? 
 What are your thoughts about this? 
 
How do you now feel about your experience of depression? 
 
Do you feel more confident about the future? 
 
Would you recommend EMDR to someone you know in your position? 
 
What have you learnt from this experience? 
 
Is there anything else you would like to say? 
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REC Favourable Opinion Letter
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Copy of Full IRAS data set for REC submission 
 
Full Project Data Set for 12.YH0523 
IRAS Project Filter 
The integrated dataset required for your project will be created from the answers you give to 
the following questions. The system will generate only those questions and sections which (a) 
apply to your study type and (b) are required by the bodies reviewing your study. Please 
ensure you answer all the questions before proceeding with your applications. 
Please complete the questions in order. If you change the response to a question, please select 
‘Save’ and review all the questions as your change may have affected subsequent questions. 
Please enter a short title for this project (maximum 70 characters) 
Sheffield EMDR and Depression Investigation (SEDI) 
1. Is your project research? 
Yes No 
2. Select one category from the list below: 
If your work does not fit any of these categories, select the option below: 
Clinical trial of an investigational medicinal product 
Clinical investigation or other study of a medical device 
Combined trial of an investigational medicinal product and an investigational medical device 
Other clinical trial to study a novel intervention or randomised clinical trial to compare 
interventions in clinical practice 
Basic science study involving procedures with human participants 
Study administering questionnaires/interviews for quantitative analysis, or using mixed 
quantitative/qualitative 
methodology 
Study involving qualitative methods only 
Study limited to working with human tissue samples (or other human biological samples) and 
data (specific project only) 
Study limited to working with data (specific project only) 
Research tissue bank 
Research database 
Other study 
2a. Will the study involve the use of any medical device without a CE Mark, or a CE marked 
device which has been modified or will be used outside its intended purposes? 
Yes No 
2b. Please answer the following question(s): 
a) Does the study involve the use of any ionising radiation? Yes No 
b) Will you be taking new human tissue samples (or other human biological samples)? Yes No 
c) Will you be using existing human tissue samples (or other human biological samples)? Yes 
No 
3. In which countries of the UK will the research sites be located?(Tick all that apply) 
England 
Scotland 
Wales 
Northern Ireland 
3a. In which country of the UK will the lead NHS R&D office be located: 
 
3. In which countries of the UK will the research sites be located?(Tick all that apply) 
England 
Scotland 
Wales 
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Northern Ireland 
3a. In which country of the UK will the lead NHS R&D office be located: 
England 
Scotland 
Wales 
Northern Ireland 
This study does not involve the NHS 
4. Which review bodies are you applying to? 
HRA Approval 
NHS/HSC Research and Development offices 
Social Care Research Ethics Committee 
Research Ethics Committee 
Confidentiality Advisory Group (CAG) 
National Offender Management Service (NOMS) (Prisons & Probation) 
5. Will any research sites in this study be NHS organisations? 
Yes No 
5a. Are all the research costs and infrastructure costs for this study provided by an NIHR 
Biomedical Research Centre, NIHR Biomedical Research Unit, NIHR Collaboration for 
Leadership in Health Research and Care (CLAHRC) or NIHR Research Centre for Patient Safety 
& Service Quality in all study sites? 
Yes No 
6. Do you plan to include any participants who are children? 
Yes No 
7. Do you plan at any stage of the project to undertake intrusive research involving adults 
lacking capacity to consent for themselves? 
Yes No 
 
8. Do you plan to include any participants who are prisoners or young offenders in the 
custody of HM Prison Service or who are offenders supervised by the probation service in 
England or Wales? 
Yes No 
9. Is the study or any part of it being undertaken as an educational project? 
Yes No 
Please describe briefly the involvement of the student(s): 
The research is a PhD project. The research run by the PhD student, the intervention will be 
given by therapists not involved in the research part of the project. 
9a. Is the project being undertaken in part fulfilment of a PhD or other doctorate? 
Yes No 
10. Will this research be financially supported by the United States Department of Health 
and Human Services or any of its divisions, agencies or programs? 
Yes No 
11. Will identifiable patient data be accessed outside the care team without prior consent at 
any stage of the project (including identification of potential participants)? 
Yes No 
Integrated Research Application System 
Application Form for Other clinical trial or investigation 
The Chief Investigator should complete this form. Guidance on the questions is available 
wherever you see this symbol displayed. We recommend reading the guidance first. The 
complete guidance and a glossary are available by selecting Help. 
Please define any terms or acronyms that might not be familiar to lay reviewers of the 
application. 
228 
 
Short title and version number: (maximum 70 characters this will be inserted as header on all 
forms) 
Sheffield EMDR and Depression Investigation (SEDI) 
PART A: Core study information 
1. ADMINISTRATIVE DETAILS 
A1. Full title of the research: 
Does Eye Movement Desensitisation and Reprocessing (EMDR) change traumatic 
autobiographical memories to reduce their emotional impact and thus reduce the pathology 
associated with them in patients with long term depression? 
A21. 
Educational projects 
Name and contact details of student(s): 
Student 1 
Title Forename/Initials Surname 
Miss Emily Wood 
Address University of Sheffield 
School of Health and Related Research 
30 Regent Street, Sheffield 
Post Code S1 4DA 
Email 
Telephone  
Fax  
 
Give details of the educational course or degree for which this research is being undertaken: 
Name and level of course/ degree: 
PhD in Health Service Research 
Name of educational establishment: 
University of Sheffield 
Name and contact details of academic supervisor(s): 
Academic supervisor 1 
Title Forename/Initials Surname 
Prof Glenys Parry 
Address University of Sheffield 
School of Health and Related Research 
30 Regent Street, Sheffield 
Post Code S1 4DA 
Email 
 
Academic supervisor 2 
Title Forename/Initials Surname 
Dr Tom Ricketts 
Address Sheffield Health and Social Care NHS FT 
75 Osborne Road 
Sheffield 
Post Code S11 9BF 
Email 
 
Student(s) Academic supervisor(s) 
Student 1 Miss Emily Wood 
Prof Glenys Parry 
Dr Tom Ricketts 
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A copy of a current CV for the student and the academic supervisor (maximum 2 pages of A4) 
must be submitted with the application. 
A22. Who will act as Chief Investigator for this study? 
Student 
Academic supervisor 
Other 
A31. Chief Investigator: 
Title Forename/Initials Surname 
Miss Emily Wood 
Post PhD student 
Qualifications MMedSci, RNMH 
Employer University of Sheffield 
Work Address University of Sheffield 
School of Health and Related Research 
30 Regent Street, Sheffield 
Post Code S1 4DA 
A4. Who is the contact on behalf of the sponsor for all correspondence relating to 
applications for this project? 
This contact will receive copies of all correspondence from REC and HRA/R&D reviewers that is 
sent to the CI. 
Title Forename/Initials Surname 
Miss Emily Wood 
Address University of Sheffield 
School of Health and Related Research 
30 Regent Street, Sheffield 
Post Code S1 4DA 
Email 
 
A51. Research reference numbers. Please give any relevant references for your study: 
Additional reference number(s): 
Applicant's/organisation's own reference number, e.g. R & D (if 
available): 
ZP57 
Sponsor's/protocol number: URMS132149 
Protocol Version: Version 1 
Protocol Date: 04/10/2012 
Funder's reference number: X/00197722 
Project website: http://clahrcsy.nihr.ac.uk/themeiquestsintroduction.html 
A52. Is this application linked to a previous study or another current application? 
Yes No 
 
A61. Summary of the study. Please provide a brief summary of the research (maximum 300 
words) using language easily understood by lay reviewers and members of the public. Where 
the research is reviewed by a REC within the UK Health Departments’ Research Ethics Service, 
this summary will be published on the Health Research Authority (HRA) website following the 
ethical review. Please refer to the question specific guidance for this question. Long term 
depression is a common but not well treated illness with a high social and economic cost. Eye 
Movement Desensitisation and Reprocessing (EMDR) has been shown to successfully treat 
Post Traumatic Stress Disorder (PTSD) and in theory should be able to be used for other mental 
health problems, however there is limited research to back this claim. The aim of this study is 
to investigate if EMDR can be a viable treatment option for people with long term depression. 
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It will also investigate if the theory behind EMDR applies to depression in the way it applies to 
PTSD. Patients will be recruited from IAPTs and if they meet the entry criteria and would like to 
try a different therapeutic approach they will be given up to 20 sessions of EMDR. Before and 
after therapy, symptom and functioning scales will monitor clinical change. As EMDR claims to 
promote clinical change by allowing patients to access and reprocess memories of significant 
life events this study will also ask the patients to describe in depth their memory before and 
after treatment so the content can be analysed for changes. Interviews with patients after 
therapy will discuss the lived experience and ask them to compare EMDR with other 
treatments they may have had. Finally the pretreatment characteristics of patients who do 
respond well to EMDR will be compared with those who do not to see if there is the potential 
to target EMDR to those who are most likely to respond well. 
 
A62. Summary of main issues. Please summarise the main ethical, legal, or management 
issues arising from your study and say how you have addressed them. Not all studies raise 
significant issues. Some studies may have straightforward ethical or other issues that can be 
identified and managed routinely. Others may present significant issues requiring further 
consideration by a REC, R&D office or other review body (as appropriate to the issue). Studies 
that present a minimal risk to participants may raise complex organisational or legal issues. 
You should try to consider all the types of issues that the different reviewers may need to 
consider. 
This research will involve implementing treatment which is not currently recommended for 
long term depression on chronically ill patients. Some people do experience adverse effects 
from psychological therapies. Patients will not be able to switch their antidepressant during 
the therapy. The therapist and researcher will be required to have access to the patient's 
medical history and to add to their mental health notes where appropriate. During therapy 
some issues maybe disclosed that have not been shared with health service workers before, 
such as past events and current risk. They will also have to undergo testing which is not routine 
for depression care, during the tests all participants will be asked to concentrate on distressing 
memories which could affect their mood and wellbeing after the testing is complete. The 
unusual nature of the testing and the intrinsic problems in motivating people with chronic 
depression could lead to problems for recruitment and retention. 
 
In an attempt to negate these problems or control them where possible, prior to the 
commencement of the therapy informed consent will be sought from the patients. They will be 
informed that the intervention will adhere to the same policies as the Sheffield Health and 
Social Care NHS FT (from which they already receive care) and that policies about sharing 
information on history and risk will therefore be the same (notes are accessible by other 
members of the patient's care team). They will also be informed about specific confidentiality 
issues around research (the researcher will be able to access their notes and will write up their 
case for the thesis and journal articles but under a false name and other identifiable 
information will either be left out or changed). All patients will be fully informed of the scope 
and aims of the study, no nondisclosure is necessary. Risks from the therapy process will be 
controlled according to Trust policy, if the patient has an extended care team they will be 
informed of risk issues if and when they arise. Patients will be able to leave therapy at any 
point without penalty. Patients who withdraw from the study will return to receiving 
treatment as usual from their IAPTs provider. 
3. PURPOSE AND DESIGN OF THE RESEARCH 
A7. Select the appropriate methodology description for this research. Please tick all that 
apply: 
Case series/ case note review 
Case control 
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Cohort observation 
Controlled trial without randomisation 
Cross sectional study 
Database analysis 
Epidemiology 
Feasibility/ pilot study 
Laboratory study 
Meta-analysis 
Qualitative research 
Questionnaire, interview or observation study 
Randomised controlled trial 
Other (please specify) 
 
A10. What is the principal research question/objective? Please put this in language 
comprehensible to a lay person. 
Is there an improvement in depressive symptoms and social functioning following a course of 
EMDR for long term depression? 
 
A11. What are the secondary research questions/objectives if applicable? Please put this in 
language comprehensible to a lay person. 
• If there is a change, is it stable at follow up? 
• Has the content of the target memory become less distressing and more adaptive, and if so it 
is stable at follow up? 
• Has the impact of the target memory and the psychophysiological (heart rate variability and 
skin conductance response) response to it decreased? 
• Is there a relationship between changes in symptoms and changes in memories? 
• Do patients find EMDR to be an acceptable treatment for long term depression? 
• Are there any significant differences between the responder group and non-responder group 
of patients which might be able to predict response in others? 
A12. What is the scientific justification for the research? Please put this in language 
comprehensible to a lay person. 
Depression is a common but debilitating mental health condition, it affects an estimated 121 
million people worldwide (WHO, 2009). For many people depression is a recurrent condition 
which requires long term management to minimise the impact of the disorder on their quality 
of life. Although the evidence for the recommended treatments, antidepressant medication 
and cognitive behavioural therapy, is good, most of the research focusses on single episode 
rather than longer term depression. There is significant potential to develop our understanding 
of the treatment of long term depression. 
EMDR was initially developed to treat Post Traumatic Stress Disorder (PTSD) and focusses on 
the client's memories of distressing incidents. Randomised controlled trials using EMDR with 
PTSD clients has shown it reduces comorbid depression along with PTSD symptoms. They have 
found this despite some underpowered studies. However this does not tell us if EMDR is 
directly responsible for the reduction in depression or if it is merely a by-product of the 
reduction in PTSD. Studies on the use of EMDR with patients with a primary diagnosis of 
depression are lacking. 
There is to date no full RCT published in English although case studies abound in the peer 
reviewed and grey literature that suggest it may be a useful tool to add to standard treatments 
for depression. There is also a lack of explanation to link the adaptive information processing 
model to the treatment of depression. 
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A13. Please summarise your design and methodology. It should be clear exactly what will 
happen to the research participant, how many times and in what order. Please complete this 
section in language comprehensible to the lay person. Do not simply reproduce or refer to the 
protocol. Further guidance is available in the guidance notes. 
Planned protocol 
1. Upon referral to IAPTs clients are assessed by a wellbeing practitioner. WBP to identify 
clients who meet the research entry requirements (require step 3 care, aged 18 or over with 
primary diagnosis of long term depression) and tell them about the study, including giving 
them the two information sheets. If client is interested in participating they sign consent form 
1 (consent for contact by research team). 
2. Researcher contacts those who have expressed an interest in participation and invites them 
for screening 
3. Screening with MINI (and asked if they meet any of the exclusion criteria not covered by the 
MINI), if volunteer still meets criteria following screening then they will be given an 
explanation of the study, however they will not be given any new information other than 
having any questions they may have answered. If they still wish to be a participant they will 
sign the consent forms. 
4. Volunteers who meet the criteria and who have signed consent forms will be assigned to an 
EMDR therapist (first 12 will be included, there will be no randomisation or matching at this 
stage). These will, mostly, be private practitioners brought in under the Sheffield Health and 
Social Care NHS FT (SHSC) governance procedures to deliver EMDR. Ideally the EMDR will take 
place in one of SHSC's buildings. Any volunteers who don’t meet the criteria or decide not to 
participate will go back into the normal IAPTs channels. 
5. EMDR will follow the manualised protocol and some sessions will be taped to check 
therapist adherence. 
6. After parts 13 of the protocol the participant will return to the University (or other arranged 
location) for pretherapy testing and will complete a range of pre intervention measures such 
as the HRSD24, BDIII, SASS,  GAF, IESr, PHQ9, describe and rate a distressing memory which 
will be targeted during therapy and have readings taken of heart rate variability and skin 
conductance response. 
7. Client returns to EMDR therapist, 2x 1 hour session per week. Up to 20 sessions as 
determined by client need. 
8. After each session the client will be asked to complete the PHQ9 and HAT forms. These will 
not be seen by the therapist but will inform the research questions and analysis. 
9. At discharge or after 20 sessions, whichever comes first, the client will again meet the 
University researcher to do the posttherapy testing and interviews (over at least 2 sessions) 
10. At 3 months posttherapy the client will be asked to do the follow up set of tests. The client 
will not be able to have CBT or other psychotherapy during the research period. They will also 
be asked not to change their antidepressant medication. If there is a medical need to do this 
they will not be included in the final analysis. 
11. If the results from the treatment group do not support the null hypothesis (i.e. it would 
appear that EMDR has had a positive effect on the participants), then a control group will be 
recruited from the South Yorkshire cohort (a group of service users who have registered an 
interest in assisting in research). 
12. This control group will go through the same testing procedures over the same time period 
as the treatment group but will receive no therapy. 
 
A141. In which aspects of the research process have you actively involved, or will you involve, 
patients, service users, and/or their carers, or members of the public? 
Design of the research 
Management of the research 
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Undertaking the research 
Analysis of results 
Dissemination of findings 
None of the above 
Give details of involvement, or if none please justify the absence of involvement. 
The University department includes service user researchers as integral members of the team. 
One of these was consulted to discuss this project and highlight any possible areas for concern. 
Their suggestion of a robust plan in the event of negative outcomes was incorporated into the 
study design. 
4. RISKS AND ETHICAL ISSUES 
RESEARCH PARTICIPANTS 
A15. What is the sample group or cohort to be studied in this research? 
Select all that apply: 
Blood 
Cancer 
Cardiovascular 
Congenital Disorders 
Dementias and Neurodegenerative Diseases 
Diabetes 
Ear 
Blood 
Cancer 
Cardiovascular 
Congenital Disorders 
Dementias and Neurodegenerative Diseases 
Diabetes 
Ear 
Eye 
Generic Health Relevance 
Infection 
Inflammatory and Immune System 
Injuries and Accidents 
Mental Health 
Metabolic and Endocrine 
Musculoskeletal 
Neurological 
Oral and Gastrointestinal 
Paediatrics 
Renal and Urogenital 
Reproductive Health and Childbirth 
Respiratory 
Skin 
Stroke 
Gender: Male and female participants 
Lower age limit: 18 Years 
Upper age limit: No upper age limit 
A171. Please list the principal inclusion criteria (list the most important, max 5000 
characters). 
People who have been referred to IAPTs for treatment for depression, are 18 and over, with 
depression, confirmed through structural interview (e.g. the MINI). The depression is long term 
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i.e. it is recurrent (2 or more episodes) or the current episode has a duration of 2 years or 
more. Patients must be able to give informed consent. 
A172. Please list the principal exclusion criteria (list the most important, max 5000 
characters). 
Those under 18, those unable to give informed consent, those with a first episode of 
depression, psychosis, bipolar disorder, PTSD, dementia, brain injury, current drug/alcohol 
dependence, epilepsy, pregnancy, current opiate analgesic use, ECT in the last 6 months or 
anyone whose primary mental health diagnosis is not long term depression. 
RESEARCH PROCEDURES, RISKS AND BENEFITS 
A18. Give details of all nonclinical intervention(s) or procedure(s) that will be received by 
participants as part of the research protocol. These include seeking consent, interviews, 
nonclinical observations and use of questionnaires. 
Please complete the columns for each intervention/procedure as follows: 
1. Total number of interventions/procedures to be received by each participant as part of the 
research protocol. 
2. If this intervention/procedure would be routinely given to participants as part of their care 
outside the research, how many of the total would be routine? 
3. Average time taken per intervention/procedure (minutes, hours or days) 
4. Details of who will conduct the intervention/procedure, and where it will take place. 
Intervention or procedure 1 2 3 4 
As part of their assessment for IAPTs clients who have long term depression will be given 
information about the research and asked if they consent to their details 
1 1 1 hour 
Assessment will be done by a Wellbeing Practitioner from their local IAPTs service at their 
usual site. 
Research associate contacts client to explain the research and arrange a MINI diagnostic 
interview if the client still wants to take part. 
1 0 30 mins 
Conversation will take place by phone (or letter/email if the client prefers) MINI diagnostic 
interview including giving consent for the interview. 
1 0 1 hour 
Research clinician will conduct the MINI at a place convenient for both client and assessor 
eg at an NHS site, University of Sheffield site or participants home if that is their preference. 
Those who meet the inclusion criteria, will meet a research clinician, give consent for the 
research and complete baseline measures, describe their memories and undergo 
psychophysiological tests 
1 0 90 mins 
The measures will be collected by a research clinician at a location suitable for the client, 
probably an NHS or University site. 
After every session of EMDR the client will complete PHQ9 and Helpful aspects of therapy (HAT) 
forms 
20 0 20mins 
The forms will be given to the client at the end of each session with an envelope to seal them 
in. 
Once the intervention is complete the client will be asked to complete the same measures as 
at the pretreatment phase. 
1 0 90 mins 
The measures will be collected by a research clinician at a location suitable for the client, 
probably an NHS or University site. 
After completion the client will be interviewed about their views of the intervention questions 
will be informed by the HAT responses 
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1 0 1 hour 
The interview will be done by a researcher at a location convenient to the participant and 
researcher. 3 months after completion the clients will be asked to complete the pre and post 
measures again. 
1 0 90 mins 
The measures will be collected by a research clinician at a location suitable for the client, 
probably an NHS or University site. 
A19. Give details of any clinical intervention(s) or procedure(s) to be received by participants 
as part of the research protocol. These include uses of medicinal products or devices, other 
medical treatments or assessments, mental health interventions, imaging investigations and 
taking samples of human biological material. Include procedures which might be received as 
routine clinical care outside of the research. 
Please complete the columns for each intervention/procedure as follows: 
1. Total number of interventions/procedures to be received by each participant as part of the 
research protocol. 
2. If this intervention/procedure would be routinely given to participants as part of their care 
outside the research, how many of the total would be routine? 
3. Average time taken per intervention/procedure (minutes, hours or days). 
4. Details of who will conduct the intervention/procedure, and where it will take place. 
Intervention or procedure 1 2 3 4 
Eye Movement Desensitisation and Reprocessing 20 0 1hour EMDR will be carried out by a 
qualified EMDR therapist at an NHS site. 
 
A20. Will you withhold an intervention or procedure, which would normally be considered a 
part of routine care? 
Yes No 
If Yes, please give details, explain the risks and justify the need to withhold the intervention or 
procedure: 
Clients referred to IAPTs with depression would normally receive cognitive behavioural 
therapy. However CBT only has around a 50% efficacy rate with long term depression. This 
study wishes to look at an alternative to CBT so clients will not be able to have both at the 
same time, it would be impossible to tell which was having an effect. It is also generally 
inadvisable to have 2 forms of psychotherapy at the same time. 
We will also request that clients do not change their medication during the intervention period. 
This is so we can be clear about what has affected the clients mood. Clients who require a 
change in medication will not be included in the final analysis. 
Many clients with long term depression will have had medication or some form of therapy 
prior to this study. As they have relapsed it is not anticipated that trying a different form of 
therapy will be detrimental to their mental health, in fact by trying a different approach they 
may benefit greatly. 
 
A21. How long do you expect each participant to be in the study in total? 
Up to 6 months. It is not anticipated that the intervention will last longer than 3 months, there 
will also be a 3 month follow period. 
 
A22. What are the potential risks and burdens for research participants and how will you 
minimise them? 
For all studies, describe any potential adverse effects, pain, discomfort, distress, intrusion, 
inconvenience or changes to lifestyle. Only describe risks or burdens that could occur as a result 
of participation in the research. Say what steps would be taken to minimise risks and burdens 
as far as possible. 
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Any psychological therapy carries a risk of causing temporary distress for the participants. To 
minimise this risk the participants and therapists are being monitored during the course of the 
therapy. If there is concern then action can be taken quickly to minimise harm. 
People may find participating in the research a burden because they will be assessed regularly 
using intervention measures such HRSD and asked to participate in an interview. To minimise 
the impact of this all participants will be fully informed about the process before starting and 
informed consent will be sought continually throughout the process rather than just once. The 
burden will be minimised by consulting with the participant about how the process can be 
made easier for them such as arranging an interview at a time and place to suit them. 
The memory recall part of the testing procedure is the part that may cause most distress for 
the participants. Having to explain a distressing memory several times can be upsetting. 
However, the memory would be identified as part of the EMDR process anyway and the client 
would have to think about it in detail several times during desensitisation. The additional ask 
here would be that they would have to verbalise their memory which they don’t have to do 
(although many people do) during therapy. However this is an unusual aspect of EMDR. In 
many other therapies the client would have to explain in detail the incident that was the focus 
of the session, and in some cases analyse it as well. If the intervention study finds that EMDR 
appears to be making a difference to client's mood and memories a control study will be 
undertaken. One of the reasons for the control group is that the repeated description of the 
distressing event may in fact be therapeutic. It resembles ‘reliving’ and may led to habituation. 
To ensure that any distress is limited the control group will be taken from a less severely ill 
population (they will still have long term depression but not requiring treatment) and the 
control group will only be used if the treatment group appear to respond to the new treatment. 
 
A23. Will interviews/ questionnaires or group discussions include topics that might be 
sensitive, embarrassing or upsetting, or is it possible that criminal or other disclosures 
requiring action could occur during the study? 
Yes No 
If Yes, please give details of procedures in place to deal with these issues: 
The majority of the outcome measures used will be quantitative of closed questions and it is 
not thought that this will lead to people discussing issues that are upsetting or lead to criminal 
disclosures. 
The qualitative interviews and memory test will be done by a clinician researcher who is 
experienced in discussing sensitive topics and managing the issue such as allowing people 
breaks in the interview if they become distressed. The interviews will focus on the client's 
experience of EMDR rather than the issues that were the focus of the therapy. 
The consent form clearly states that if participants disclose that they are a risk to themselves 
or others or disclose specific criminal incidents then the researcher, therapist or supervisor will 
if necessary inform the appropriate services, breaking confidentiality if required. The interview 
questions will be based on the responses given to the HAT questionnaires so will be relevant to 
the patient experience. 
 
A24. What is the potential for benefit to research participants? 
The purpose of the investigation is to discover if this type of therapy has potential as a 
treatment for long term depression. Participants may benefit from having this form of therapy. 
A25. What arrangements are being made for continued provision of the intervention for 
participants, if appropriate, once the research has finished? May apply to any clinical 
intervention, including a drug, medical device, mental health intervention, complementary 
therapy, physiotherapy, dietary manipulation, lifestyle change, etc. 
Continued provision will remain limited initially as this research will form a pilot study and 
IAPTs have limited resources to offer nonstandard therapies. 
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A26. What are the potential risks for the researchers themselves? (if any) 
Researchers may experience distress from listening to the potentially distressing experiences 
of service users. The line management system in place will ensure the opportunity to seek 
support where necessary. 
The safety researchers travelling in public places and interviewing people in their homes has 
been given consideration. A policy on lone working is held by the University of Sheffield and 
will be adhered to. This includes tracking visits and procedures for alerting emergency services. 
where appropriate. 
A271. 
How will potential participants, records or samples be identified? Who will carry this out and 
what resources will be used? For example, identification may involve a disease register, 
computerised search of social care or GP records, or review of medical records. Indicate 
whether this will be done by the direct care team or by researchers acting under arrangements 
with the responsible care organisation(s). 
Clients will be told of the research as part of their assessment interview for IAPTs. Any client 
who has been referred, has had 2 or more episodes of depression and is suitable for step 3 
(individual psychotherapy) care will be told about the research. If they are interested in finding 
out more they will be asked to sign the 'consent for contact' form and a University researcher 
will contact them with more information and invite them for a screening interview. The 
'consent to contact' form is for that purpose alone and the client will be required to consent 
again for the screening interview and again to receive the intervention. They will also be given 
2 participant information sheets which will explain the research and what will happen to the 
client in laymen's terms. 
The researcher from the University of Sheffield will have an honorary contract with the 
Sheffield Health and Social Care NHS FT. 
 
A272. Will the identification of potential participants involve reviewing or screening the 
identifiable personal information of patients, service users or any other person? 
Yes No 
Please give details below: 
Initially the Wellbeing practitioner who conducted the client's assessment at the IAPTs team 
will identify those they wish to inform about the research and with the client's permission, 
advise the researcher to send them the study information. No one outside the client's care 
team will have access to their details until the client consents to this. 
 
A273. Describe what measures will be taken to ensure there is no breach of any duty of 
confidentiality owed to patients, service users or any other person in the process of 
identifying potential participants. Indicate what steps have been or will be taken to inform 
patients and service users of the potential use of their records for this purpose. Describe the 
arrangements to ensure that the wishes of patients and service users regarding access to their 
records are respected. Please consult the guidance notes on this topic. 
Clients will be told of the research by a Wellbeing Practitioner whom they would have seen 
anyway. Unless they consent their details will not be passed on to the research team. They will 
be asked to sign a 'consent to contact' form (they will keep a copy and one will go to the 
research team). 
 
A274. Will researchers or individuals other than the direct care team have access to 
identifiable personal information patients, service users or any other person in the process 
of identifying potential participants.  
Yes No 
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A275. 
Has prior consent been obtained or will it be obtained for access to identifiable personal 
information? 
Yes No 
If Yes, please give details below. 
Clients will be told of the research by a Wellbeing Practitioner whom they would have seen 
anyway. Unless they consent their details will not be passed on to the research team. They will 
be asked to sign a 'consent to contact' form (they will keep a copy and one will go to the 
research team). This will be used to allow the diagnostic screening interview to be held. 
A28. Will any participants be recruited by publicity through posters, leaflets, adverts or 
websites? 
Yes No 
A29. How and by whom will potential participants first be approached? 
Potential participants will be approached by the Wellbeing Practitioner (WP) conducting their 
assessment at the IAPTs team. The WP will explain about the research at the end of their 
assessment session and given them the information sheets and permission form for having a 
researcher contact them. The assessor will inform the client about the research. 
A301. Will you obtain informed consent from or on behalf of research participants? 
Yes No 
If you will be obtaining consent from adult participants, please give details of who will take 
consent and how it will be done, with details of any steps to provide information (a written 
information sheet, videos, or interactive material). Arrangements for adults unable to consent 
for themselves should be described separately in Part B Section 6, and for children in Part B 
Section 7. If you plan to seek informed consent from vulnerable groups, say how you will ensure 
that consent is voluntary and fully informed. 
During their assessment at IAPTs clients will be asked if they wish to be contacted by a 
researcher about the research and will give permission for their details to be given to the 
researcher for this purpose. 
For those that do wish to proceed, a screening interview will be arranged. At this stage the 
researcher will send the potential participant the information sheets again if they want them. 
The participant will not receive any new information as all the information about EMDR and 
SEDI will have been included in the leaflets given out by the WP but the researcher will be able 
to answer any questions they have or give them another leaflet if they wish. The EMDR 
information sheet has been developed by clinicians for patients receiving this intervention and 
is designed to be comprehensive yet accessible. At the screening interview the client will 
consent to have this without further commitment at this stage. 
Those who progress to the intervention stage will sign a consent form for the intervention 
when they meet with a researcher to complete the baseline measures. 
Potential participants will be provided with contact details for the researcher whom they can 
contact if they have any queries regarding the research or wish to withdraw. At each stage 
they will be asked if they still consent to taking part. 
Those who do not wish to participate or drop out will proceed through the IAPT service as 
usual. 
If you are not obtaining consent, please explain why not. 
Please enclose a copy of the information sheet(s) and consent form(s). 
 
A302. Will you record informed consent (or advice from consultees) in writing? 
Yes No 
A31. How long will you allow potential participants to decide whether or not to take part? 
A minimum of 24 hours 
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A32. Will you recruit any participants who are involved in current research or have recently 
been involved in any research prior to recruitment? 
Yes 
No 
Not Known 
 
A331. What arrangements have been made for persons who might not adequately 
understand verbal explanations or written information given in English, or who have special 
communication needs?(e.g. translation, use of interpreters) 
People with no spoken English will have difficulty in completing the outcome measures as 
psychometrically valid 
measures are not always available in languages other than English, they would also have 
difficulty in describing their memories, this would make it difficult for them to participate. 
If someone has other needs such as literacy problems the research team will support them. 
For example a researcher could read out the questions on the outcome questions and record 
their response for them rather than leaving the person to complete it themselves 
 
A34. What arrangements will you make to ensure participants receive any information that 
becomes available during the course of the research that may be relevant to their continued 
participation? 
The nature of the information will effect what action is taken. 
If it is urgent information, such as discovering that EMDR is harmful to people with long term 
depression then relevant participants will be contacted by telephone to explain the new 
information in laymen's terms. 
If the information is nonurgent then a report will be written in laymen's terms and sent to the 
relevant participants along with the researcher's contact details if they wish to discuss the 
issue further. 
In all cases the participants, rather than the research, will be prioritised. 
 
A35. What steps would you take if a participant, who has given informed consent, loses 
capacity to consent during the 
study? Tick one option only. 
The participant and all identifiable data or tissue collected would be withdrawn from the study. 
Data or tissue which is not identifiable to the research team may be retained. 
The participant would be withdrawn from the study. Identifiable data or tissue already 
collected with consent would be retained and used in the study. No further data or tissue 
would be collected or any other research procedures carried out on or in relation to the 
participant. 
The participant would continue to be included in the study. 
Not applicable – informed consent will not be sought from any participants in this research. 
Not applicable – it is not practicable for the research team to monitor capacity and continued 
capacity will be assumed. 
Further details: 
and use of personal data during the study 
A36. Will you be undertaking any of the following activities at any stage (including in the 
identification of potential participants)?(Tick as appropriate) 
Access to medical records by those outside the direct healthcare team 
Access to social care records by those outside the direct social care team 
Electronic transfer by magnetic or optical media, email or computer networks 
Sharing of personal data with other organisations 
Export of personal data outside the EEA 
240 
 
Use of personal addresses, postcodes, faxes, emails or telephone numbers 
Publication of direct quotations from respondents 
Publication of data that might allow identification of individuals 
Use of audio/visual recording devices 
Storage of personal data on any of the following: 
Manual files (includes paper or film) 
NHS computers 
Social Care Service computers 
Home or other personal computers 
University computers 
Private company computers 
Laptop computers 
Further details: 
As the participants will have been recruited to the study from an NHS service, NHS computers 
will have their personal details. Access to personal information will only occur after the 
research project has been explained to the participant and they have consented. 
Personal addresses and phone numbers will be used by a researcher to arrange meetings for 
screening, outcome measures and interviews. Paper files will be kept in a locked filing cabinet. 
Recordings will be made of some of the therapy sessions this is to ensure the therapists are 
adhering to the manualised process correctly. They will be viewed by another, highly 
experienced therapist and they destroyed. The recordings will be concerned with the therapist 
not the client. 
 
A37. Please describe the physical security arrangements for storage of personal data during 
the study? 
Any personal data on paper will be stored in a locked filing cabinet. Electronic data will be 
password protected. 
A38. How will you ensure the confidentiality of personal data? Please provide a general 
statement of the policy and procedures for ensuring confidentiality, e.g. anonymisation or 
pseudonymisation of data. 
No personal details will be passed outside of the direct care team until the client consents to 
this occurring. Even then they will be seen by the fewest number of people possible. 
Any data used in the thesis or papers that come from the research will be anonymised. 
Pseudonyms will be used for the reporting of the interviews. 
Data is stored for 5 years in compliance with the University of Sheffield's data management 
policies. Personal identifiable information will be stored securely at NHS sites. Audio-visual 
recordings will be destroyed once they have been transcribed and analysed. 
A40. Who will have access to participants' personal data during the study? Where access is by 
individuals outside the direct care team, please justify and say whether consent will be sought. 
As the participants will have been recruited to the study from an NHS service, NHS computers 
will have their personal details. Access to personal information will only occur after the 
research project has been explained to the participant and they have consented. Personal 
addresses and phone numbers will be used by a researcher to arrange meetings for screening, 
outcome measures and interviews. 
Storage and use of data after the end of the study 
A41. Where will the data generated by the study be analysed and by whom? 
Data collected will be analysed by Emily Wood at the University of Sheffield. 
A42. Who will have control of and act as the custodian for the data generated by the study? 
Title Forename/Initials Surname 
Mr David Saxon 
Post Research Associate/Data Manager 
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Qualifications MSc in Heath Service Research 
Work Address ScHARR, Regent Court 
30 Regent Street 
Sheffield 
Post Code S1 4DA 
A43. How long will personal data be stored or accessed after the study has ended? 
Less than 3 months 
3 – 6 months 
6 – 12 months 
12 months – 3 years 
Over 3 years 
If longer than 12 months, please justify: 
Data is stored for 5 years in compliance with the University of Sheffield's data management 
policies. Personal identifiable information will be stored securely at NHS sites. Audiovisual 
recordings will be destroyed once they have been transcribed and analysed. 
A44. For how long will you store research data generated by the study? 
Years: 5 
Months: 
A45. Please give details of the long term arrangements for storage of research data after the 
study has ended. Say where data will be stored, who will have access and the arrangements to 
ensure security. 
Long term storage will follow the University of Sheffield's archive protocol. 
INCENTIVES AND PAYMENTS 
A46. Will research participants receive any payments, reimbursement of expenses or any 
other benefits or incentives for taking part in this research? 
Yes No 
If Yes, please give details. For monetary payments, indicate how much and on what basis this 
has been determined. 
Therapists will be paid to deliver therapy at a rate similar to normal local levels. 
Participants will receive travel expenses for attending the screening and outcome measure 
appointments but will not be paid to attend therapy sessions, unless they would normally be 
able to claim travel expenses due to the state benefits they receive. 
A47. Will individual researchers receive any personal payment over and above normal salary, 
or any other benefits or incentives, for taking part in this research? 
Yes No 
A48. Does the Chief Investigator or any other investigator/collaborator have any direct 
personal involvement (e.g. financial, share holding, personal relationship etc.) in the 
organisations sponsoring or funding the research that may give rise to a possible conflict of 
interest? 
Yes No 
NOTIFICATION OF OTHER PROFESSIONALS 
A491. Will you inform the participants’ General Practitioners (and/or any other health or 
care professional responsible for their care) that they are taking part in the study? 
Yes No 
If Yes, please enclose a copy of the information sheet/letter for the GP/health professional with 
a version number and date. 
A492. 
Will you seek permission from the research participants to inform their GP or other health/ 
care professional? 
Yes No 
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It should be made clear in the participant’s information sheet if the GP/health professional will 
be informed. 
PUBLICATION AND DISSEMINATION 
UBLICATION AND DISSEMINATION 
A501. 
Will the research be registered on a public database? 
The Department of Health's Research Governance Framework for Health and Social Care and 
the researchgovernance frameworks for Wales, Scotland and Northern Ireland set out the 
requirement for registration of trials. 
Furthermore: Article 19 of the World Medical Association Declaration of Helsinki adopted in 
2008 states that “every clinical trial must be registered on a publicly accessible database before 
recruitment of the first subject”; and the International Committee of Medical Journal Editors 
(ICMJE) will consider a clinical trial for publication only if it has been registered in an 
appropriate registry. Please see guidance for more information. 
Yes No 
Please give details, or justify if not registering the research. 
As this is not a standard clinical trial there is no appropriate database in which to register it. 
Please ensure that you have entered registry reference number(s) in question A51. 
A51. How do you intend to report and disseminate the results of the study? Tick as 
appropriate: 
PhD thesis 
Peer reviewed scientific journals 
Internal report 
Conference presentation 
Publication on website 
Other publication 
Submission to regulatory authorities 
Access to raw data and right to publish freely by all investigators in study or by Independent 
Steering Committee 
on behalf of all investigators 
No plans to report or disseminate the results 
Other (please specify) 
A52. If you will be using identifiable personal data, how will you ensure that anonymity will 
be maintained when publishing the results? 
All identifiable information will be removed prior to publication; pseudonyms will be used 
where necessary. 
A53. Will you inform participants of the results? 
Yes No 
Please give details of how you will inform participants or justify if not doing so. 
Participants will be asked if they want to be informed of the results. If they do a short report 
written in laymen's terms will be sent to them at the end of the research. 
5. Scientific and Statistical Review 
A541. 
How has the scientific quality of the research been assessed? Tick as appropriate: 
Independent external review 
Review within a company 
Review within a multi−centre research group 
Review within the Chief Investigator's institution or host organisation 
Review within the research team 
Review by educational supervisor 
Other 
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Justify and describe the review process and outcome. If the review has been undertaken but not 
seen by the researcher, give details of the body which has undertaken the review: 
A research proposal was produced by the chief investigator in consultation with educational 
supervisors. 
This was reviewed by as part of the Mphil to PhD 'Upgrade' by 2 experts in the subject field 
from the University of Sheffield. 
It is noted that no major changes were necessary following the reviewers comments. 
 
For all studies except nondoctoral student research, please enclose a copy of any available 
scientific critique reports, together with any related correspondence. 
For nondoctoral student research, please enclose a copy of the assessment from your 
educational supervisor/ institution. 
A56. How have the statistical aspects of the research been reviewed? Tick as appropriate: 
Review by independent statistician commissioned by funder or sponsor 
Other review by independent statistician 
Review by company statistician 
Review by a statistician within the Chief Investigator’s institution 
Review by a statistician within the research team or multi−centre group 
Review by educational supervisor 
Other review by individual with relevant statistical expertise 
No review necessary as only frequencies and associations will be assessed – details of 
statistical input not required 
In all cases please give details below of the individual responsible for reviewing the statistical 
aspects. If advice has been provided in confidence, give details of the department and 
institution concerned. 
Title Forename/Initials Surname 
Mr David Saxon 
Department School of Health and Related Research 
Institution University of Sheffield 
Work Address 30 Regent Street 
Sheffield 
Post Code S1 4DA 
Please enclose a copy of any available comments or reports from a statistician. 
 
A57. What is the primary outcome measure for the study? 
Hamilton rating scale for depression 
A58. What are the secondary outcome measures?(if any) 
BDIII, IESr, SASS, GAF, PHQ9psychophysiological measures and memory impact scales. 
A59. What is the sample size for the research? How many participants/samples/data records 
do you plan to study in total? If there is more than one group, please give further details below. 
Total UK sample size: 24 
Total international sample size (including UK): 24 
Total in European Economic Area: 24 
Further details: 
12 participants will be given the EMDR intervention, if the null hypothesis is NOT confirmed 
and it appears that EMDR has made a difference on the outcome measures then a second 
group of 12 participants will be given the outcome measure tests over the same time period as 
the intervention group but with no EMDR (or any other intervention). 
A60. How was the sample size decided upon? If a formal sample size calculation was used, 
indicate how this was done, giving sufficient information to justify and reproduce the 
calculation. 
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A formal sample size calculation was not done. As this is a pilot, we do not know what the 
expected effect size will be. We have included as many people as we can realistically treat 
within the timescale and budget. 
A611. Will participants be allocated to groups at random? 
Yes No 
A62. Please describe the methods of analysis (statistical or other appropriate methods, e.g. 
for qualitative research) by which the data will be evaluated to meet the study objectives. 
Study 1 
Paired t tests can be used (assuming test assumptions are met – data are normally distributed) 
to see if there are any significant differences between the participants scores before and after 
the intervention. This will be done on all measures (Likert scales, BDIII, HRSD, GAF, SASS, IESr, 
HRV and SCR) although the HRSD is the primary outcome and the others are to support the 
primary outcome or provide possible explanations for unexpected results. 
An ANCOVA test can be used (assuming test assumptions are met) to compare the differences 
in the before/after scores in the treatment and control groups. Here the outcome will be the 
change in the measures before and after therapy and the test will be able to control for 
baseline differences between the two groups. The ANCOVA will be able to generate 
confidence intervals for the data. 
Correlations can be carried out to see if the different measurements change in relation to each 
other. As the memory content data is categorical this data can be transformed into those who 
showed a change towards more positive emotions and those who did not. This can then be 
analysed using ANCOVA to look for correlations. 
The memory descriptions will be analysed by content analysis. Content analysis will require the 
transcriptions to be coded for distressing, positive/adaptive and miscellaneous themes. As 
deciding what is a positive or negative theme could be subjective this will be done by the 
researcher but will also cross check the scoring with someone else to ensure reliability of the 
coding. The ratios of the different themes can then be compared before and after EMDR 
therapy and also between the treatment and control groups to see if the EMDR has led to an 
increase in the amount of positive/adaptive themes being expressed. This will be done using 
chi–squared tests. As this research involves small numbers of patients it is possible that an 
expected count may be below 5, in this case a Yates’s correction can be used. SPSS will be used 
for the statistical analysis and when undertaking a chisquared analysis it will automatically do 
additional tests when expected counts of less than 5 occur. 
The chisquared table for the treatment group will compare time 1 and time 2 (before and after 
therapy) with the proportion of positive and negative content. To compare the control group 
to the treatment group will look at the proportions of each group who got more positive and 
those that didn’t. 
Study 2 
The interviews will be transcribed and analysed on the latest version of Nvivo. A framework 
analysis approach will be used. This involves five steps: familiarisation, identifying a thematic 
framework, indexing, charting and mapping and interpretation (Srivastava and Thomson, 
2009). 
Familiarisation: getting to know the transcripts of the data, becoming immersed in it. 
Identifying a thematic framework: key to the framework analysis is the concept that although 
the research questions were designed around a priori issues, and these may form some of the 
key themes, it is also possible for unexpected themes to emerge from the data. 
Indexing: identifying portions of data that correspond to certain themes and coding these 
appropriately. 
Charting: indexed data is now removed from the transcript and placed in charts of 
corresponding themes linking key portions of data. 
Mapping and interpretation: Analysing key characteristics of the data set. 
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Study 3 
Independent t tests can be used (assuming test assumptions are met) to compare the 
differences in the before/after scores and the initial data in the responder and non responder 
groups. Due to the low numbers involved in this research it may be that the numbers in each 
group are too low to undertake meaningful statistical analysis. In this case the outcome will be 
descriptive instead. Identifying a thematic framework: key to the framework analysis is the 
concept that although the research questions were designed around a priori issues, and these 
may form some of the key themes, it is also possible for unexpected themes to emerge from 
the data. 
Indexing: identifying portions of data that correspond to certain themes and coding these 
appropriately. 
Charting: indexed data is now removed from the transcript and placed in charts of 
corresponding themes linking key portions of data. 
Mapping and interpretation: Analysing key characteristics of the data set. 
6. MANAGEMENT OF THE RESEARCH 
A63. Other key investigators/collaborators. Please include all grant co−applicants, protocol 
co−authors and other key members of the Chief Investigator’s team, including nondoctoral 
student researchers.  
Title Forename/Initials Surname 
Post 
Qualifications 
Employer 
Work Address 
Post Code 
Telephone 
Fax 
Mobile 
Work Email 
A64. Details of research sponsor(s) 
A641. Sponsor Lead Sponsor Contact person 
Status: NHS or HSC care organisation 
Academic 
Pharmaceutical industry 
Medical device industry 
Other 
If Other, please specify: 
Commercial status: NonCommercial 
Name of organisation The University of Sheffield 
Given name Kirsty 
Family name Woodhead 
Address Scharr, Regent Court, 30 Regent Street 
Town/city Sheffield 
Post code S1 4DA 
Country UNITED KINGDOM 
 
Is the sponsor based outside the UK? 
Under the Research Governance Framework for Health and Social Care, a sponsor outside the 
UK must appoint a legal representative established in the UK. Please consult the guidance 
notes. 
Yes No 
A65. Has external funding for the research been secured? 
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Funding secured from one or more funders 
External funding application to one or more funders in progress 
No application for external funding will be made 
What type of research project is this? 
Standalone project 
Project that is part of a programme grant 
Project that is part of a Centre grant 
Project that is part of a fellowship/ personal award/ research training award 
Other 
Other – please state: 
A66. Has responsibility for any specific research activities or procedures been delegated to a 
subcontractor (other than a cosponsor listed in A641)? Please give details of subcontractors if 
applicable. 
Yes No 
A67. Has this or a similar application been previously rejected by a Research Ethics 
Committee in the UK or another country? 
Yes No 
Please provide a copy of the unfavourable opinion letter(s). You should explain in your answer 
to question A62 
how the reasons for the unfavourable opinion have been addressed in this application. 
A681. Give details of the lead NHS R&D contact for this research: 
Title Forename/Initials Surname 
Ms Yiwei Harland 
Organisation Sheffield Health and Social Care NHS FT 
Address R&D office 
Fulwood House, Old Fulwood Road 
Sheffield 
Post Code S10 3TH 
Details can be obtained from the NHS R&D Forum website: http://www.rdforum.nhs.uk 
 
A682. Select Local Clinical Research Network for NHS Organisation identified in A681: 
Not Selected For more information, please refer to the question specific guidance. 
A691. How long do you expect the study to last in the UK? 
Planned start date: 01/01/2013 
Planned end date: 29/08/2014 
Total duration: 
Years: 1 Months: 8 Days: 
A711. Is this study? 
Single centre 
Multicentre 
A712. Where will the research take place? (Tick as appropriate) 
Total UK sites in study 1 
Does this trial involve countries outside the EU? 
England 
Scotland 
Wales 
Northern Ireland 
Other countries in European Economic Area 
Yes No 
A72. Which organisations in the UK will host the research? Please indicate the type of 
organisation by ticking the box and give approximate numbers if known: 
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NHS organisations in England 1 
NHS organisations in Wales 
NHS organisations in Scotland 
HSC organisations in Northern Ireland 
GP practices in England 
GP practices in Wales 
GP practices in Scotland 
GP practices in Northern Ireland 
Joint health and social care agencies (eg community mental health teams) 
Local authorities 
Phase 1 trial units 
HSC organisations in Northern Ireland 
GP practices in England 
GP practices in Wales 
GP practices in Scotland 
GP practices in Northern Ireland 
Joint health and social care agencies (eg community mental health teams) 
Local authorities 
Phase 1 trial units 
Prison establishments 
Probation areas 
Independent (private or voluntary sector) organisations 
Educational establishments 
Independent research units 
Other (give details) 
Total UK sites in study: 1 
 
A731. Will potential participants be identified through any organisations other than the 
research sites listed above? 
Yes No 
A74. What arrangements are in place for monitoring and auditing the conduct of the 
research? 
University of Sheffield educational supervisory team and Sheffield Health and Social Care NHS 
FT research governance protocol. 
A751. What arrangements will be made to review interim safety and efficacy data from the 
trial? Will a formal data monitoring committee or equivalent body be convened? 
University of Sheffield educational supervisory team and Sheffield Health and Social Care NHS 
FT research governance protocol. Regular meetings with the supervisory team rather than a 
separate formal body. 
 
If a formal DMC is to be convened, please forward details of the membership and standard 
operating procedures to the Research Ethics Committee when available. The REC should also be 
notified of DMC recommendations and receive summary reports of interim analyses. 
A752. What are the criteria for electively stopping the trial or other research prematurely? 
If information from outside the study suggests EMDR may be harmful to people with 
depression: 
The nature of the information will effect what action is taken. 
If it is urgent information, such as discovering that EMDR is harmful to people with long term 
depression then relevant participants will be contacted by telephone to explain the new 
information in laymen's terms. 
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If the information is non-urgent then a report will be written in laymen's terms and sent to the 
relevant participants along with the researcher's contact details if they wish to discuss the 
issue further. 
If information arises within the study that suggests EMDR may be harmful to people with 
depression: 
No new treatment will be started until the issue has been resolved, if this is not possible no 
new treatment will be started at all. 
Those currently receiving therapy will be contacted immediately by telephone to explain the 
new information in laymen's terms. This contact will be made by a clinical researcher with 
many years experience in working with people with mental health problems. The participant 
will be assisted to decide if they wish to continue. 
In the case of severe risk, the option to continue with EMDR will be removed and the 
participants will be assisted to access other treatment options. 
Any participants who have finished treatment will be contacted to explain the new information 
in laymen's terms. They may be advised to consult their healthcare provider about further 
support or treatment. 
In all cases the participants, rather than the research, will be prioritised. 
In psychological therapy it is not unusual for some people to deteriorate slightly before they 
start to improve. However sustained and/or dramatic deterioration will be cause for concern. 
If 3 (25%) of the participants suffer sustained deterioration that cannot be attributed to 
external factors than the research will be stopped. 
A76. Insurance/ indemnity to meet potential legal  
(HSC) in Northern Ireland 
A761. What arrangements will be made for insurance and/or indemnity to meet the 
potential legal liability of the sponsor(s) for harm to participants arising from the 
management of the research? Please tick box(es) as applicable. 
Note: Where a NHS organisation has agreed to act as sponsor or cosponsor, indemnity is 
provided through NHS schemes. Indicate if this applies (there is no need to provide 
documentary evidence). For all other sponsors, please describe the arrangements and provide 
evidence. 
NHS indemnity scheme will apply (NHS sponsors only) 
Other insurance or indemnity arrangements will apply (give details below) 
Please enclose a copy of relevant documents. 
A762. What arrangements will be made for insurance and/ or indemnity to meet the 
potential legal liability of the sponsor(s) or employer(s) for harm to participants arising from 
the design of the research? Please tick box(es) as applicable. 
Note: Where researchers with substantive NHS employment contracts have designed the 
research, indemnity is provided through NHS schemes. Indicate if this applies (there is no need 
to provide documentary evidence). For other protocol authors (e.g. company employees, 
university members), please describe the arrangements and provide evidence. 
NHS indemnity scheme will apply (protocol authors with NHS contracts only) 
Other insurance or indemnity arrangements will apply (give details below) 
Please enclose a copy of relevant documents. 
 
A763. What arrangements will be made for insurance and/ or indemnity to meet the 
potential legal liability of investigators/collaborators arising from harm to participants in the 
conduct of the research? 
Note: Where the participants are NHS patients, indemnity is provided through the NHS schemes 
or through professional indemnity. Indicate if this applies to the whole study (there is no need 
to provide documentary evidence). Where nonNHS sites are to be included in the research, 
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including private practices, please describe the arrangements which will be made at these sites 
and provide evidence. 
NHS indemnity scheme or professional indemnity will apply (participants recruited at NHS 
sites only) 
Research includes nonNHS sites (give details of insurance/ indemnity arrangements for these 
sites below) 
Please enclose a copy of relevant documents. 
A77. Has the sponsor(s) made arrangements for payment of compensation in the event of 
harm to the research participants where no legal liability arises? 
Yes No 
Please enclose a copy of relevant documents. 
A78. Could the research lead to the development of a new product/process or the 
generation of intellectual property? 
Yes No Not sure 
Please enclose a copy of relevant documents. 
PART C: Overview of research sites 
Please enter details of the host organisations (Local Authority, NHS or other) in the UK that 
will be responsible for the research sites. For NHS sites, the host organisation is the Trust or 
Health Board. Where the research site is a primary care site, e.g. GP practice, please insert the 
host organisation (PCT or Health Board) in the Institution row and insert the research site in the 
departmental row. 
Investigator identifier 
Research site Investigator Name 
IN1 
NHS site 
NonNHS 
site 
Country: England 
Organisation 
name 
SHEFFIELD HEALTH AND SOCIAL CARE 
NHS FOUNDATION TRUST 
Address FULWOOD HOUSE 
OLD FULWOOD ROAD 
SHEFFIELD SOUTH YORKSHIRE 
Post Code S10 3TH 
Forename Emily 
Middle name 
Family name Wood 
Email  
Qualification: MMedSci, RNMH 
Country UNITED KINGDOM 
PART D: Declarations 
D1. Declaration by Chief Investigator 
1. The information in this form is accurate to the best of my knowledge and belief and I take 
full responsibility for it. 
2. I undertake to abide by the ethical principles underlying the Declaration of Helsinki and 
good practice guidelines on the proper conduct of research. 
3. If the research is approved I undertake to adhere to the study protocol, the terms of the full 
application as approved and any conditions set out by review bodies in giving approval. 
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4. I undertake to notify review bodies of substantial amendments to the protocol or the terms 
of the approved application, and to seek a favourable opinion from the main REC before 
implementing the amendment. 
5. I undertake to submit annual progress reports setting out the progress of the research, as 
required by review bodies. 
6. I am aware of my responsibility to be up to date and comply with the requirements of the 
law and relevant guidelines relating to security and confidentiality of patient or other personal 
data, including the need to register when necessary with the appropriate Data Protection 
Officer. I understand that I am not permitted to disclose identifiable data to third parties 
unless the disclosure has the consent of the data subject or, in the case of patient data in 
England and Wales, the disclosure is covered by the terms of an approval under Section 251 of 
the NHS Act 2006. 
7. I understand that research records/data may be subject to inspection by review bodies for 
audit purposes if required. 
8. I understand that any personal data in this application will be held by review bodies and 
their operational managers and that this will be managed according to the principles 
established in the Data Protection Act1998. 
9. I understand that the information contained in this application, any supporting 
documentation and all correspondence with review bodies or their operational managers 
relating to the application:  
10. I understand that information relating to this research, including the contact details on this 
application, may be held on national research information systems, and that this will be 
managed according to the principles established in the Data Protection Act 1998. 
11. I understand that the main REC or its operational managers may share information in this 
application or supporting documentation with the Medicines and Healthcare products 
Regulatory Agency (MHRA) where it is relevant to the Agency’s statutory responsibilities. 
12. Where the research is reviewed by a REC within the UK Health Departments Research 
Ethics Service, I understand that the summary of this study will be published on the website of 
the National Research Ethics Service (NRES), together with the contact point for enquiries 
named below. Publication will take place no earlier than 3 months after issue of the ethics 
committee’s final opinion or the withdrawal of the application. 
l Will be held by the REC (where applicable) until at least 3 years after the end of the study; 
and by NHS R&D offices (where the research requires NHS management permission) in 
accordance with the NHS Code of Practice on Records Management. 
l May be disclosed to the operational managers of review bodies, or the appointing authority 
for the REC (where applicable), in order to check that the application has been processed 
correctly or to investigate any complaint. 
l May be seen by auditors appointed to undertake accreditation of RECs (where applicable). 
l Will be subject to the provisions of the Freedom of Information Acts and may be disclosed in 
response to requests made under the Acts except where statutory exemptions apply. 
l May be sent by email to REC members. 
Contact point for publication (Not applicable for R&D Forms) 
NRES would like to include a contact point with the published summary of the study for those 
wishing to seek further information. We would be grateful if you would indicate one of the 
contact points below. 
Chief Investigator 
Sponsor 
Study coordinator 
Student 
Other – please give details 
None 
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Access to application for training purposes (Not applicable for R&D Forms) 
Optional – please tick as appropriate: 
I would be content for members of other RECs to have access to the information in the 
application in confidence for training purposes. All personal identifiers and references to 
sponsors, funders and research units would be removed. 
Signature: ..................................................... 
Print Name: Emily Wood 
Date: 23/10/2012 (dd/mm/yyyy) 
 
 
D2. Declaration by the sponsor's representative 
If there is more than one sponsor, this declaration should be signed on behalf of the 
co−sponsors by a representative of the lead sponsor named at A641. 
I confirm that: 
1. This research proposal has been discussed with the Chief Investigator and agreement in 
principle to sponsor the research is in place. 
2. An appropriate process of scientific critique has demonstrated that this research proposal is 
worthwhile and of high scientific quality. 
3. Any necessary indemnity or insurance arrangements, as described in question A76, will be in 
place before this research starts. Insurance or indemnity policies will be renewed for the 
duration of the study where necessary. 
4. Arrangements will be in place before the study starts for the research team to access 
resources and support to deliver the research as proposed. 
5. Arrangements to allocate responsibilities for the management, monitoring and reporting of 
the research will be in place before the research starts. 
6. The duties of sponsors set out in the Research Governance Framework for Health and Social 
Care will be undertaken in relation to this research. Please note: The declarations below do not 
form part of the application for approval above. They will not be considered by the Research 
Ethics Committee. 
7. Where the research is reviewed by a REC within the UK Health Departments Research Ethics 
Service, I understand that the summary of this study will be published on the website of the 
National Research Ethics 
Service (NRES), together with the contact point for enquiries named in this application. 
Publication will take place no earlier than 3 months after issue of the ethics committee's final 
opinion or the withdrawal of the application. 
8. Specifically, for submissions to the Research Ethics Committees (RECs) I declare that any and 
all clinical trials approved by the HRA since 30th September 2013 (as defined on IRAS 
categories as clinical trials of medicines, devices, combination of medicines and devices or 
other clinical trials) have been registered on a publically accessible register in compliance with 
the HRA registration requirements for the UK, or that any deferral granted by the HRA still 
applies. 
Signature: ..................................................... 
Print Name: John Brazier  
Post: Director of Research 
Organisation: The University of Sheffield 
Date: 23/10/2012 (dd/mm/yyyy) 
 
 
D3. Declaration for student projects by academic supervisor(s) 
1. I have read and approved both the research proposal and this application. I am satisfied that 
the scientific content of the research is satisfactory for an educational qualification at this level. 
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2. I undertake to fulfil the responsibilities of the supervisor for this study as set out in the 
Research GovernanceFramework for Health and Social Care. 
3. I take responsibility for ensuring that this study is conducted in accordance with the ethical 
principles underlying the Declaration of Helsinki and good practice guidelines on the proper 
conduct of research, in conjunction with clinical supervisors as appropriate. 
4. I take responsibility for ensuring that the applicant is up to date and complies with the 
requirements of the law and relevant guidelines relating to security and confidentiality of 
patient and other personal data, in conjunction with clinical supervisors as appropriate. 
Academic supervisor 1 
Signature: ..................................................................................................................... 
Print Name: Glenys Parry 
Post: Professor of Applied Psychological Therapies 
Organisation: The University of Sheffield 
Date: 23/10/2012 (dd/mm/yyyy) 
Academic supervisor 2 
Signature: ..................................................................................................................... 
Print Name: Tom Ricketts 
Post: Honorary Research Fellow 
Organisation: The University of Sheffield 
Date: 23/10/2012 (dd/mm/yyyy) 
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NHS R&D permission letter 
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Tables from chapter 4 
 
Table 4.3: Correlations between the different repeated measures for each participant 
  interest energy 
001 low mood Person correlation .873** .614** 
 Sig (2 tailed) .000 .000 
 N 137 137 
003 low mood Person correlation .811** .648** 
 Sig (2 tailed) .000 .000 
 N 107 107 
004 low mood Person correlation .968** .938** 
 Sig (2 tailed) .000 .000 
 N 100 100 
005 low mood Person correlation .943** .742** 
 Sig (2 tailed) .000 .000 
 N 109 109 
006 low mood Person correlation .934** .986** 
 Sig (2 tailed) .000 .000 
 N 45 45 
007 low mood Person correlation .922** .917** 
 Sig (2 tailed) .000 .000 
 N 75 75 
008 low mood Person correlation .953** .918** 
 Sig (2 tailed) .000 .000 
 N 69 69 
011 low mood Person correlation .773** .723** 
 Sig (2 tailed) .000 .000 
 N 118 118 
012 low mood Person correlation .702** .718** 
 Sig (2 tailed) .000 .000 
 N 111 111 
** Correlation is significant at the 0.01 level (2 tailed)  
 
Table 4.4: Means for the repeated measures 
 low mood interest energy 
001 42.83 42.19 55.34* 
003 34.74 33.02 39.74* 
004 45.88^ 47.81^ 50.87* 
005 63.50^ 65.02^ 73.82* 
006 56.38 53.78 57.78* 
007 63.55 63.16 62.56* 
008 67.99^ 58.59^ 53.99* 
011 64.51^ 58.06^ 55.92* 
012 32.39 32.25 39.97* 
⃰Paired t test shows energy is significantly different from at least one other at the 5% level 
^Paired t test shows low mood and interest are significantly different from one another at the 
5% level 
 
255 
 
 
 Rank final 
HRSD 
Rank final 
SASS 
Rank final 
GAF 
Rank final 
IES 
Rank 
final BDI 
Rank 
final 
PHQ 
Spearm
an's rho 
Rank 
final 
Correlation Coefficient 1.000      
Sig. (2-tailed) .      
Table 4.18: Correlations of the ranked pre-therapy outcome measures 
 
rank 
HRSD 
score 
rank 
BDI 
score 
rank 
GAF 
score 
rank 
PHQ-9 
score 
rank 
SASS 
score 
rank 
IES-r 
score 
Spearman's 
rho 
rank HRSD 
score 
Correlation Coefficient 1.000      
Sig. (2-tailed) .      
N 11      
rank BDI 
score 
Correlation Coefficient .782** 1.000     
Sig. (2-tailed) .004 .     
N 11 11     
rank GAF 
score 
Correlation Coefficient .418 .418 1.000    
Sig. (2-tailed) .201 .201 .    
N 11 11 11    
rank PHQ-9 
score 
Correlation Coefficient .827** .945** .391 1.000   
Sig. (2-tailed) .002 .000 .235 .   
N 11 11 11 11   
rank SASS 
score 
Correlation Coefficient .718* .464 .373 .655* 1.000  
Sig. (2-tailed) .013 .151 .259 .029 .  
N 11 11 11 11 11  
rank IES-r 
score 
Correlation Coefficient .779** .861** .497 .875** .528 1.000 
Sig. (2-tailed) .005 .001 .120 .000 .095 . 
N 11 11 11 11 11 11 
**. Correlation is significant at the 0.01 level (2-tailed).  *. Correlation is significant at the 0.05 level 
(2-tailed). 
 
Table 4.19: The rank orders of severity of symptoms on the post therapy measures 
 best symptoms       worst 
HRSD 11 1 5 3 7 12 4 10 6 
BDI-ii 11 3 3 5 1 6 12 10 4 
GAF 5 11 1 3 12 4 7 10 6 
PHQ-9 3 5 12 7 11 1 4 10 6 
SASS 12 10 3 11 1 7 4 5 6 
IES-r 11 1 3 5 4 12 7 10 6 
 
 
 
 
 
 
 
 
Table 4.20: Correlations of the ranked post-therapy outcome measures 
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HRSD N 9      
Rank 
final 
SASS 
Correlation Coefficient .117 1.000     
Sig. (2-tailed) .765 .     
N 9 9     
Rank 
final 
GAF 
Correlation Coefficient .900
**
 .067 1.000    
Sig. (2-tailed) .001 .865 .    
N 9 9 9    
Rank 
final IES 
Correlation Coefficient .917
**
 .167 .883
**
 1.000   
Sig. (2-tailed) .001 .668 .002 .   
N 9 9 9 9   
Rank 
final BDI 
Correlation Coefficient .533 -.150 .433 .467 1.000  
Sig. (2-tailed) .139 .700 .244 .205 .  
N 9 9 9 9 9  
Rank 
final 
PHQ 
Correlation Coefficient .567 .283 .650 .483 .317 1.000 
Sig. (2-tailed) .112 .460 .058 .187 .406 . 
N 9 9 9 9 9 9 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
  
Table 4.21: Correlations of the changes among the different standardised measures 
 Change  
in HRSD 
score 
Change 
in SASS 
score 
Change 
in GAF 
score 
Change 
in IES-r 
score 
Change 
in BDI-ii 
score 
Change 
in PHQ-
9 score 
Spearm
an's rho 
Change  in 
HRSD 
score 
Correlation Coefficient 1.000      
Sig. (2-tailed) .      
N 9      
Change in 
SASS 
score 
Correlation Coefficient .356 1.000     
Sig. (2-tailed) .347 .     
N 9 9     
Change in 
GAF score 
Correlation Coefficient .186 .113 1.000    
Sig. (2-tailed) .631 .771 .    
N 9 9 9    
Change in 
IES-r 
score 
Correlation Coefficient .515 .059 .485 1.000   
Sig. (2-tailed) .156 .881 .185 .   
N 9 9 9 9   
Change in 
BDI-ii 
score 
Correlation Coefficient .136 -.177 .726
*
 .538 1.000  
Sig. (2-tailed) .727 .648 .027 .135 .  
N 9 9 9 9 9  
Change in 
PHQ-9 
score 
Correlation Coefficient .638 .076 .481 .941
**
 .487 1.000 
Sig. (2-tailed) .064 .846 .190 .000 .183 . 
N 9 9 9 9 9 9 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Outcome measures  
(HRSD, BDI-ii, PHQ-9, GAF, SASS, IES-r, HAT, Likert scales for psychological impact and repeated 
measure)
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BDI-ii 
 
 
262 
 
 
 
 
263 
 
PHQ-9 
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GAF 
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Social Adaptation Self Evaluation Scale (SASS) 
You are asked to answer some simple questions, stating what you opinion is at this moment. 
Please answer all questions and circle ONE answer for each question.  
1 Do you have an occupation                 Yes             No 
If yes- How interested are in you occupation? 
3 – very                           2 – moderately                           1 – a little                    0 – not at all 
If no – How interested are you in your home activities? 
3 – very                           2 – moderately                           1 – a little                    0 – not at all 
2 Do you pursue this occupation/these activities with: 
3- a lot of enjoyment     2 – some enjoyment      1- only a little enjoyment      0 – no enjoyment 
at all? 
3 Are you interested in hobbies/leisure? 
3 – very                           2 – moderately                           1 – a little                    0 – not at all 
4 Is the quality of your spare time 
3- very good                          2 – good                                1 – fair                         0 – unsatisfactory? 
5 How frequently do you seek contacts with you family members (e.g. spouse, children, 
parents)? 
3 – very frequently              2 – frequently                       1 – rarely                    0 – never  
6 Is the state of relations in your family: 
3- very good                          2 – good                                1 – fair                         0 – unsatisfactory? 
7 Outside your family, do you have relationships with: 
3 – many people                  2 – some people                  1 – only a few people             0 – nobody? 
8 Do you try to form relationships with others? 
3 – very actively                   2 – actively                       1 – moderately actively        0 – in no active 
way 
9 How – in general – do you rate you relationships with other people? 
3- very good                          2 – good                                1 – fair                          0 – unsatisfactory? 
10 What value do you attach to you relationship with others? 
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3 – great value                     2 – some value                     1 – only a little value              0 – no value 
at all 
 
11 How often do people in your social circle seek contact with you? 
3 – very often                      2 – often                                1 – rarely                        0 – never 
12 Do you observe the social rules, good manners, politeness etc? 
3 – always                            2 – most of the time            1- rarely                          0 – never 
13 To what extent are you involved in community life (e.g. clubs, church etc)? 
3 – fully                                 2 – moderately                     1 – slightly                      0 – not at all 
14 Do you like searching for information about things, situations and people to improve your 
understanding of them? 
3 – very much                     2 – moderately                      1 – not much                 0 – not at all  
15 Are you interested in scientific, technical or cultural information? 
3 – very                                2- moderately                        1 – only slightly             0 – not at all 
16 How often do you find it difficult to express your opinions to people? 
0 – always                           1 – often                                  2 – sometimes               3 – never 
17 How often do you feel rejected, excluded from you circle? 
0 – always                           1 – often                                  2 – sometimes               3 – never 
18 How important do you consider your physical appearance? 
3 – very                               2 – moderately                       1 – not very much          0 – not at all 
19 To what extent do you have difficulties managing your resources and income? 
0 – always                           1 – often                                  2 – sometimes               3 – never 
20 Do you feel able to organise your environment according to your wishes and needs? 
3 – very much so               2 – moderately                        1 – not very                   0 – not at all 
 
Thank you 
 
 
267 
 
 
IES-r 
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HAT 
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Participant number 
Insight number 
Date 
Pre / Post / Follow up 
 
Likert scales for impact of memory 
When you are thinking about the unpleasant memory please rate how intense the impact of it is. Please mark on the line to show the memories impact in 
terms of emotional response (does it make you have strong feelings?), vividness (how bright or detailed it is), completeness (is it a logical story or are bits 
missing?) and how distant it feels on a scale of 0-10 where 0= no impact and 10=extreme impact. 
  0 1 2 3 4 5 6 7 8 9 10  
Emotionality No 
emotion 
           Extremely 
emotional 
Vividness Not at all 
clear 
           Extremely 
vivid 
Completeness Not at all 
complete 
           Extremely 
complete 
Distance Very 
distant 
           Extremely 
close 
 
 
Thank you 
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Daily measure 
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The EMDR Standard Protocol 
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Therapy Process Record       
        Participant ID  
SEDI - Therapy Process Record  
 
Client INSIGHT number …………………………….     
   
Actual session number..............                                    Date………………………....... 
 
Suggested session to 
include intervention 
action 
Intervention action Tick when you 
have done an 
action 
 
1 
Check client has completed baseline 
phase daily measures 
 
Offer client EMDR information sheet  
Phase 1 History taking 
 
 
Give out new daily measures sheet, 
PHQ- 9 and HAT 
 
 
2 
Phase 2 Preparation/stabilisation  
Phase 3 Assessment of target memories   
Give out new daily measures sheet, 
PHQ- 9 and HAT 
 
Refer client back to researcher for 
memory testing 
 
 
3 to 20 inclusive 
Phase 4 Desensitisation  
Phase 5 Installation  
Phase 6 Body Scan  
Phase 7 Closure  
Phase 8 Re-evaluation  
 
 
Give out new daily measures sheet, 
PHQ- 9 and HAT at end of every session 
 
 
20/end of therapy 
Review therapy  
 
 
Let researcher know therapy has ended  
 
